Home Bistro (HBIS) 10-Q18 May 232023 Q1 Quarterly reportFinancial data

Company Profile

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
Document And Entity Information - shares	Jan. 31, 2023	May 16, 2023
Document Information Line Items
Entity Registrant Name	Home Bistro, Inc
Document Type	10-Q
Current Fiscal Year End Date	--10-31
Entity Common Stock, Shares Outstanding		896,166
Amendment Flag	false
Entity Central Index Key	0001489588
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Jan. 31, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-56222
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	27-1517938
Entity Address, Address Line One	4014 Chase Avenue
Entity Address, Address Line Two	#212
Entity Address, City or Town	Miami Beach
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33140
City Area Code	(631)
Local Phone Number	964-1111
Entity Interactive Data Current	Yes

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Jul. 31, 2022	Oct. 31, 2021
CURRENT ASSETS:
Cash	$ 71,613	$ 2,275,397
Inventory	47,134	16,020
Prepaid expenses and other current assets	108,982	80,641
Total Current Assets	227,729	2,372,058
OTHER ASSETS:
Property and equipment, net	101,527	130,970
Finance lease right-of-use assets, net	130,888	181,015
Operating lease right-of-use assets, net	182,878	268,509
Intangible assets, net	2,550,479	3,225,361
Deposits	10,000	10,000
Goodwill	1,809,357	1,809,357
Total Assets	5,012,858	7,997,270
CURRENT LIABILITIES:
Accounts payable	873,093	568,302
Accrued expenses and other liabilities	169,985	181,037
Liabilities to be settled with common stock		209,688
Convertible notes payable, net of debt discount and put premium	713,916	550,638
Convertible notes payable - related party, net of debt discount		30,172
Notes payable - current portion	17,198	15,361
Advances payable	243,564	101,945
Derivative liabilities	153,206	86,884
Unredeemed gift cards	234,632	164,912
Financing lease liability - current portion	66,926	62,210
Operating lease liabilities - current portion	86,699	101,431
Common stock repurchase obligations	605,203	618,275
Total Current Liabilities	3,164,422	2,690,855
LONG-TERM LIABILITIES:
Financing lease liability - long-term portion	73,935	124,649
Operating lease liability- long-term portion	101,095	166,923
Notes payable - long-term portion	289,702	291,539
Total Long-Term Liabilities	464,732	583,111
Total Liabilities	3,629,154	3,273,966
Commitments and contingency (Note 12)
STOCKHOLDERS’ EQUITY:
Preferred Stock: $0.001 par value; 20,000,000 shares authorized;
Common stock: $0.001 par value; 1,000,000,000 shares authorized; 42,740,581 and 35,152,623 shares issued and outstanding as of July 31, 2022 and October 31, 2021, respectively	42,741	35,152
Additional paid-in capital	31,530,170	25,198,035
Deferred compensation	(237,603)	(1,374,219)
Accumulated deficit	(29,951,604)	(19,135,664)
Total Stockholders’ Equity	1,383,704	4,723,304
Total Liabilities and Stockholders’ Equity	$ 5,012,858	$ 7,997,270

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - $ / shares	Jul. 31, 2022	Oct. 31, 2021
Statement of Financial Position [Abstract]
Preferred stock par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	20,000,000	20,000,000
Common stock par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	42,740,581	35,152,623
Common stock, shares outstanding	42,740,581	35,152,623

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
Consolidated Statements of Operations (Unaudited) - USD ($)	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Income Statement [Abstract]
Product Sales, net	$ 619,187	$ 408,821	$ 2,164,248	$ 1,135,872
Cost of Sales	707,346	371,118	2,069,942	951,440
Gross Profit	(88,159)	37,703	94,306	184,432
Operating Expenses:
Compensation and related expenses (includes $374,560 and $24,750 of stock-based compensation for the nine months ended July 31, 2022 and 2021, respectively)	273,348	111,406	1,265,025	277,228
Professional and consulting expenses (includes $2,243,589 and $600,000 of stock-based professional fees for the nine months ended July 31, 2022 and 2021, respectively)	371,451	756,886	3,439,253	1,279,609
Professional and consulting expenses - related party (includes $27,500 of stock-based professional fees for the nine months ended July 31, 2022)	57,500		117,500
Product development expense (includes $370,677 and $0 of stock-based compensation for the nine months ended July 31, 2022 and 2021, respectively)	99,063		370,677
Selling and marketing expenses	368,344	96,732	956,413	307,980
General and administrative expenses	394,032	108,779	1,229,076	262,523
Settlement expense	365,140		365,140
Total Operating Expenses	1,928,878	1,073,803	7,743,084	2,127,340
Loss from Operations	(2,017,037)	(1,036,100)	(7,648,778)	(1,942,908)
Other Income (Expense):
Interest expense, net	(259,085)	(437,186)	(644,571)	(908,528)
Change in fair value of derivative liabilities	(11,553)	81,107	55,855	263,428
Gain on extinguishment of debt		7,075		33,704
Gain on extinguishment of accounts payable		7,679		14,754
Total Other Expense, net	(270,638)	(341,325)	(588,716)	(596,642)
Net Loss	(2,287,675)	(1,377,425)	(8,237,494)	(2,539,550)
Deemed Dividend	(2,578,446)		(2,578,446)
Net Loss Attributable to Common Shareholders	$ (4,866,121)	$ (1,377,425)	$ (10,815,940)	$ (2,539,550)
NET LOSS PER COMMON SHARE:
Basic and diluted (in Dollars per share)	$ (0.12)	$ (0.06)	$ (0.28)	$ (0.12)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic and diluted (in Shares)	41,891,630	22,619,862	38,951,375	20,577,274

Consolidated Statements of Op_2

Consolidated Statements of Operations (Unaudited) (Parentheticals) - USD ($)	3 Months Ended		9 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Income Statement [Abstract]
Compensation and related expenses, includes of stock-based compensation			$ 374,560	$ 24,750
Professional and consulting expenses, includes of stock-based professional fees			2,243,589	600,000
Professional and consulting expenses - related party			27,500
Product development expense, includes of stock-based compensation			$ 370,677	$ 0
Basic and diluted (in Dollars per share)	$ (0.12)	$ (0.06)	$ (0.28)	$ (0.12)
Basic and diluted (in Shares)	41,891,630	22,619,862	38,951,375	20,577,274

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited) - USD ($)	Preferred Stock	Common Stock	Additional Paid-in Capital	Deferred Compensation	Accumulated Deficit	Total
Balance at Oct. 31, 2020		$ 19,004	$ 4,349,657		$ (6,238,085)	$ (1,869,424)
Balance (in Shares) at Oct. 31, 2020		19,004,232
Common stock issued for commitment fee included in interest expense		$ 149	61,584			61,733
Common stock issued for commitment fee included in interest expense (in Shares)		148,920
Common stock warrant issued for professional services			11,471			11,471
Net loss					(142,936)	(142,936)
Balance at Jan. 31, 2021		$ 19,153	4,422,712		(6,381,021)	(1,939,156)
Balance (in Shares) at Jan. 31, 2021		19,153,152
Balance at Oct. 31, 2020		$ 19,004	4,349,657		(6,238,085)	(1,869,424)
Balance (in Shares) at Oct. 31, 2020		19,004,232
Net loss						(2,539,550)
Balance at Jul. 31, 2021		$ 25,052	9,816,472	(1,200,000)	(8,777,635)	(136,111)
Balance (in Shares) at Jul. 31, 2021		25,053,067
Balance at Jan. 31, 2021		$ 19,153	4,422,712		(6,381,021)	(1,939,156)
Balance (in Shares) at Jan. 31, 2021		19,153,152
Common stock issued for services and prepaid services		$ 2,000	1,798,000	(1,650,000)		150,000
Common stock issued for services and prepaid services (in Shares)		2,000,000
Reduction of the repurchase obligation pursuant to the Put Option Agreement			145,634			145,634
Net loss					(1,019,189)	(1,019,189)
Balance at Apr. 30, 2021		$ 21,628	6,690,897	(1,650,000)	(7,400,210)	(2,337,685)
Balance (in Shares) at Apr. 30, 2021		21,628,152
Common stock warrant issued for stock based compensation		$ 25	24,725			24,750
Common stock warrant issued for stock based compensation (in Shares)		25,000
Common stock and common stock warrants issued as commitment fee		$ 450	299,826			300,276
Common stock and common stock warrants issued as commitment fee (in Shares)		450,000
Common stock issued for cash		$ 1,206	865,564			866,770
Common stock issued for cash (in Shares)		1,206,605
Reduction of the repurchase obligation pursuant to the Put Option Agreement			99,272			99,272
Net loss					(1,377,425)	(1,377,425)
Balance at Jul. 31, 2021		$ 25,052	9,816,472	(1,200,000)	(8,777,635)	(136,111)
Balance (in Shares) at Jul. 31, 2021		25,053,067
Common stock and common stock warrants issued as commitment fee		$ 210	134,354			134,564
Common stock and common stock warrants issued as commitment fee (in Shares)		210,000
Common stock issued for acquisition of subsidiary (see Note 3)		$ 2,008	2,026,385			2,028,393
Common stock issued for acquisition of subsidiary (see Note 3) (in Shares)		2,008,310
Accretion of stock-based compensation				450,000		450,000
Balance at Oct. 31, 2021		$ 35,152	25,198,035	(1,374,219)	(19,135,664)	4,723,304
Balance (in Shares) at Oct. 31, 2021		35,152,623
Common stock issued for cash		$ 1,378	989,790			991,168
Common stock issued for cash (in Shares)		1,378,399
Common stock issued for services and prepaid services		$ 660	785,940	87,000		873,600
Common stock issued for services and prepaid services (in Shares)		660,000
Common stock warrant issued for professional services			36,777			36,777
Reduction of the repurchase obligation pursuant to the Put Option Agreement			93,498			93,498
Common stock issued for product development agreements		$ 100	99,900	46,614		146,614
Common stock issued for product development agreements (in Shares)		100,000
Common stock issued pursuant to lock-up agreements		$ 273	276,623	2,041		278,937
Common stock issued pursuant to lock-up agreements (in Shares)		272,541
Net loss					(2,896,336)	(2,896,336)
Balance at Jan. 31, 2022		$ 37,563	27,480,563	(1,238,564)	(22,032,000)	4,247,562
Balance (in Shares) at Jan. 31, 2022		37,563,563
Balance at Oct. 31, 2021		$ 35,152	25,198,035	(1,374,219)	(19,135,664)	4,723,304
Balance (in Shares) at Oct. 31, 2021		35,152,623
Net loss						(8,237,494)
Balance at Jul. 31, 2022		$ 42,741	31,530,170	(237,603)	(29,951,604)	1,383,704
Balance (in Shares) at Jul. 31, 2022		42,740,581
Balance at Jan. 31, 2022		$ 37,563	27,480,563	(1,238,564)	(22,032,000)	4,247,562
Balance (in Shares) at Jan. 31, 2022		37,563,563
Common stock issued for cash		$ 450	312,110			312,560
Common stock issued for cash (in Shares)		449,303
Accretion of stock-based professional fees				663,000		663,000
Common stock issued for commitment fee included in interest expense		$ 45	29,834			29,879
Common stock issued for commitment fee included in interest expense (in Shares)		45,989
Reduction of the repurchase obligation pursuant to the Put Option Agreement			19,574			19,574
Accretion related to common stock issued for product development agreements				125,000		125,000
Common stock issued pursuant to lock-up agreements		$ 245	277,132	113,898		391,275
Common stock issued pursuant to lock-up agreements (in Shares)		244,207
Net loss					(3,053,483)	(3,053,483)
Balance at Apr. 30, 2022		$ 38,303	28,493,773	(336,666)	(25,085,483)	3,109,927
Balance (in Shares) at Apr. 30, 2022		38,303,062
Common stock warrant issued for stock based compensation			374,560			374,560
Common stock issued for cash		$ 105	64,659			64,764
Common stock issued for cash (in Shares)		104,502
Accretion related to common stock issued for product development agreements				99,063		99,063
Common stock issued pursuant to lock-up agreements		$ 25	27,475			27,500
Common stock issued pursuant to lock-up agreements (in Shares)		25,000
Common stock issued for cashless exercise and settlement of warrants		$ 3,723	2,770,213		(2,578,446)	195,490
Common stock issued for cashless exercise and settlement of warrants (in Shares)		3,723,017
Common stock issued pursuant to settlement agreements		$ 585	169,065			169,650
Common stock issued pursuant to settlement agreements (in Shares)		585,000
Repurchase obligation pursuant to stock repurchase agreement			(150,000)			(150,000)
Relative fair value of warrants issued with convertible debt			154,985			154,985
Net loss					(2,287,675)	(2,287,675)
Balance at Jul. 31, 2022		$ 42,741	$ 31,530,170	$ (237,603)	$ (29,951,604)	$ 1,383,704
Balance (in Shares) at Jul. 31, 2022		42,740,581

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
Consolidated Statements of Cash Flows (Unaudited) - USD ($)	Jul. 31, 2022	Jul. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (8,237,494)	$ (2,539,550)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	176,951	10,390
Amortization of intangible assets	674,882
Common stock and warrants issued for stock-based compensation	374,560	24,750
Common stock and warrants issued for professional services – related party	27,500	11,471
Common stock and warrants issued for services and prepaid services	1,573,377	600,000
Common stock issued for commitment fee in interest expense	29,879
Interest expense related to put premium on stock-settled debt	83,058
Common stock and warrants issued for product development	370,677
Common stock issued pursuant to lock-up agreements	670,212
Gain on extinguishment of accounts payable		(7,075)
Gain on extinguishment of debt		(41,241)
Common stock issued for settlement expense	365,140
Amortization of debt discount on convertible notes payable and advances payable	426,495	817,922
Change in fair value of derivative liabilities	(55,855)	(289,351)
Change in operating assets and liabilities:
Inventory	(31,114)	(1,566)
Prepaid expenses and other current assets	(28,341)	(50,406)
Accounts payable	280,791	28,955
Accrued expense and other liabilities	(113,610)	(73,998)
Unredeemed gift cards	69,720	19,836
Net cash used in operating activities	(3,343,172)	(1,489,863)
CASH FLOWS FROM INVESTING ACTIVITIES:
Payment for acquisition of subsidiary		(60,000)
Purchases of property and equipment	(11,750)	(127,075)
Net cash used by investing activities	(11,750)	(187,075)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from sale of common stock, net of issuance costs	1,368,492	866,770
Proceeds from note payable		7,000
Proceeds from convertible notes payable, net of debt discount		1,647,300
Proceeds from convertible note payable - related party, net of debt discount	790,500	100,000
Proceeds from advances payable	322,502	274,040
Payment on stock repurchase agreement	(50,000)
Repayment of convertible notes payable	(998,054)	(652,667)
Repayments of advance payable	(219,233)	(186,654)
Repayment of convertible notes payable - related party	(63,069)
Net cash provided by financing activities	1,151,138	2,055,789
Net change in cash	(2,203,784)	378,851
Cash - beginning of period	2,275,397	57,082
Cash - end of period	71,613	435,933
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest	61,780	55,198
Income taxes
Non-cash investing and financing activities:
Initial amount of ROU asset and related liability		460,987
Reduction of the repurchase obligation pursuant to the Put Option Agreement	113,072	244,906
Common stock and common stock warrants issued as commitment fee in connection with convertible notes payable, recorded as debt discount		494,165
Liabilities to be settled with common stock in connection with convertible notes payable
Fair value of true-up shares in connection with the commitment fee		244,213
Initial derivative liability recorded in connection with convertible notes payable	122,177	419,838
Increase in debt discount for relative fair value of warrants	154,985
Increase in stock repurchase obligation and reduction of additional paid-in capital pursuant to settlement agreement	150,000
Net Assets and Liabilities Assumed in Acquisition:
Prepaid expenses and other assets		241
Inventory		20,763
Operating right-of-use asset		76,136
Computer software		66,198
Customer relationships		43,000
Trademark		505,000
Goodwill		1,749,357
Accounts payable and accrued liabilities		(203,348)
Operating right-of-use liability		(79,054)
Note Payable		(149,900)
Net assets acquired (liabilities assumed)		$ 2,028,393

Organization and Nature of Oper

Organization and Nature of Operations	9 Months Ended
Organization and Nature of Operations	Jul. 31, 2022
Accounting Policies [Abstract]
ORGANIZATION AND NATURE OF OPERATIONS	NOTE 1 – ORGANIZATION AND NATURE OF OPERATIONS Home Bistro, Inc. (formerly known as Gratitude Health, Inc.) (the “Company”) was incorporated in the State of Nevada on December 17, 2009. Effective March 23, 2018, the Company changed its name from Vapir Enterprises Inc. to Gratitude Health, Inc. On September 14, 2020, the Company changed its name from Gratitude Health, Inc. to Home Bistro, Inc. The Company is in the business of providing prepackaged and prepared meals to consumers focused on offering a broad array of the highest quality meal delivery, and preparation services. The ongoing COVID-19 global and national health emergency has caused significant disruption in the international and United States economies and financial markets. In March 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. The spread of COVID-19 has caused illness, quarantines, cancellation of events and travel, business and school shutdowns, reduction in business activity and financial transactions, labor shortages, supply chain interruptions and overall economic and financial market instability. The COVID-19 pandemic has the potential to significantly impact the Company’s supply chain, food manufacturers, distribution centers, or logistics and other service providers. Additionally, the Company’s service providers and their operations may be disrupted, temporarily closed or experience worker or meat or other food shortages, which could result in additional disruptions or delays in shipments of Home Bistro’s products. To date, the Company has been able to avoid layoffs and furloughs of employees. The Company is not able to estimate the duration of the pandemic and potential impact on the business if disruptions or delays in shipments of product occur. To date, the Company is not aware of any such disruptions. In addition, a severe prolonged economic downturn could result in a variety of risks to the business, including weakened demand for product and a decreased ability to raise additional capital when needed on acceptable terms, if at all. As the situation continues to evolve, the Company will continue to closely monitor market conditions and respond accordingly. The Company has applied for and received certain financial assistance under the Coronavirus, Aid, Relief, and Economic Security Act (“CARES Act”) enacted in March 2020 by the U.S. Government in response to COVID-19 (see Note 6). On July 6, 2021, the Company entered and closed on an Agreement and Plan of Merger with the members of Model Meals, LLC (“Model Meals”), acquiring Model Meals through a reverse triangular merger, whereby Model Meals merged with Model Meals Acquisition Corp., a wholly owned subsidiary of the Company, with Model Meals being the surviving entity (the “Acquisition”). As a result, Model Meals became a wholly owned subsidiary of the Company, and the members of Model Meals received and aggregate of 2,008,310 shares of common stock with grant date fair value of $ 2,028,393 (see Note 3) and were paid $60,000 in cash. In January 2022, the Company’s board of directors and management changed the Company’s fiscal year end from December 31 st st

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
Summary of Significant Accounting Policies	Jul. 31, 2022
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission (“SEC”) for interim financial information, which present the unaudited consolidated financial statements of the Company and its active wholly owned subsidiaries, Home Bistro Holdings, Inc. and Model Meals LLC (acquired on July 6, 2021) for the period ending July 31, 2022. All intercompany transactions and balances have been eliminated. It is management’s opinion that all material adjustments (consisting of normal recurring adjustments) have been made, which are necessary for a fair financial statement presentation. The results for the interim period are not necessarily indicative of the results to be expected for the fiscal year ending October 31, 2022. Certain information and disclosures normally included in the notes to the annual consolidated financial statements have been condensed or omitted from these interim consolidated financial statements. Accordingly, these interim consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Transition Report, due to our change in fiscal year end, on Form 10-KT filed with the SEC on January 31, 2022. Going Concern The consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying unaudited consolidated financial statements, for the nine months ended July 31, 2022, the Company had a net loss and cash used in operations of $8,237,494 and $3,343,172, respectively. On July 31, 2022, the Company had an accumulated deficit, stockholders’ equity, and working capital deficit of $(29,951,604), $1,383,704 and $(2,936,693), respectively. These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the issuance date of this report. The Company’s primary source of operating funds has primarily from the sale of common stock and the issuance of convertible debt notes. The Company has experienced net losses from operations since inception but expects these conditions to improve in the near term and beyond as it develops its business model. Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash flow positive or raise additional debt and/or equity capital. Management believes that the Company’s capital resources are not currently adequate to continue operating and maintaining its business strategy for a period of twelve months from the issuance date of this report. If the Company is unable to raise additional capital or secure additional lending in the near future, management expects that the Company will need to curtail or cease operations. These consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. Use of Estimates The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates as of July 31, 2022 and October 31, 2021 include the assumptions used in the redemption recognition method for unredeemed gift cards, useful life of property and equipment and intangible assets, valuation of right-of-use (“ROU”) assets and lease liabilities, estimates of current and deferred income taxes and deferred tax valuation allowances, fair value of assets acquired and liabilities assumed in a business combination, and the fair value of non-cash equity transactions and derivative liabilities. Cash For purposes of the statements of cash flows, the Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and money market accounts to be cash equivalents. On July 31, 2022 and October 31, 2021, the Company did not have any cash equivalents. The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits. As of July 31, 2022 and October 31, 2021, the bank balance was in excess of FDIC insured levels by approximately $0 and $2,025,000, respectively. The Company has not experienced any losses in such accounts through July 31, 2022. Fair Value of Financial Instruments and Fair Value Measurements FASB ASC 820 - Fair Value Measurements and Disclosures, defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. FASB ASC 820 requires disclosures about the fair value of all financial instruments, whether or not recognized, for financial statement purposes. Disclosures about the fair value of financial instruments are based on pertinent information available to the Company on July 31, 2022. Accordingly, the estimates presented in these financial statements are not necessarily indicative of the amounts that could be realized on disposition of the financial instruments. FASB ASC 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The three levels of the fair value hierarchy are as follows: Level 1—Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date. Level 2—Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data. Level 3—Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information. The carrying amounts reported in the consolidated balance sheets for cash, due from and to related parties, prepaid expenses, accounts payable and accrued liabilities approximate their fair market value based on the short-term maturity of these instruments. Assets or liabilities measured at fair value on a recurring basis include embedded conversion options in convertible debt (see Note 4) and were as follows on July 31, 2022 and October 31, 2021: July 31, 2022 October 31, 2021 Description Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Derivative liabilities $ — $ — $ 153,206 $ — $ — $ 86,884 A roll forward of the level 3 valuation financial instruments is as follows: Nine Months Ended (Unaudited) Balance on October 31, 2021 $ 86,884 Increase in derivative liabilities included in debt discount 122,177 Change in fair value of derivative liabilities (55,855 ) Balance on July 31, 2022 $ 153,206 ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding equity instruments. Derivative Liabilities The Company has certain financial instruments that are embedded derivatives associated with capital raises. The Company evaluates all its financial instruments to determine if those contracts or any potential embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 815-10 – Derivative and Hedging – Contract in Entity’s Own Equity Goodwill and Indefinite Lived Intangible Assets Goodwill represents the excess of purchase prices over the fair value of nets assets acquired, is carried at cost. Goodwill is not amortized; rather, it is subject to a periodic assessment for impairment by applying a fair value-based test. Goodwill is evaluated for impairment on an annual basis at a level of reporting referred to as the reporting unit, and more frequently if adverse events or changes in circumstances indicate that the asset may be impaired. Goodwill and indefinite lived intangible assets are tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not (that is, a likelihood of more than 50%) that the fair value of the reporting unit is less than its carrying amount. The qualitative assessment considers macroeconomic conditions, industry and market considerations, cost factors and overall company financial performance. If the reporting unit does not pass the qualitative assessment, the carrying amount of the reporting unit, including goodwill, is compared to its fair value. When the carrying amount of the reporting unit exceeds its fair value, a goodwill impairment loss is recognized up to a maximum amount of the recorded goodwill related to the reporting unit. Goodwill impairment losses are not reversed. There was no impairment loss of goodwill or indefinite lived intangible assets for the nine months ended July 31, 2022. Impairment of Long-Lived Assets In accordance with ASC Topic 360, the Company reviews long-lived assets including intangible assets with finite life, for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value. Inventory Inventory consists of non-perishable food items distributed by the Company and are stated at the lower of cost and net realizable value utilizing the first-in first-out (FIFO) method. A reserve is established when management determines that certain inventories may not be saleable. If inventory costs exceed expected net realizable value due to obsolescence or quantities in excess of expected demand, the Company will record reserves for the difference between the cost and the net realizable value. These reserves are based on estimates and included in cost of sales. As of July 31, 2022 and October 31, 2021, the inventory balances were insignificant and the Company determined that there was no allowance needed. Revenue Recognition The Company’s revenues consist of high quality, direct-to-consumer, ready-made meals that can be ordered by customers through www.homebistro.com, www.modelmeals.com and restaurant quality meats and seafood through its Colorado Prime Brand. Revenues from the Company’s ready-made meals are recognized when the product is delivered to the customer and title has transferred. It is at this point in time that the Company’s performance obligations have been completed. Product sales are recorded net of any discounts or allowances and include shipping charges. Customers can purchase gift cards via phone or online through the Company’s e-commerce website. Gift card purchases are initially recorded as unredeemed gift card liabilities and are recognized as product sales upon redemption. Historically, the majority of gift cards are redeemed within two to three years of issuance. The Company does not charge administrative fees on unused gift cards, and its gift cards do not have an expiration date. Based on historical redemption patterns, a portion of issued gift cards are not expected to be redeemed (breakage). The Company uses the redemption recognition method for recognizing breakage related to unredeemed gift cards for which it has sufficient historical redemption information. Under the redemption recognition method, breakage revenue is recorded in proportion to, and over the time period gift cards are actually redeemed. The estimated breakage rate is based on historical issuance and redemption patterns and is re-assessed by the Company on a regular basis. At least three years of historical data, which is updated annually, is used to estimate redemption patterns. Model meals, the Company’s wholly-owned subsidiary, does not have sufficient historical redemption information to recognize breakage. Therefore, all issued gift cards are recorded as a liability upon issuance and revenue when used. Cost of Sales The Company’s policy is to recognize product related cost of sales in conjunction with revenue recognition, when the product costs are incurred which is upon delivery of product. Cost of sales includes the food and processing costs directly attributable to fulfillment and the delivery of the product to customers including both inbound and outbound shipping costs. In addition, the royalty fee related to the Joint Product Development and Distribution Agreement (see Note 11) was also included in cost of sales. Shipping and handling costs incurred for product shipped to customers are included in cost of sales and amounted to $411,380 and $152,070 for the nine months ended July 31, 2022 and 2021, respectively. Shipping and handling costs charged to customers are included in product sales. Stock-Based Compensation Stock-based compensation is accounted for based on the requirements of ASC 718 – “Compensation–Stock Compensation”, which requires recognition in the financial statements of the cost of employee, non-employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award. Advertising Costs The Company participates in various advertising programs. All costs related to advertising of the Company’s products are expensed in the period incurred. Advertising costs charged to operations were $940,580 and $307,980 for the nine months ended July 31, 2022 and 2021, respectively, which are presented on the accompanying unaudited consolidated statements of operations as selling and marketing expenses. Income Taxes The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date. The Company follows the accounting guidance for uncertainty in income taxes using the provisions of ASC 740. Using that guidance, tax positions initially need to be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. For the nine months ended July 31, 2022, the Company had no uncertain tax positions that qualify for either recognition or disclosure in the financial statements. Leases The Company accounts for its leases using the method prescribed by ASC 842 – Lease Accounting Operating and financing lease ROU assets represents the right to use the leased asset for the lease term. Operating and financing lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the adoption date in determining the present value of future payments. Lease expense for minimum lease payments is amortized on a straight-line basis over the lease term and is included in general and administrative expenses in the consolidated statements of operations. Basic and Diluted Loss Per Share Pursuant to ASC 260-10-45, basic loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the periods presented. Diluted loss per share is computed by dividing net loss by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during the period. Potentially dilutive common shares consist of common stock issuable for stock options and stock warrants (using the treasury stock method), convertible notes and common stock issuable. These common stock equivalents may be dilutive in the future. The potentially dilutive common stock equivalents as of July 31, 2022 and 2021 were excluded from the dilutive loss per share calculation as they would be antidilutive due to the net loss and included the following: July 31, 2022 2021 Common Stock Equivalents: Stock Warrants 17,750,156 12,071,461 Convertible Notes 7,821,102 1,512,844 Total 25,571,258 13,584,305 Concentration Risk The Company purchased approximately 100% of its food products from one vendor during the nine months ended July 31, 2021. The Company is not obligated to purchase from these vendors and, if necessary, there are other vendors from which the Company can purchase food products. As of July 31, 2021, the Company had no accounts payable balance to this vendor. During the nine months ended July 31, 2022, the Company had two kitchen facilities located at Pembroke Pines, FL 33009 and Santa Ana, CA. The Company started producing and packaging its food products at these locations in addition to purchasing food products from other vendors which mitigated this concentration risk. Recent Accounting Pronouncements In August 2020, the FASB issued ASU 2020-06— Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and edging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”) Debt with Conversion and Other Options 1. Add a disclosure objective 2. Add information about events or conditions that occur during the reporting period that cause conversion contingencies to be met or conversion terms to be significantly changed 3. Add information on which party controls the conversion rights 4. Align disclosure requirements for contingently convertible instruments with disclosure requirements for other convertible instruments 5. Require that existing fair value disclosures in Topic 825, Financial Instruments, be provided at the individual convertible instrument level rather than in the aggregate. Additionally, for convertible debt instruments with substantial premiums accounted for as paid-in capital, amendments in ASU 2020-06 added disclosures about (1) the fair value amount and the level of fair value hierarchy of the entire instrument for public business entities and (2) the premium amount recorded as paid-in capital. The amendments in ASU 2020-06 are effective for public business entities, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Entities should adopt the guidance as of the beginning of its annual fiscal year and are allowed to adopt the guidance through either a modified retrospective method of transition or a fully retrospective method of transition. In applying the modified retrospective method, entities should apply the guidance to transactions outstanding as of the beginning of the fiscal year in which the amendments are adopted. Transactions that were settled (or expired) during prior reporting periods are unaffected. The cumulative effect of the change should be recognized as an adjustment to the opening balance of retained earnings at the date of adoption. If an entity elects the fully retrospective method of transition, the cumulative effect of the change should be recognized as an adjustment to the opening balance of retained earnings in the first comparative period presented. The Company early adopted ASU 2020-06 effective November 1, 2021 and did not have a significant impact on its consolidated financial statements. In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40). The new ASU addresses issuer’s accounting for certain modifications or exchanges of freestanding equity-classified written call options. This amendment is effective for all entities, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted. The Company does not believe the adoption of this ASU will have a significant impact on its consolidated financial statements. Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on its consolidated financial statements.

Acquisition of a Subsidiary

Acquisition of a Subsidiary	9 Months Ended
Acquisition of a Subsidiary	Jul. 31, 2022
Acquisition of a Subsidiary [Abstract]
ACQUISITION OF A SUBSIDIARY	NOTE 3 – ACQUISITION OF A SUBSIDIARY Acquisition of Model Meals Model Meals was formed on May 1, 2015. Model Meals provides prepackaged and prepared meals as a solution for time-constrained but discerning consumers focused on satisfying every member of the family by offering a broad array of the highest quality meal planning, delivery, and preparation services. Products are customized meal solutions, delivered fresh directly to the home and utilizes third-party food delivery services to fulfill customers’ orders. On July 6, 2021, the Company entered and closed on an Agreement and Plan of Merger with the members of Model Meals, acquiring Model Meals through a reverse triangular merger, whereby Model Meals merged with Model Meals Acquisition Corp., a wholly owned subsidiary of the Company, with Model Meals being the surviving entity (the “Acquisition”). As a result, Model Meals became a wholly owned subsidiary of the Company, and the members of Model Meals received an aggregate of 2,008,310 shares of common stock with grant date fair value of $ 2,028,393 (see Note 1) and were paid $60,000 in cash. The shares are subject to a 24-month Lockup and Leak-Out Agreement and were issued pursuant to Section 4(a)(2) of the Securities Act. The acquisition of Model Meals will allow the Company the ability to increase its customer base, geographic distribution area, and prepared meals available on its ecommerce sights. Further, on August 12, 2021, the Company filed, an amended current report Form 8-K/A, Model Meals’; (i) audited balance sheets and audited statement of operations as of December 31, 2020 and 2019 and for the years ended December 31, 2020 and 2019, respectively; (ii) unaudited balance sheet and unaudited statement of operations as of March 31, 2021 and for the three months ended March 31, 2021, respectively, and; (iii) unaudited pro forma combined financial information derived by the application of pro forma adjustments to the historical consolidated financial statements of the Company and Model Meals which gives effect to the Acquisition between the Company and Model Meals as if the Acquisition had occurred on January 1, 2020 with respect to the unaudited annual pro forma combined statement of operation, and as of January 1, 2021 for the three months ended March 31, 2021 unaudited pro forma combined statement of operation, and as of March 31, 2021 with respect to the unaudited pro forma combined balance sheets. In connection with the Acquisition, the assets acquired and liabilities assumed were recorded at fair value on the acquisition date. The fair values are subject to adjustment during measurement period with subsequent changes recognized in earnings or loss. These estimates are inherently uncertain and are subject to refinement. Management develops estimates based on assumptions as a part of the purchase price allocation process to value the assets acquired and liabilities assumed as of the business acquisition date. As a result, during the purchase price measurement period, which may be up to one year from the business acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. After the purchase price measurement period, the Company will record any adjustments to assets acquired or liabilities assumed in operating expenses in the period in which the adjustments may have been determined. Based upon the purchase price allocation, the following table summarizes the preliminary fair value of the assets acquired and liabilities assumed at the date of the acquisition: Total Assets acquired: Current assets $ 97,140 Computer software 66,198 Customer relationships 43,000 Trademark 505,000 Goodwill 1,809,357 Total assets acquired at fair value 2,520,695 Less: total liabilities assumed (432,302 ) Net asset acquired $ 2,088,393 Purchase consideration paid: Fair value of common shares issued $ 2,028,393 Cash consideration 60,000 Total purchase consideration paid $ 2,088,393 Goodwill recognized as a result of the acquisition is not deductible for tax purposes. See Note 4 for additional information about other intangible assets. The recognized goodwill related to Model Meals is directly attributable to synergies expected to arise after the acquisition. The following unaudited pro forma consolidated results of operations for the nine months ended July 31, 2021 have been prepared as if the acquisition of Model Meals had occurred as of the beginning of the period: Nine Months Ended July 31, (Unaudited) Net Revenues $ 2,485,615 Net Loss $ (2,539,633 ) Net Loss per Share $ (0.12 ) Pro forma data does not purport to be indicative of the results that would have been obtained had these events actually occurred at the beginning of the periods presented and is not intended to be a projection of future results.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
Goodwill and Intangible Assets	Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND INTANGIBLE ASSETS	NOTE 4 – GOODWILL AND INTANGIBLE ASSETS On July 6, 2021, the Company acquired Model Meals’ net assets with total fair value of $279,036, which includes computer software, customer relationships and trademarks, for a total consideration of $2,088,393 (see Note 3). The excess consideration over the fair value of the net assets acquired of $1,809,357 was recorded as goodwill. On June 24, 2021, the Company entered into a licensing agreement (“License Agreement”) with a celebrity chef and majority member interest holder of Homemade Meals, LLC (“Homemade Meals”). As a condition to finalizing the License Agreement, the Company executed a Membership Interest Purchase Agreement (the “Member Agreement”) and issued an aggregate of 2,266,667 shares of common stock to other members of Homemade Meals with an aggregate fair value of $2,969,334, based on the market price of common stock on the close date of October 25, 2021. The shares issued to the other members were consideration to terminate an exclusivity and non-compete agreement the celebrity chef had with Homemade Meals. Further, the Company issued the celebrity chef 2,000,000 shares of common stock with a fair value of $2,620,000, based on the market price of common stock on the close date of Company’s common stock. The Company’s primary reason for acquiring the membership interests in Homemade Meals was to terminate the non-compete agreement between the celebrity chef and Homemade Meals, thereby enabling the celebrity chef to execute the License Agreement with the Company. At the time of execution of the Member Agreement, Homemade meals held no significant assets and had no business operations, and the Member Agreement was solely executed to terminate the exclusivity and non-compete agreement the celebrity chef had with Homemade Meals. The Company recorded the shares given to the celebrity chef and the members of Homemade Meals has two separate transactions. The Company and the celebrity chef (collectively as “Parties”) had a preexisting relationship and other arrangements before negotiations for the acquisition of Homemade Meals and had planned to enter into a License Agreement during the negotiations, which is separate from the Member Agreement. Since ASC 805-50 includes only general principles related to accounting for an asset acquisition and in the absence of specific guidance, the Company analogized to the guidance in ASC 805-10-25-20 through 25-21– Business Combination Therefore, in accordance with ASC 805-10-25-21, the Company accounted for the 2,000,000 shares of common stock with fair value of $2,620,000, based on the market price of common stock on the acquisition date, issued to the celebrity chef as the cost of the License Agreement which was recorded as an intangible asset in the accompanying consolidated balance sheet and will be amortized over the three-year term of the License Agreement. In addition, the aggregate of 2,266,667 shares of common stock issued to other members with an aggregate fair value of $2,969,334, based on the market price of common stock on the acquisition date, was accounted for as compensation to terminate the exclusivity and non-compete agreement and was recorded as product development expense in the accompanying consolidated statement of operations. Goodwill Estimated July 31, October 31, (Unaudited) Goodwill Indefinite $ 1,809,357 $ 1,809,357 Less: impairment — — Goodwill, net $ 1,809,357 $ 1,809,357 Intangible Assets Estimated July 31, October 31, (Unaudited) Computer software 3.5 years $ 66,198 $ 66,198 Customer relationships 7 years 43,000 43,000 Trademark Indefinite 505,000 505,000 License agreement 3 years 2,620,000 2,620,000 Total 3,234,198 3,234,198 Less: accumulated amortization (683,719 ) (8,837 ) Intangible assets, net $ 2,550,479 $ 3,225,361 Intangible assets with a finite life, net $ 2,045,479 $ 2,720,361 During the three and nine months ended July 31, 2022, the Company recorded a total of $224,961 and $674,882, respectively, of amortization expense related to the intangible assets. Amortization of intangible assets attributable to future periods is as follows: Year ending October 31: Amount 2022 $ 224,962 2023 899,845 2024 898,147 2025 6,143 2026 6,143 2027 6,143 2028 4,096 Total $ 2,045,479

Convertible Notes

Convertible Notes	9 Months Ended
Convertible Notes	Jul. 31, 2022
Debt Disclosure [Abstract]
CONVERTIBLE NOTES	NOTE 5 – CONVERTIBLE NOTES On July 31, 2022 and October 31, 2021, convertible notes consisted of the following: July 31, October 31, (Unaudited) Principal amount $ 992,302 $ 1,028,179 Add: put premium on stock-settled debt 83,058 - Less: debt discount (361,444 ) (477,541 ) Convertible notes payable, net $ 713,916 $ 550,638 Principal amount – related party $ — $ 63,069 Less: debt discount – related party — (32,897 ) Convertible note payable - related party, net $ — $ 30,172 Total convertible notes payable, net $ 713,916 $ 580,810 January 2021 Financing January 2021 Note II On January 27, 2021, the Company entered into a Securities Purchase Agreement (the “January 2021 SPA II”) with an investor for the sale of the Company’s convertible note. Pursuant to the January 2021 SPA II, the Company; (i) issued a convertible note with principal amount of $330,000 (the “January 2021 Note II”) with the Company receiving $300,000 in net proceeds, net of $33,000 of OID recorded as a debt discount to be amortized over the twelve-month term of the note; (ii) issued 150,000 shares of common stock, subject to a true-up based upon the trading price of the common stock and the investor’s ownership limitations (“Commitment Share True-up”) (as discussed below under Commitment Share True-Up Provision) The January 2021 Warrant II, issued to the investor as commitment fee, provides for the right to purchase up to 150,000 shares of common stock; (i) valued at $31,821 using the relative fair value method and recorded as a debt discount to be amortized over the twelve-month term of the note; (ii) has an exercise price of $2.50; (iii) subject to adjustments and 4.99%, ownership limitation and; (iv) expires on the fifth-year anniversary from the date of issuance. March 2021 Financings March 2021 Note I On March 22, 2021, the Company entered into a Securities Purchase Agreement (the “March 2021 SPA I”) with an investor for the sale of the Company’s convertible note. Pursuant to the March 2021 SPA I, the Company; (i) issued a convertible note with principal amount of $55,000 (the “March 2021 Note I”) with the Company receiving $50,000 in net proceeds, net of $5,000 of OID recorded as a debt discount to be amortized over the twelve-month term of the note; (ii) issued 25,000 shares of common stock, subject to a true-up based upon the trading price of the common stock and the investor’s ownership limitations (“Commitment Share True-up”) (as discussed below under Commitment Share True-Up Provision) The March 2021 Warrant I, issued to the investor as a commitment fee, provides for the right to purchase up to 25,000 shares of common stock; (i) valued at $1,346 using the relative fair value method and recorded as a debt discount to be amortized over the twelve-month term of the note; (ii) has an exercise price of $2.50; (iii) subject to adjustments and 4.99%, ownership limitation and; (iv) expires on the fifth-year anniversary from the date of issuance. March 2021 Note III – Related Party On March 30, 2021, the Company entered into a Securities Purchase Agreement (the “March 2021 SPA III”) with an investor, who is also a major stockholder and director and considered to be a related party, for the sale of the Company’s convertible note. Pursuant to the March 2021 SPA III, the Company; (i) issued a convertible note with principal amount of $110,000 (the “March 2021 Note III”) with the Company receiving $100,000 in net proceeds, net of $10,000 of OID recorded as a debt discount to be amortize over the twelve-month term of the note; (ii) issued 50,000 shares of common stock, subject to a true-up based upon the trading price of the common stock and the investor’s ownership limitations (“Commitment Share True-up”) (as discussed below under Commitment Share True-Up Provision) The March 2021 Warrant III, issued to the investor as a commitment fee, provides for the right to purchase up to 50,000 shares of common stock; (i) valued at $7,924 using the relative fair value method and recorded as a debt discount to be amortized over the twelve-month term of the note; (ii) has an exercise price of $2.50; (iii) subject to adjustments and 4.99%, ownership limitation and; (iv) expires on the fifth-year anniversary from the date of issuance. March 2021 Note V On March 31, 2021, the Company entered into a Securities Purchase Agreement (the “March 2021 SPA V”) with an investor for the sale of the Company’s convertible note. Pursuant to the March 2021 SPA V, the Company; (i) issued a convertible note with principal amount of $165,000 (the “March 2021 Note V”) with the Company receiving $150,000 in net proceeds, net of $15,000 of OID recorded as a debt discount to be amortized over the twelve-month term of the note; (ii) issued 75,000 shares of common stock, subject to a true-up based upon the trading price of the common stock and the investor’s ownership limitations (“Commitment Share True-up”) (as discussed below under Commitment Share True-Up Provision) The March 2021 Warrant V, issued to the investor as a commitment fee, provides for the right to purchase up to 75,000 shares of common stock; (i) valued at $12,352 using the relative fair value method and recorded as a debt discount to be amortized over the twelve-month term of the note; (ii) has an exercise price of $2.50; (iii) subject to adjustments and 4.99%, ownership limitation and; (iv) expires on the fifth-year anniversary from the date of issuance. April 2021 Financing On April 7, 2021, the Company closed a Securities Purchase Agreement dated March 29, 2021 (the “April 2021 SPA”) with an investor for the sale of the Company’s convertible note. Pursuant to the April 2021 SPA, the Company; (i) issued a convertible note with principal amount of $165,000 (the “April 2021 Note”) with the Company receiving $146,500 in net proceeds, net of $15,000 of OID and $3,500 of legal fees; (ii) issued 75,000 shares of common stock, subject to a true-up based upon the trading price of the common stock and the investor’s ownership limitations (“Commitment Share True-up”) and; (iii) issued warrant to purchase up to 75,000 shares of common stock (the “April 2021 Warrant”, and together with the April 2021 SPA and the April 2021 Note, the “April 2021Agreements”). The 75,000 shares of common stock and 75,000 warrant issued were valued at $31,913 and $9,669, respectively, using the relative fair value method and the Commitment Share True-up had a fixed monetary value of $27,375, recorded as a debt discount to be amortized over the twelve-month term of the note. The April 2021 Note I matured on March 30, 2022 and a one-time interest charge of 8% was applied on the issue date and will be payable on the maturity date. Upon an event of default, the outstanding balance will immediately and automatically increase to 140% of the outstanding balance under the April 2021 Note immediately prior to the occurrence of the Event of Default and becomes immediately due and payable. The Company made nine monthly cash payments (“Amortization Payments”), in the amount of $19,800 due on the first day of each month, beginning July 1, 2021. The investor may only convert the April 2021 Note at any time or times on or after the occurrence of an Event of Default. The April 2021 Note is convertible at the rate equal to 105% of the lowest trading price occurring during the twenty-five consecutive trading days immediately preceding the applicable conversion date (“Conversion Price”). The April 2021 Agreements contain other provisions, covenants, and restrictions common with this type of debt transaction. The April 2021 SPA also provides the investor with certain “piggyback” registration rights, permitting them to request that the Company include the issued shares for sale in certain registration statements filed by the Company under the Securities Act of 1934, as amended. During the transitional period ending October 31, 2021, the Company paid $69,316 of principal and $9,884 of accrued interest. During the nine months ended July 31, 2022, the Company paid the remaining $95,684 of principal and $3,316 of accrued interest. As of July 31, 2022 and October 31, 2021, the April 2021 Note had outstanding principal of $0 and $95,684, respectively. The April 2021 Warrant, issued to the investor as a commitment fee, provides for the right to purchase up to 75,000 shares of common stock; (i) valued at $9,669 using the relative fair value method and recorded as a debt discount to be amortized over the twelve-month term of the note; (ii) has an exercise price of $2.50; (iii) subject to adjustments and 4.99%, ownership limitation and; (iv) expires on the fifth-year anniversary from the date of issuance. May 2021 Financings May 2021 Note I On May 17, 2021, the Company closed a Securities Purchase Agreement (the “May 2021 SPA I”) with an investor for the sale of the Company’s convertible note. Pursuant to the May 2021 SPA I, the Company (i) issued a convertible note with principal amount of $132,000 (the “May 2021 Note I”) with the Company receiving $111,700 in net proceeds, net of $12,000 of OID and $8,300 of legal fees; (ii) issued 60,000 shares of common stock (the “First Commitment Shares”) as a commitment fee and shall issue 165,000 shares of common stock (the “Second Commitment Shares”) issued as a returnable commitment fee, accordingly, the Company deems the Second Commitment Shares as unissued for accounting purposes and; (iii) issued a warrant to purchase up to 60,000 shares of common stock (the “May 2021 Warrant I”, and together with the May 2021 SPA I and the May 2021 Note I, the “May 2021 Agreements I”). The 60,000 shares of common stock and 60,000 warrant issued were valued at $26,824 and $9,767, respectively, using the relative fair value method and the Commitment Share True-up had a fixed monetary value of $26,700, recorded as a debt discount to be amortized over the twelve-month term of the note. The May 2021 Note I matured on May 10, 2022 and a one-time interest charge of 10% was applied on the issue date and will be payable on the maturity date; in an event of default, the interest rate shall increase to 16% per annum. Upon an event of default, the outstanding balance will immediately and automatically increase to 140% of the outstanding balance under the May 2021 Note I immediately prior to the occurrence of the event of default and becomes immediately due and payable. The Company made nine monthly cash payments (“Amortization Payments”), in the amount of $15,667 due on the first day of each month, beginning August 9, 2021. The investor may only convert the May 2021 Note I at any time or times on or after the occurrence of an event of default. The May 2021 Note I is convertible at the rate equal to 105% of the lowest trading price occurring during the twenty-five consecutive trading days immediately preceding the applicable conversion date (“Conversion Price”). The May 2021 Agreements I contain other provisions, covenants, and restrictions common with this type of debt transaction. The May 2021 SPA I also provides the investor with certain “piggyback” registration rights, permitting them to request that the Company include the issued shares for sale in certain registration statements filed by the Company under the Securities Act of 1934, as amended. During the transitional period ending October 31, 2021, the Company paid $41,159 of principal and $5,842 of accrued interest. During the nine months ended July 31, 2022, the Company paid the remaining $90,841 of principal and $3,161 of accrued interest. As of July 31, 2022 and October 31, 2021, the May 2021 Note I had outstanding principal of $0 and $90,841, respectively. The May 2021 Warrant I, issued to the investor as a commitment fee, provides for the right to purchase up to 60,000 shares of common stock; (i) valued at $9,767 using the relative fair value method and recorded as a debt discount to be amortized over the twelve-month term of the note; (ii) has an exercise price of $2.50; (iii) subject to adjustments and 4.99%, ownership limitation and; (iv) expires on the fifth-year anniversary from the date of issuance. May 2021 Note II On May 28, 2021, the Company closed a Securities Purchase Agreement (the “May 2021 SPA II”) with an investor for the sale of the Company’s convertible note. Pursuant to the May 2021 SPA II, the Company (i) issued a convertible note with principal amount of $285,000 (the “May 2021 Note II”) with the Company receiving $250,000 in net proceeds, net of $28,500 of OID and $6,500 of legal fees; (ii) issued 150,000 shares of common stock (the “Commitment Shares”) as commitment fee and; (iii) issued warrant to purchase up to 150,000 shares of common stock (the “May 2021 Warrant II”, and together with the May 2021 SPA II and the May 2021 Note II, the “May 2021Agreements II”). The 150,000 shares of common stock and 150,000 warrant issued were valued at $69,583 and $30,326, respectively, using the relative fair value method, all recorded as a debt discount to be amortized over the twelve-month term of the note. The May 2021 Note II matured on May 26, 2022 and a one-time interest charge of 10% was applied on the issue date and will be payable on the maturity date. Upon an event of default, the outstanding balance will immediately and automatically increase to 140% of the outstanding balance under the May 2021 Note II immediately prior to the occurrence of the event of default and becomes immediately due and payable. The Company made nine monthly cash payments (“Amortization Payments”), in the amount of $31,350 due on the first day of each month, beginning August 26, 2021. The investor may only convert the May 2021 Note II at any time or times on or after the occurrence of an event of default. The May 2021 Note II is convertible at a conversion price of $0.70 (“Conversion Price”). The May 2021 Agreements II contain other provisions, covenants, and restrictions common with this type of debt transaction. The May 2021 SPA II also provides the investor with certain “piggyback” registration rights, permitting them to request that the Company include the issued shares for sale in certain registration statements filed by the Company under the Securities Act of 1934, as amended. During the transitional period ending October 31, 2021, the Company paid $48,219 of principal and $14,481 of accrued interest. During the nine months ended July 31, 2022, the Company paid $236,781 of principal and $14,019 of accrued interest. As of July 31, 2022 and October 31, 2021, the May 2021 Note II had outstanding principal of $0 and $236,781, respectively. The May 2021 Warrant II, issued to the investor as a commitment fee, provides for the right to purchase up to 150,000 shares of common stock; (i) valued at $30,326 using the relative fair value method and recorded as a debt discount to be amortized over the twelve-month term of the note; (ii) has an exercise price of $1.50; (iii) subject to adjustments and 4.99%, ownership limitation and; (iv) expires on the fifth-year anniversary from the date of issuance. September 2021 Financings September 2021 Note I On September 1, 2021, the Company closed a Securities Purchase Agreement (the “September 2021 SPA I”) with an investor for the sale of the Company’s convertible note. Pursuant to the September 2021 SPA I, the Company (i) issued a convertible note with principal amount of $110,000 (the “September 2021 Note I”) with the Company receiving $100,000 in net proceeds, net of $10,000 of OID; (ii) issued 50,000 shares of common stock (the “First Commitment Shares”) as commitment fee and; (iii) issued warrant to purchase up to 50,000 shares of common stock (the “September 2021 Warrant I”, and together with the September 2021 SPA I and the September 2021 Note I, the “September 2021 Agreements I”). The 50,000 shares of common stock and 50,000 warrant issued were valued at $24,877 and $9,493, respectively, using the relative fair value method, recorded as a debt discount to be amortized over the nine-month term of the note. The September 2021 Note I matured on June 1, 2022 and a one-time OID charge of 10% was applied on the issue date and will be payable on the maturity date. Upon an event of default, the outstanding balance will immediately and automatically increase to 140% of the outstanding balance under the September 2021 Note I immediately prior to the occurrence of the event of default and becomes immediately due and payable. The Company made nine monthly cash payments (“Amortization Payments”), in the amount of $13,444 due on the first day of each month, beginning October 1, 2021. The investor may only convert the September 2021 Note I at any time or times on or after the occurrence of an event of default. The September 2021 Note I was convertible at the rate equal to 105% of the lowest trading price occurring during the twenty-five consecutive trading days immediately preceding the applicable conversion date (“Conversion Price”). The September 2021 Agreements I contain other provisions, covenants, and restrictions common with this type of debt transaction. The September 2021 SPA I also provides the investor with certain “piggyback” registration rights, permitting them to request that the Company include the issued shares for sale in certain registration statements filed by the Company under the Securities Act of 1934, as amended. During the nine months ended July 31, 2022, the Company paid $110,000 of principal and $10,996 of accrued interest. As of July 31, 2022 and October 31, 2021, the September 2021 Note I had outstanding principal of $0 and $110,000, respectively. The September 2021 Warrant I, issued to the investor as a commitment fee, provides for the right to purchase up to 50,000 shares of common stock; (i) valued at $9,493 using the relative fair value method and recorded as a debt discount to be amortized over the nine-month term of the note; (ii) has an exercise price of $2.50; (iii) subject to adjustments and 4.99%, ownership limitation and; (iv) expires on the fifth-year anniversary from the date of issuance. September 2021 Note II On September 8, 2021, the Company closed a Securities Purchase Agreement (the “September 2021 SPA II”) with an investor for the sale of the Company’s convertible note. Pursuant to the September 2021 SPA II, the Company (i) issued a convertible note with principal amount of $250,000 (the “September 2021 Note II”) with the Company receiving $218,250 in net proceeds, net of $25,000 of OID and $6,750 of legal fees; (ii) issued 114,000 shares of common stock (the “First Commitment Shares”) as commitment fee and; (iii) issued warrant to purchase up to 114,000 shares of common stock (the “September 2021 Warrant II”, and together with the September 2021 SPA II and the September 2021 Note II, the “September 2021 Agreements II”). The 114,000 shares of common stock and 114,000 warrant issued were valued at $59,468 and $21,004, respectively, using the relative fair value method, recorded as a debt discount to be amortized over the twelve-month term of the note. The September 2021 Note II matured on August 1, 2022 and 10% of OID was applied on the issue date and will be payable on the maturity date. Upon an event of default, the outstanding balance will immediately and automatically increase to 140% of the outstanding balance under the September 2021 Note II immediately prior to the occurrence of the event of default and becomes immediately due and payable. The Company shall make nine monthly cash payments (“Amortization Payments”), in the amount of $30,556 due on the first day of each month, beginning December 1, 2021. If the first day of any calendar month is not on a business day, then the Company shall make monthly payments on the next business day. The investor may only convert the September 2021 Note II at any time or times on or after the occurrence of an event of default. The September 2021 Note II is convertible at the rate equal to 105% of the lowest trading price occurring during the twenty-five consecutive trading days immediately preceding the applicable conversion date (“Conversion Price”). The September 2021 Agreements II contain other provisions, covenants, and restrictions common with this type of debt transaction. The September 2021 SPA II also provides the investor with certain “piggyback” registration rights, permitting them to request that the Company include the issued shares for sale in certain registration statements filed by the Company under the Securities Act of 1934, as amended. During the nine months ended July 31, 2022, the Company paid $219,875 of principal and $24,573 of accrued interest. As of July 31, 2022 and October 31, 2021, the September 2021 Note II had outstanding principal of $30,125 and $250,000, respectively. The September 2021 Warrant II, issued to the investor as commitment fee, provides for the right to purchase up to 114,000 shares of common stock; (i) valued at $21,004 using the relative fair value method and recorded as a debt discount to be amortized over the twelve-month term of the note; (ii) has an exercise price of $2.50; (iii) subject to adjustments and 4.99%, ownership limitation and; (iv) expires on the fifth-year anniversary from the date of issuance. May 2022 Note I On May 18, 2022, the Company entered into a Securities Purchase Agreement (“May 2022 SPA I”) with an investor for the sale of the Company’s convertible note. Pursuant to the May 2022 SPA I, the Company; (i) issued a convertible note with principal amount of $500,000 (“May 2022 Note I”) with the Company receiving $450,000 in net proceeds, net of $40,000 of OID and $10,000 of legal fees; (ii) issued warrants to purchase up to 769,231 shares of common stock (“May 2022 Warrant I”). The 869,565 warrants issued were valued at $93,641 using the relative fair value method, recorded as a debt discount to be amortized over the twelve-month term of the note. The May 2022 Note I bears an annual interest rate of 15% and matures on May 18, 2023. The May 2022 Note I is convertible at any time or times on or after the occurrence of an event of default, at a price equal to $0.39, provided, however, that if the Company consummates an Uplist Offering (as defined in this May 2022 Note I) within 180 calendar days after the issuance date, then the conversion price shall equal 75% of the Uplist Offering. If the date of a respective conversion under the May 2022 Note I, is prior to the date of the Uplist Offering, then the Conversion Price shall equal $0.39 per share. At any time prior to an event of default the Company shall have the option to pre-pay the outstanding principal at an amount equal to 115% of the outstanding balance plus accrued. The May 2022 Warrant I issued to the investor, provides for the right to purchase up to 869,565 shares of common stock; (i) valued at $93,641 using the relative fair value method and recorded as a debt discount to be amortized over the twelve-month term of the May 2022 Note I; (ii) exercisable at $0.575, provided, however, upon the Uplist Offering, the exercise price shall equal 120% of the Uplist Offering; after180 calendar days from the issuance date the exercise price shall be $0.575; (iii) subject to adjustments and 4.99% ownership limitation and; (iv) expires on the third-year anniversary from the date of issuance. If the Company at any time while the May 2022 Note I and May 2022 Warrant I are outstanding, sell or grant any option to purchase, sell, grant any right to re-price, or otherwise dispose of or issue any common stock or common stock equivalents (other than an exempt issuance as defined in the May 2022 Note I and May 2022 Warrant I), at a share price per less than the initial conversion and/or exercise price then the conversion and/or exercise price shall be reduced equal to such price and the number of common stock and/or warrant shares issuable thereunder shall be increased. The May 2022 Note I and May 2022 Warrant I also provide the investor with certain “piggyback” registration rights, permitting them to request that the Company include the shares issued upon conversion of the note or exercise of the warrant, respectively, for sale in certain registration statements filed by the Company under the Securities Act of 1933, as amended. As of July 31, 2022, the May 2022 Note I had outstanding principal of $500,000. May 2022 Note II On May 24, 2022, the Company entered into a Securities Purchase Agreement (“May 2022 SPA II”) with an investor for the sale of the Company’s convertible note. Pursuant to the May 2022 SPA II, the Company; (i) issued a convertible note with principal amount of $125,000 (“May 2022 Note II”) with the Company receiving $102,500 in net proceeds, net of $12,500 of OID and $10,000 of legal fees; (ii) issued warrants to purchase up to 217,391 shares of common stock (“May 2022 Warrant II”). The 217,391 warrants issued were valued at $24,902 using the relative fair value method, recorded as a debt discount to be amortized over the twelve-month term of the note. The May 2022 Note II bears an annual interest rate of 15% and matures on May 24, 2023. The May 2022 Note II is convertible at any time or times on or after the occurrence of an event of default, at a price equal to the lower of; (i) 75% of the closing price of the common stock on the date of the investment, and (ii) 90% of the lowest VWAP for the common stock during the five trading day period ending on the latest complete trading day prior to the conversion date however if the Company consummates an Uplist Offering (as defined in the May 2022 Note II) within the 180 calendar days after the issuance date, then the conversion price shall equal 75% of the offering price per share of common stock at which the Uplist Offering is made. Unless otherwise adjusted pursuant to the terms of the May 2022 Note II, if the date of a conversion under the May 2022 Note II is prior to the date of the Uplist Offering, then the conversion price shall equal $0.345 per share. At any time prior to an event of default the Company shall have the option to pre-pay the May 2022 Note II at an amount equal to 115% of the outstanding balance plus accrued and unpaid interest on the outstanding balance. Upon the occurrence and during the continuation of any event of default, the May 2022 Note II shall become immediately due and payable at an amount equal to 150% of the outstanding principal plus accrued and unpaid interest and any default interest, if any. The May 2022 Warrant II issued to the investor, provides for the right to purchase up to 217,391 shares of common stock; (i) valued at $24,902 using the relative fair value method and recorded as a debt discount to be amortized over the twelve-month term of the May 2022 Note II; (ii) exercisable at $0.575, provided, however, that if the Company consummates an Uplist Offering within 180 calendar days from the issuance date in which case the exercise price shall be equal to 120% of the Uplist Offering price; after180 calendar days from the issuance date the exercise price shall be $0.575; (iii) subject to adjustments and 4.99% ownership limitation and; (iv) expires on the third-year anniversary from the date of issuance. If the Company at any time while the May 2022 Note II and May 2022 Warrant II are outstanding, sell or grant any option to purchase, sell, grant any right to re-price, or otherwise dispose of or issue any common stock or common stock equivalents (other than an exempt issuance as defined in the May 2022 Note II and May 2022 Warrant II), at a share price per less than the initial conversion and/or exercise price then the conversion and/or exercise price shall be reduced equal to such price and the number of common stock and/or warrant shares issuable thereunder shall be increased. The May 2022 Note II and the May 2022 Warrant II also provide the investor with certain “piggyback” registration rights, permitting them to request that the Company include the shares issued upon conversion of the note or exercise of the warrant, respectively, for sale in certain registration statements filed by the Company under the Securities Act of 1933, as amended. As of July 31, 2022, the May 2022 Note II had outstanding principal of $125,000. May 2022 Note III On May 24, 2022, the Company entered into a Securities Purchase Agreement (“May 2022 SPA III”) with an investor for the sale of the Company’s convertible note. Pursuant to the May 2022 SPA III, the Company; (i) issued a convertible note with principal amount of $182,927 (“May 2022 Note III”) with the Company receiving $150,000 in net proceeds, net of $18,293 of OID and $14,634 of legal fees; (ii) issued warrants to purchase up to 318,134 shares of common stock (“May 2022 Warrant III”). The 318,134 warrants issued were valued at $36,442 using the relative fair value method, recorded as a debt discount to be amortized over the twelve-month term of the note. The May 2022 Note III bears an annual interest rate of 15% and matures on May 24, 2023. The May 2022 Note III is convertible at any time or times on or after the occurrence of an event of default, at a price equal to the lower of; (i) 75% of the closing price of the common stock on the date of the investment, and (ii) 90% of the lowest VWAP for the common stock during the five trading day period ending on the latest complete trading day prior to the conversion date however if the Company consummates an Uplist Offering (as defined in the May 2022 Note III) within the 180 calendar days after the issuance date, then the conversion price shall equal 75% of the offering price per share of common stock at which the Uplist Offering is made. Unless otherwise adjusted pursuant to the terms of the May 2022 Note III, if the date of a conversion under the May 2022 Note III is prior to the date of the Uplist Offering, then the conversion price shall equal $0.345 per share. At any time prior to an event of default the Company shall have the option to pre-pay the May 2022 Note III at an amount equal to 115% of the outstanding balance plus accrued and unpaid interest on the outstanding balance. Upon the occurrence and during the continuation of any event of default, the May 2022 Note III shall become immediately due and payable at an amount equal to 150% of the outstanding principal plus accrued and unpaid interest and any default interest, if any. Upon an event of default, at the option of the investor the conversion price shall equal 90% of the lowest VWAP for the common stock during the five-trading day period prior to the conversion date. The May 2022 Warrant III issued to the investor, provides for the right to purchase up to 318,134 shares of common stock; (i) valued at $36,442 using the relative fair value method and recorded as a debt discount to be amortized over the twelve-month term of the May 2022 Note III; (ii) exercisable at $0.575 however if the Company consummates an Uplist Offering within 180 calendar days from the issuance date in which case the exercise price shall be equal to 120% of the Uplist Offering price; after180 calendar days from the issuance date the exercise price shall be $0.575; (iii) subject to adjustments and 4.99% ownership limitation and; (iv) expires on the third-year anniversary from the date of issuance. If the Company at any time while the May 2022 Note III and May 2022 Warrant III are outstanding, sell or grant any option to purchase, sell, grant any right to re-price, or otherwise dispose of or issue any common stock or common stock equivalents (other than an exempt issuance as defined in the May 2022 Note III and May 2022 Warrant III), at a share price per less than the initial conversion and/or exercise price then the conversion and/or exercise price shall be reduced equal to such price and the number of common stock and/or warrant shares issuable thereunder shall be increased. The May 2022 Note III and the May 2022 Warrant III also provide the investor with certain “piggyback” registration rights, permitting them to request that the Company include the shares issued upon conversion of the note or exercise of the warrant, respectively, for sale in certain registration statements filed by the Company under the Securities Act of 1933, as amended. As of July 31, 2022, the May 2022 Note III had outstanding principal of $182,927. July 2022 Note On July 19, 2022 (the “ Issue Date SPA Investor Note The July 2022 Note accrues interest at an annual interest rate of 8%, has a default interest rate of 22%, and matures on January 19, 2024 (the “ Maturity Date Conversion Price The Company has the right to prepay the outstanding principal amount of the Note, plus any accrued interest on the outstanding

Notes Payable

Notes Payable	9 Months Ended
Notes Payable	Jul. 31, 2022
Debt Disclosure [Abstract]
NOTES PAYABLE	NOTE 6 – NOTES PAYABLE Notes payable is summarized below: July 31, October 31, (Unaudited) Principal amount $ 306,900 $ 306,900 Less: current portion (17,198 ) (15,361 ) Notes payable – long-term portion $ 289,702 $ 291,539 Minimum principal payments under notes payable are as follows: Year ended October 31, 2022 (remaining) $ 15,620 Year ended October 31, 2023 6,369 Year ended October 31, 2024 6,608 Year ended October 31, 2025 6,859 Thereafter 271,444 Total principal payments $ 306,900 Economic Injury Disaster Loan On May 20, 2020, the Company entered into a Loan Authorization and Agreement (“SBA Loan Agreement”) with the SBA, under the SBA’s Economic Injury Disaster Loan assistance program in light of the impact of the COVID-19 pandemic. Pursuant to the SBA Loan Agreement, the Company received an advanced of $149,900, net of $100 processing fee, to be used for working capital purposes only. Pursuant to the SBA Loan Agreement, the Company executed; (i) a note for the benefit of the SBA (“SBA Note”), which contains customary events of default; and (ii) a Security Agreement, granting the SBA a security interest in all tangible and intangible personal property of the Company, which also contains customary events of default. The SBA Note bears an interest rate of 3.75% per annum which accrue from the date of the advance. Instalment payments in the amount of $731, including principal and interest, are due monthly beginning May 20, 2021 (twelve months from the date of the SBA Note). The balance of principal and interest is payable thirty years from the date of the SBA Note. As of July 31, 2022 and October 31, 2021, the SBA Note had outstanding principal balance of $149,900. As of July 31, 2022 and October 31, 2021, the SBA Note had an accrued interest of $12,360 and $8,152, respectively, reflected in the accompanying unaudited consolidated balance sheets under accrued expense and other liabilities. On June 17, 2020, the Company entered into a Loan Authorization and Agreement (“SBA Loan Agreement”) with the SBA, under the SBA’s Economic Injury Disaster Loan assistance program in light of the impact of the COVID-19 pandemic. Pursuant to the SBA Loan Agreement, the Company received an advanced of $150,000, to be used for working capital purposes only. Pursuant to the SBA Loan Agreement, the Company executed; (i) a note for the benefit of the SBA (“SBA Note”), which contains customary events of default; and (ii) a Security Agreement, granting the SBA a security interest in all tangible and intangible personal property of the Company, which also contains customary events of default. The SBA Note bears an interest rate of 3.75% per annum which accrue from the date of the advance. Instalment payments, including principal and interest, are due monthly beginning June 17, 2021 (twelve months from the date of the SBA Note) in the amount of $731. The balance of principal and interest is payable thirty years from the date of the SBA Note. As of July 31, 2022 and October 31, 2021, the SBA Note had an outstanding principal balance of $150,000. As of July 31, 2022 and October 31, 2021, the SBA Note had accrued interest of $11,927 and $7,721, respectively, reflected in the accompanying unaudited consolidated balance sheets under accrued expense and other liabilities. November Note Payable On November 12, 2020, the Company entered into a Note Agreement with an investor for the sale of the Company’s note (the “Note”). Pursuant to the terms provided for in the Note Agreement, the Company issued to the investor a Note and the Company received proceeds in the amount of $7,000. The Note bears an interest of 5% per annum and matured on November 12, 2021. This Note is currently in default. As of October 31, 2021, the Note had an outstanding principal balance of $7,000 and accrued interest of $338 and as of July 31, 2022, the Note had an outstanding principal balance of $7,000 and accrued interest of $600, reflected in the accompanying unaudited consolidated balance sheets under accrued expense and other liabilities.

Advance Payable

Advance Payable	9 Months Ended
Advance Payable	Jul. 31, 2022
Advance Payable [Abstract]
ADVANCE PAYABLE	NOTE 7 – ADVANCE PAYABLE On July 9, 2021, the Company entered into a capital advance agreement with Shopify (“July Advance Agreement”). Under the terms of the July Advance Agreement, the Company has received $95,000 of principal and will repay $107,350 by remitting 17% of the total customer payments processed daily by the e-commerce platform provider until the advance is repaid in full. During the transition period ending October 31, 2021, the Company paid $27,055 of the outstanding balance. During the nine months ended July 31, 2022, the Company repaid all remaining outstanding balance of $67,945. On August 31, 2021, the Company entered into a capital advance agreement with Shopify (“August Advance Agreement”). Under the terms of the August Advance Agreement, the Company has received $34,000 of principal and will repay $38,420 by remitting 17% of the total customer payments processed daily by the e-commerce platform provider until the advance is repaid in full. During the nine months ended July 31, 2022, the Company repaid all remaining outstanding balance of $34,000. On April 5, 2022, the Company entered into a capital advance agreement with PayPal (“PayPal Advance Agreement I”). Under the terms of the PayPal Advance Agreement I, the Company received $25,000 of principal and will repay $27,502 by remitting 30% of the total customer payments processed daily by the e-commerce platform provider until the advance is repaid in full. The Company recorded $2,502 of debt discount which was amortized immediately to interest expense. During the nine months ended July 31, 2022, the Company paid $15,822 of the outstanding balance. The advance has an outstanding balance of $11,680 as of July 31, 2022, reflected as advance payable On April 6, 2022, the Company entered into a capital advance agreement with Shopify (“April Advance Agreement I”). Under the terms of the April Advance Agreement I, the Company received $23,000 of principal and will repay $25,990 by remitting 17% of the total customer payments processed daily by the e-commerce platform provider until the advance is repaid in full. The Company recorded $2,990 of debt discount which was amortized immediately to interest expense. During the nine months ended July 31, 2022, the Company repaid all remaining outstanding balance of $25,990. On April 6, 2022, the Company entered into a capital advance agreement with Shopify (“April Advance Agreement II”). Under the terms of the April Advance Agreement II, the Company received $120,000 of principal and will repay $135,600 by remitting 17% of the total customer payments processed daily by the e-commerce platform provider until the advance is repaid in full. The Company recorded $15,600 of debt discount which was amortized immediately to interest expense. Additionally, on April 6, 2022, the Company entered into a capital advance agreement with Shopify (“April Advance Agreement III”). Under the terms of the April Advance Agreement III, the Company received $42,000 of principal and will repay $47,460 by remitting 30% of the total customer payments processed daily by the e-commerce platform provider until the advance is repaid in full. The Company recorded $5,460 of debt discount which was amortized immediately to interest expense. During the nine months ended July 31, 2022, the Company paid $48,043 of the April Advance Agreement II and III. The advance has an outstanding balance of $135,017 as of July 31, 2022, reflected as advance payable On April 16, 2022, the Company entered into a capital advance agreement with Shopify (“April Advance Agreement IV”). Under the terms of the April Advance Agreement III, the Company received $110,000 of principal and will repay $124,300 by remitting 17% of the total customer payments processed daily by the e-commerce platform provider until the advance is repaid in full. The Company recorded $14,300 of debt discount which was amortized immediately to interest expense. During the nine months ended July 31, 2022, the Company paid $27,433 of the April Advance Agreement IV. The advance has an outstanding balance of $96,867 as of July 31, 2022, reflected as advance payable

Unredeemed Gift Cards

Unredeemed Gift Cards	9 Months Ended
Unredeemed Gift Cards	Jul. 31, 2022
Unredeemed Gift Card Disclosure Abstract
UNREDEEMED GIFT CARDS	NOTE 8 – UNREDEEMED GIFT CARDS Unredeemed gift cards activities as of July 31, 2022 and October 31, 2021 are summarized as follows: July 31, October 31, (Unaudited) Beginning balance $ 164,912 $ 48,311 Acquired gift card liability (see Note 3) — 87,260 Sale of gift cards 121,603 186,749 Promotional and other gift cards issued 84,250 — Revenue from breakage (22,810 ) (60,515 ) Gift card redemptions (113,323 ) (96,893 ) Ending balance $ 234,632 $ 164,912

Lease Liabilities

Lease Liabilities	9 Months Ended
Lease Liabilities	Jul. 31, 2022
Lease Liabilities [Abstract]
LEASE LIABILITIES	NOTE 9 – LEASE LIABILITIES Operating Lease Right-of-Use (“ROU”) Asset and Operating Lease Liabilities On July 6, 2021, the Company acquired Model Meals (see Note 3), which had a lease agreement for its facility in Santa Ana, California which expired in December 2021 (see Note 12) and had remaining operating right-of-use asset and liability of $76,136 and $79,054, respectively. Pursuant to the lease agreement, the lease required the Company to pay a monthly base rent of $14,140 for the remainder of the lease term. On June 1, 2021, the Company entered into a lease agreement, effective July 13, 2021, for its facility in Pembroke Pine, Florida. The lease is for a period of 36 months commencing in July 2021 and expiring in July 2024. Pursuant to the lease agreement, the Company shall pay a monthly base rent of; (i) $8,062 in the first year; (ii) $8,465 in the second year and; (iii) $8,888 in the third year. On November 11, 2021, the Company renewed its lease agreement (“Renewed Lease Agreement”) for their California kitchen facility, effective on January 1, 2022. The Renewed Lease Agreement provides for (i) a term of six months from the effective date which terminated on June 30, 2022; (ii) a monthly base rent of $9,960 and; (iii) a monthly storage fee of $2,340. The Renewed Lease Agreement can be terminated with two months’ notice. The Company has elected not to recognize right-of-use (“ROU”) assets and lease liabilities for short-term leases that have a term of 12 months or less (see Note 2). As of July 1, 2022, the Company is leasing storage space on a month-to month basis and is no longer operating the kitchen at this facility. For the nine months ended July 31, 2022, total rent expense amounted to $182,043 which is included in general and administrative expenses The significant assumption used to determine the present value of the operating lease liabilities was a discount rate of 10% which was based on the Company’s estimated incremental borrowing rate. July 31, October 31, (Unaudited) Operating ROU assets $ 336,614 $ 336,614 Less accumulated reductions (153,736 ) (68,105 ) Balance of Operating ROU assets, net $ 182,878 $ 268,509 Operating lease liabilities related to the Operating ROU assets is summarized below: July 31, 2022 October 31, (Unaudited) Operating lease liabilities $ 339,532 $ 339,532 Reduction of operating lease liabilities (151,738 ) (71,178 ) Total 187,794 268,354 Less: short term portion (86,699 ) (101,431 ) Long term portion $ 101,095 $ 166,923 Future minimum operating lease payments under the operating lease agreements on July 31, 2022 are as follows: Year Amount Ending October 31, 2022 (remaining) $ 25,394 Ending October 31, 2023 102,846 Ending October 31, 2024 79,991 Total minimum non-cancellable operating lease payments 208,231 Less: discount to fair value (20,437 ) Total operating lease liabilities on July 31, 2022 $ 187,794 Financing Lease Right-of-Use (“ROU”) Assets and Financing Lease Liability On July 13, 2021, the Company entered into a financing agreement with a lessor for the purchase of equipment. Pursuant to the financing agreement, the Company shall make a monthly payment of $6,500 for a period of 36 months commencing in August 2021 through August 2024. The monthly payment shall consist of $6,000 cash and $500 in gift card allowance, reflected in the accompanying unaudited consolidated balance sheet under accrued expense and other liabilities The significant assumption used to determine the present value of the financing lease liability was a discount rate of 10% which was based on the Company’s estimated incremental borrowing rate. Financing right-of-use (“Financing ROU”) asset is summarized below: July 31, 2022 October 31, (Unaudited) Financing ROU assets $ 200,509 $ 200,509 Less accumulated depreciation (69,621 ) (19,494 ) Balance of financing ROU assets, net $ 130,888 $ 181,015 For the three and nine months ended July 31, 2022, depreciation expense related to Financing ROU assets amounted to $16,709 and $50,127, respectively. Financing lease liability related to the Financing ROU assets is summarized below: July 31, October 31, (Unaudited) Financing lease payables for equipment $ 200,509 $ 200,509 Reduction of financing lease liability (59,648 ) (13,650 ) Total 140,861 186,859 Less: short term portion (66,926 ) (62,210 ) Long term portion $ 73,935 $ 124,649 Future minimum lease payments under the financing lease agreement on July 31, 2022 are as follows: Year Amount Year ending October 31, 2022 (remaining) $ 19,500 Year ending October 31, 2023 78,000 Year ending October 31, 2024 58,500 Total minimum non-cancellable financing lease payments 156,000 Less: discount to fair value (15,139 ) Total financing lease liabilities on July 31, 2022 $ 140,861

Related Party Balances and Tran

Related Party Balances and Transactions	9 Months Ended
Related Party Balances and Transactions	Jul. 31, 2022
Related Party Transactions [Abstract]
RELATED PARTY BALANCES AND TRANSACTIONS	NOTE 10 – RELATED PARTY BALANCES AND TRANSACTIONS The Company utilizes the shipping carrier account of a related entity, owned 50% by the Company’s current chief executive officer and principal stockholder for its inbound and outbound shipping needs. The related entity bills the Company for the direct cost of the shipping charges plus a 10% fee. The total amount incurred and paid to the related entity during the nine months ended July 31, 2022 and 2021 was $288,731 and $121,008, respectively, which is included in cost of goods sold in the accompanying unaudited consolidated statement of operations. There were no amounts due to this related party for these services as of July 31, 2022 and October 31, 2021. See also related party convertible note in Note 5 – March 2021 Note III – Related Party. See consulting agreement in Note 12 – Consulting Agreement – Related Party

Stockholders_ Equity (Deficit)

Stockholders’ Equity (Deficit)	9 Months Ended
Stockholders’ Equity (Deficit)	Jul. 31, 2022
Stockholders’ Equity (Deficit) [Abstract]
STOCKHOLDERS’ EQUITY (DEFICIT)	NOTE 11 – STOCKHOLDERS’ EQUITY (DEFICIT) Preferred Stock The Company is authorized to issue 20,000,000 shares of common stock with a par value of $0.001. Common Stock Shares Authorized The Company is authorized to issue 1,000,000,000 shares of common stock with a par value of $0.001. Common Stock Issued for Cash ● During the nine months ended July 31, 2021, the Company issued an aggregate of 1,206,605 shares of common stock, to non-affiliate investors for aggregate net cash proceeds of $866,770. ● During the nine months ended July 31, 2022, the Company issued an aggregate of 1,932,204 shares of common stock, to non-affiliate investors for aggregate net cash proceeds of $1,368,492. Common Stock Issued for Services and Prepaid Services ● On April 1, 2021, the Company issued an aggregate of 2,000,000 shares of common stock with grant date fair value of $1,800,000 or $0.90 per share based on the market price of common stock on grant date, to a consultant pursuant to a consulting agreement. The fair value of the common stock was recorded in equity as deferred compensation which will be amortized over the twelve-month service period. During the nine months ended July 31, 2022 and 2021, the Company amortized $750,000 and $600,000 of the deferred compensation related to this consulting agreement, respectively, which was charged to professional and consulting fee in the accompanying unaudited consolidated statements of operations. As of July 31, 2022 and October 31, 2021, there was $0 and $750,000, respectively, of deferred compensation related to this consulting agreement. ● On November 8, 2021, the Company issued an aggregate of 600,000 shares of common stock with grant date fair value of $726,000 or $1.21 per share based on the market price of common stock on grant date, to a consultant pursuant to a consulting agreement. The fair value of the common stock was recorded in equity as deferred compensation which will be amortized over the six-month service period. During the nine months ended July 31, 2022, the Company amortized the $726,000 of the deferred compensation which was charged to professional and consulting fee in the accompanying unaudited consolidated statements of operations. As of July 31, 2022, there was no deferred compensation related to this consulting agreement. ● During the nine months ended July 31, 2022, the Company granted 60,000 shares of common stock with grant date fair value of $60,600 or $1.01 per share based on the market price of common stock on grant date, to a consultant for services. The grant fair value of the common stock of $60,600 was charged to professional and consulting fee in the accompanying unaudited consolidated statements of operations. Common Stock for Commitment Fee with Convertible Notes Payable ● In December 2020, the Company issued an aggregate of 119,535 shares of common stock valued at $38,264 using the relative fair value method to two non-affiliate investors as a commitment fee in connection with the December 2020 Financings which was recorded as debt discount which will be amortized over the life of the notes. ● On January 12, 2021, the Company issued 29,385 shares of common stock to a non-affiliate investor as commitment fee, pursuant to a securities purchase agreement, valued at $17,296 using the relative fair value method and was recorded as debt discount to be amortized over the life of the note. ● On February 3, 2021, the Company issued 150,000 shares of common stock to a non-affiliate investor as commitment fee, pursuant to a securities purchase agreement, valued at $85,981 using the relative fair value method and was recorded as debt discount to be amortized over the life of the note. ● On March 22, 2021, the Company issued 25,000 shares of common stock to a non-affiliate investor as commitment fee pursuant to a securities purchase agreement, valued at $6,949 using the relative fair value method and was recorded as debt discount to be amortized over the life of the note. ● On March 29, 2021, the Company issued 50,000 shares of common stock to a non-affiliate investor as commitment fee pursuant to a securities purchase agreement, valued at $24,504 using the relative fair value method and was recorded as debt discount to be amortized over the life of the note. ● On March 30, 2021, the Company issued 50,000 shares of common stock to a related party investor as commitment fee pursuant to a securities purchase agreement, valued at $23,718 using the relative fair value method and was recorded as debt discount to be amortized over the life of the note. ● On March 30, 2021, the Company issued 25,000 shares of common stock to a non-affiliate investor as commitment fee pursuant to a securities purchase agreement, valued at $11,845 using the relative fair value method and was recorded as debt discount to be amortized over the life of the note. ● On March 31, 2021, the Company granted 75,000 shares of common stock to a non-affiliate investor as commitment fee pursuant to a securities purchase agreement, valued at $36,499 using the relative fair value method and was recorded as debt discount to be amortized over the life of the note. ● On April 7, 2021, the Company granted 75,000 shares of common stock to a non-affiliate investor as commitment fee pursuant to a securities purchase agreement, valued at $30,694 using the relative fair value method and was recorded as debt discount to be amortized over the life of the note. ● On May 17, 2021, the Company granted 60,000 shares of common stock to a non-affiliate investor as commitment fee pursuant to a securities purchase agreement (see Note 5), valued at $26,824 using the relative fair value method and was recorded as debt discount to be amortized over the life of the note. ● On May 28, 2021, the Company granted 150,000 shares of common stock to a non-affiliate investor as commitment fee pursuant to a securities purchase agreement (see Note 5), valued at $67,645 using the relative fair value method and was recorded as debt discount to be amortized over the life of the note. ● During the nine months ended July 31, 2022, the Company granted 45,989 shares of common stock with grant date fair value of $29,879 or $0.65 per share based on the market price of common stock on grant date, to a convertible note holder as a commitment fee. The grant fair value of the common stock of $29,879 was charged to interest expense in the accompanying unaudited consolidated statements of operations. Common Stock Issued Pursuant to Lock-Up & Leak Out Agreements ● During the nine months ended July 31, 2022, the Company issued as consideration, to several stockholders, an aggregate of 516,748 shares of common stock with grant date fair value of $554,273 or an average per share price of $1.07, based on the market price of common stock on grant date, for the stockholders’ execution of a Lock-Up & Leak Out Agreement. The grant date fair value of the common stock was initially recorded in equity as deferred compensation and is being amortized over the lock up period of three-to-four- months through July 31, 2022. During the nine months ended July 31, 2022, the Company amortized $670,212 including $115,939 of deferred compensation as of October 31, 2021, of deferred compensation which was recorded as professional and consulting expenses in the accompanying unaudited consolidated statement of operations. As of July 31, 2022, there were no deferred compensation related to the Lock-Up & Leak Out Agreements. On May 1, 2022, the Company issued as consideration to a related party stockholder 25,000 shares of common stock with grant date fair value of $27,500, or $1.10 per share, based on the market price of common stock on grant date, for the stockholder’s execution of a Lock-Up & Leak Out Agreement. In connection with this issuance, on May 1, 2022, the Company recorded stock-based professional fees – related party of $27,500. Common Stock Issued Pursuant to Product Development Agreements ● During the three months ended January 31, 2022, the Company issued 100,000 shares of common stock with grant date fair value of $100,000 based on the fair value of common stock on the date of grant, pursuant to an agreement which was recorded as deferred compensation and is being amortized over the 2-year term of the agreement. During the nine months ended July 31, 2022, $370,677 of the accumulated deferred compensation was expensed as product development expense in the accompanying unaudited consolidated statements of operations related to shares issued in the prior and current period connection with joint product development agreements. As of July 31, 2022, there was $237,603 of deferred compensation related to the product development agreements. Common Stock Issued Pursuant to Stock-Based Compensation ● On April 29, 2021, the Company issued 25,000 shares of common stock with an aggregate grant date fair value of $24,750 or $0.99 per share based on the market price of common stock on grant date, to a board member for services rendered and was charged to compensation and related expenses in the accompanying condensed consolidated statements of operations. Common Stock Issued for Acquisition of Subsidiary ● On July 6, 2021, the Company issued an aggregate of 2,008,310 shares of common stock with fair value of $2,028,393, based on the market price of common stock on date of acquisition, to members of Model Meals, LLC in exchange for 100% membership, pursuant to the Agreement and Plan of Merger (see Note 1 and Note 3). Common Stock Issued for Warrant Exchange Agreements ● On May 1, 2022, in connection with the settlement of a down round exercise price trigger, the Company entered into a warrant exchange agreement with various warrant holders (collectively as “Parties”) pursuant to which the Parties exercised an aggregate of 922,495 warrants with initial exercise price of $2.50 issued between January to September 2021, at an agreed upon reduced exercise price of $0.75 with the Company issuing an aggregate of 3,048,917 shares of common stock in exchange for the outstanding warrants and no cash consideration. In connection with this warrant exchange, the Company recorded a deemed dividend of $2,578,446, which was calculated as the fair value of excess shares issued to the Parties with a grant date fair value of $2,578,446, or $0.51 per share, based on the market price of common stock on grant date. ● On June 30, 2022, in connection with a lock-up and leak out settlement agreement, the Company issued 674,100 shares of its common stock in connection with the cashless exercise of 674,100 warrants and no cash consideration. The 674,100 had grant date fair value of $195,490 or $0.29 per share based on the market price of common stock on grant date. In connection with this cashless exercise of warrants, the Company recorded settlement expense of $195,490. Common stock issued pursuant to settlement agreements ● On June 30, 2022, pursuant to a stock repurchase and settlement agreement and a lock-up and settlement agreement, the Company issued an aggregate of 585,000 shares of its common stock with grant date fair value of 169,650, or $0.29 per share, based on the market price of common stock on grant date, for the stockholders’ execution of a Lock-Up & Leak Out Agreement. In connection with these agreements, the Company recorded settlement expense of $185,344. In connection with the stock repurchase and settlement agreement the Company agreed to repurchase 166,667 shares of its common stock from an investor for $150,000. In connection with this agreement the Company recorded a common stock repurchase obligation of $150,000 and reduced additional paid-in capital by $150,000. In July 2022, the Company paid $50,000 towards this common stock repurchase agreement. On July 31, 2022, the common stock repurchase obligation related to this agreement amounted to $100,000. Stock Warrants Warrants Issued Pursuant to Stock-Based Compensation ● On March 25, 2022, the Company issued to two executives fully vested warrants to purchase up to an aggregate of 250,000 shares of the Company’s common stock, in connection with their employment agreements dated March 25, 2022. These warrants are exercisable, in whole or in part, upon issuance at $0.001 per share, and expire on March 25, 2027. These warrants have an aggregate grant date fair value of $374,560 or $1.50 per share based on the market price of common stock on grant date, recorded as compensation expense in the accompanying unaudited consolidated statements of operations. Warrants Issued for Professional Services ● During the three months ended January 31, 2021, the Company issued fully vested warrants to purchase up to 10,640 shares of the Company’s common stock to a third-party entity in connection with a consulting agreement. This warrant is exercisable, in whole or in part, upon issuance at $1.27 per share, and expires on December 8, 2025. These warrants have a grant date fair value of $11,471, recorded as professional and consulting expenses in the accompanying unaudited consolidated statements of operations. ● During the three months ended January 31, 2022, the Company issued fully vested warrants to purchase up to 100,000 shares of the Company’s common stock to a third-party entity in connection with a consulting agreement. This warrant is exercisable, in whole or in part, upon issuance at $1.50 per share, and expires on May 18, 2025. These warrants have a grant date fair value of $36,777, recorded as professional and consulting expenses in the accompanying unaudited consolidated statements of operations. Warrants for Commitment Fee with Convertible Notes Payable ● On January 12, 2021, the Company issued a warrant to purchase up to 55,000 shares of common stock to a non-affiliate investor as an additional commitment fee pursuant to a note amendment. The warrant; (i) was valued at $6,173 using the relative fair value method and recorded as a debt discount to be amortized over the life of the note; (ii) has an exercise price of $2.50; (iii) subject to the adjustments and 4.99%, ownership limitation and; (iv) expires on the fifth-year anniversary from the date of issuance. ● On February 2, 2021, the Company issued a warrant to purchase up to 150,000 shares of common stock to a non-affiliate investor as an additional commitment fee pursuant to a note amendment. The warrant; (i) was valued at $31,821 using the relative fair value method and recorded as a debt discount to be amortized over the life of the note; (ii) has an exercise price of $2.50; (iii) subject to the adjustments and 4.99%, ownership limitation and; (iv) expires on the fifth-year anniversary from the date of issuance. ● On March 22, 2021, the Company issued a warrant to purchase up to 25,000 shares of common stock to a non-affiliate investor as additional commitment fee pursuant to a note amendment. The warrant; (i) was valued at $1,346 using the relative fair value method and recorded as a debt discount to be amortized over the life of the note; (ii) has an exercise price of $2.50; (iii) subject to the adjustments and 4.99%, ownership limitation and; (iv) expires on the fifth-year anniversary from the date of issuance. ● On March 25, 2021, the Company issued warrant to purchase up to 78,250 shares of common to a non-affiliate investor as additional commitment fee pursuant to a note amendment. The warrant; (i) was valued at $4,744 using the relative fair value method and recorded as a debt discount to be amortized over the life of the note; (ii) has an exercise price of $2.50; (iii) subject to the adjustments and 4.99%, ownership limitation and; (iv) expires on the fifth-year anniversary from the date of issuance. ● On March 29, 2021, the Company issued a warrant to purchase up to 50,000 shares of common stock to a non-affiliate investor as additional commitment fee pursuant to a note amendment. The warrant; (i) was valued at $8,350 using the relative fair value method and recorded as a debt discount to be amortized over the life of the note; (ii) has an exercise price of $2.50; (iii) subject to the adjustments and 4.99%, ownership limitation and; (iv) expires on the fifth-year anniversary from the date of issuance. ● On March 29, 2021, the Company issued a warrant to purchase up to 50,000 shares of common stock to a related party investor as additional commitment fee pursuant to a note amendment. The warrant; (i) was valued at $7,924 using the relative fair value method and recorded as a debt discount to be amortized over the life of the note; (ii) has an exercise price of $2.50; (iii) subject to the adjustments and 4.99%, ownership limitation and; (iv) expires on the fifth-year anniversary from the date of issuance. ● On March 30, 2021, the Company issued a warrant to purchase up to 25,000 shares of common stock to a non-affiliate investor as additional commitment fee pursuant to a note amendment. The warrant; (i) was valued at $3,957 using the relative fair value method and recorded as a debt discount to be amortized over the life of the note; (ii) has an exercise price of $2.50; (iii) subject to the adjustments and 4.99%, ownership limitation and; (iv) expires on the fifth-year anniversary from the date of issuance. ● On March 31, 2021, the Company issued a warrant to purchase up to 75,000 shares of common stock to a non-affiliate investor as additional commitment fee pursuant to a note amendment. The warrant; (i) was valued at $12,352 using the relative fair value method and recorded as a debt discount to be amortized over the life of the note; (ii) has an exercise price of $2.50; (iii) subject to the adjustments and 4.99%, ownership limitation and; (iv) expires on the fifth-year anniversary from the date of issuance. ● On April 7, 2021, the Company issued a warrant to purchase up to 75,000 shares of common stock to a non-affiliate investor as an additional commitment fee pursuant to a note amendment. The warrant; (i) was valued at $9,592 using the relative fair value method and recorded as a debt discount to be amortized over the life of the note; (ii) has an exercise price of $2.50; (iii) subject to the adjustments and 4.99%, ownership limitation and; (iv) expires on the fifth-year anniversary from the date of issuance. ● On May 17, 2021, the Company issued a warrant to purchase up to 60,000 shares of common stock to a non-affiliate investor as additional commitment fee pursuant to a note amendment (see Note 5). The warrant; (i) was valued at $9,767 using the relative fair value method and recorded as a debt discount to be amortized over the life of the note; (ii) has an exercise price of $2.50; (iii) subject to the adjustments and 4.99%, ownership limitation and; (iv) expires on the fifth-year anniversary from the date of issuance. ● On May 28, 2021, the Company issued a warrant to purchase up to 150,000 shares of common stock to a non-affiliate investor as additional commitment fee pursuant to a note amendment (see Note 5). The warrant; (i) was valued at $30,328 using the relative fair value method and recorded as a debt discount to be amortized over the life of the note; (ii) has an exercise price of $1.50; (iii) subject to the adjustments and 4.99%, ownership limitation and; (iv) expires on the fifth-year anniversary from the date of issuance. ● On May 18, 2022, the Company issued a warrant to purchase up to 869,565 shares of common stock to a non-affiliate investor as additional commitment fee pursuant to a convertible (see Note 5). The warrant; (i) was valued at $93,641 using the relative fair value method and recorded as a debt discount to be amortized over the life of the note; (ii) has an exercise price of $0.575; (iii) subject to the adjustments and 4.99%, ownership limitation and; (iv) expires on the third-year anniversary from the date of issuance. ● On May 24, 2022, the Company issued a warrant to purchase up to 217,391 shares of common stock to a non-affiliate investor as additional commitment fee pursuant to a convertible (see Note 5). The warrant; (i) was valued at $24,902 using the relative fair value method and recorded as a debt discount to be amortized over the life of the note; (ii) has an exercise price of $0.575; (iii) subject to the adjustments and 4.99%, ownership limitation and; (iv) expires on the third-year anniversary from the date of issuance. ● On May 24, 2022, the Company issued a warrant to purchase up to 318,134 shares of common stock to a non-affiliate investor as additional commitment fee pursuant to a convertible (see Note 5). The warrant; (i) was valued at $36,442 using the relative fair value method and recorded as a debt discount to be amortized over the life of the note; (ii) has an exercise price of $0.575; (iii) subject to the adjustments and 4.99%, ownership limitation and; (iv) expires on the third-year anniversary from the date of issuance. The Company used the Binomial pricing model to determine the fair value of its common stock warrants which requires the Company to make several key judgments including: ● the expected life of issued stock warrants; ● the expected volatility of the Company’s stock price; ● the expected dividend yields to be realized over the life of the stock warrants; and ● the risk-free interest rate over the expected life of the stock warrants. The Company’s computation of the expected life of issued stock warrants was based on the simplified method as the Company does not have adequate exercise experience to determine the expected term and was estimated to be 2 years. The interest rate was based on the U.S. Treasury yield curve in effect at the time of grant. The computation of volatility was based on the historical volatility of the Company’s common stock and the Company’s expected divided yield was estimated to be zero. Dividend rate — Term (in years) 2.5 to 5 years Volatility 61% to 69% Risk-free interest rate 0.14% to 2.80% A summary of the Company’s outstanding stock warrants as of July 31, 2022 and changes during the period ended are presented below: Number of Weighted Weighted Balance on October 31, 2021 15,745,066 $ 0.170 7.4 Warrants issued for services 100,000 1.500 4.1 Warrants issued pursuant to employment agreements 500,000 0.001 4.9 Warrants issued in connection with convertible debt 1,405,090 0.575 3.0 Warrants exercised (1,596,595 ) 1.350 Balance on July 31, 2022 16,153,561 $ 0.090 6.4 Stock warrants exercisable on July 31, 2022 16,153,561 $ 0.090 6.4 Certain exercisable stock warrants had per share intrinsic value of $0.22 on July 31, 2022, totaling $2,876,945.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Jul. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 12 – COMMITMENTS AND CONTINGENCIES Employment Agreement On October 1, 2021, the Company entered into an employment agreement (“Duchman Employment Agreement”) with Zalmi Scher Duchman to serve as the Company’s Chief Executive Officer. The Duchman Employment Agreement has a term of three years (“Term”) from the effective date and provides for (i) an annual salary of $120,000 and (ii) a one-time warrant grant of 2,000,000 shares of common stock, with grant a date fair value of $2,714,971, which vested upon issuance, exercisable at $0.001 and expires on October 1, 2026. Mr. Duchman is entitled to vacation, sick and holiday pay and other benefits, in accordance with the Company’s policies established and in effect from time to time. The Company may terminate the Mr. Duchman for cause (as defined in the Duchman Employment Agreement) by giving Mr. Duchman written notice approved by the Board of Directors (“Board”) of such termination, such notice (i) to state in detail the particular act or acts or failure or failures to act that constitute the grounds on which the proposed termination for cause is based and (ii) to be given within six months of the Board learning of such act or acts or failure or failures to act. The Duchman Employment Agreement may be terminated at Board’s discretion during the Term, provided that if Mr. Duchman is terminated without cause, the Company shall pay to Mr. Duchman an amount calculated by multiplying Mr. Duchman monthly salary, at the time of such termination, times the number of months remaining in the Term. On March 25, 2022, the Company entered into an employment agreement (“May Employment Agreement”) with Camille May to serve as the Company’s Chief Financial Officer. The May Employment Agreement has a term of two years (“Term”) from the effective date and provides for (i) an annual salary of $120,000 and (ii) a one-time warrant grant of 250,000 shares of common stock, with grant a date fair value of $187,280, which vested upon issuance, exercisable at $0.001 and expires on March 27, 2027. Ms. May is entitled to vacation, sick and holiday pay and other benefits, in accordance with the Company’s policies established and in effect from time to time. The Company may terminate the Ms. May for cause (as defined in the May Employment Agreement) by giving Ms. May written notice approved by the Board of Directors of such termination. Lease Obligation Settlement On February 22, 2018, the Company entered into a Surrender Agreement with a former landlord for rental obligations dating back to the year ended December 31, 2017 until the space was vacated by the Company on March 31, 2017. Upon executing the Surrender Agreement, the former landlord and the Company agreed that the total rental obligation due was $109,235. The former landlord agreed to $50,000 as full satisfaction of all obligations owed at the time of the Surrender Agreement. The Company agreed to make regular payments on the outstanding rental obligation until paid in full through September 2019; however, there is no penalty if the obligation is not fully paid by such date. As of July 31, 2022 and October 31, 2021, the balance remaining due on this obligation were $21,400 and $22,900, respectively, included in accounts payable on the accompanying unaudited consolidated balance sheets. Put Option Agreement and Stock Repurchase Agreement On April 20, 2020, the Company and a stockholder entered into a Put Option Agreement (see Note 3), pursuant to which, among other things, the Company agreed, at the election of the stockholder, to purchase certain shares of common stock from such stockholder no sooner than two years from the date of the Put Option Agreement also referred to herein as Market Period. Pursuant to the Put Option Agreement, in the event that the stockholder does not generate $1.3 million dollars also referred to herein as Total Investment in gross proceeds from the sale of its shares of common stock by the second anniversary of the Put Option Agreement, then the stockholder has the right to cause the Company to purchase shares held by the stockholder at a price equal to the difference between the Total Investment and the net proceeds actually realized by the stockholder from shares of common stock sold during the Market Period and the number of shares of common stock held by the stockholder on the date the put right is exercised. The put right expired fourteen (14) days from end of the Market Period. In connection with the Put Option Agreement, the Company recorded an initial common stock repurchase obligation in the amount of $1.3 million, reflected in the accompanying consolidated balance sheets as common stock repurchase obligation, and reduction of additional paid in capital upon entering the Put Option Agreement. The repurchase obligation is re-assessed by the Company each reporting period and adjusted for the proceeds received by the stockholder from sale of common stock. During the ten months ended October 31, 2021, the Company recorded a reduction of $681,725. During the nine months ended July 31, 2022, the Company recorded a reduction of $113,072. As of July 31, 2022, the Company has recorded an aggregate reduction of $794,797 for net proceeds realized by the stockholder on sale of Company common stock which was reclassified to additional paid in capital. As of July 31, 2022 and October 31, 2021, the Company had $505,203 and $618,275 million of common stock repurchase obligation outstanding, respectively. On June 30, 2022, the Company and a stockholder entered into a Stock Repurchase Agreement, pursuant to which, among other things, the Company agreed to purchase certain shares of common stock from such stockholder for an aggregate purchase price of $150,000. In connection with this Stock Repurchase Agreement, the Company recorded an initial common stock repurchase obligation in the amount of $150,000 which was recorded in the accompanying consolidated balance sheets as common stock repurchase obligation, and reduction of additional paid in capital upon entering the Stock Repurchase Agreement. The Company shall pay to the Shareholder the Purchase Price in immediately available funds, as follows: (1) $50,000 which was be paid upon the complete execution of this Stock Repurchase Agreement, and the related Settlement Agreement and Release, and the Lock-up and Leak-out Agreement; (2) $50,000 to be paid 30 days after the complete execution of the Stock Repurchase Agreement, the Settlement Agreement and Release, and the Lock-up and Leak-out Agreement; and (3) the final $50,000 to be paid 60 days after the complete execution of the Stock Repurchase Agreement, the Settlement Agreement and Release, and the Lock-up and Leak-out Agreement.. As of July 31, 2022, the Company had $100,000 of common stock repurchase obligation outstanding. Joint Product Development and Distribution Agreement Corlich Enterprises, Inc On September 22, 2020, the Company and Corlich Enterprises, Inc., a New Jersey corporation (“Corlich”) entered into a Joint Product Development and Distribution Agreement (the “Development Agreement”), effective the same date, pursuant to which, among other things, Corlich agreed to provide certain commercial services (the “Services”) of Cat Cora, an American professional chef, in order for the Company and Corlich to collaboratively develop a brand of meals (the “Cat Cora Meals”). In consideration for the Services, the Company agreed to (i) pay Corlich a royalty on net revenues generated from (A) the Cat Cora Meals, and (B) Home Bistro and Prime Chop brand orders where a dedicated code is used at purchase, and (ii) issue a warrant to purchase up to 300,000 shares of common stock. The Development Agreement has a three-year term, unless sooner terminated pursuant to its terms. During the first year of the Development Agreement’s term, Corlich is guaranteed a minimum royalty payment of $109,210. For the second and third year of the Development Agreement’s term, the Development Agreement estimates that Corlich will be guaranteed a minimum royalty payment of $218,380 and $436,770, respectively, subject to the achievement of the prior year’s guaranteed minimum royalty (“GMR”) payment and the parties’ agreement to negotiate in good faith a lower guaranteed minimum royalty if such guaranteed minimum royalty payment is not achieved or to otherwise terminate the Development Agreement. Royalties above the guaranteed minimum royalty are based on an increasing percentage of net revenues generated from the sale of Cat Cora Meals as certain revenue milestones are met as defined in the Distribution Agreement. The GMR is expensed to cost of sales over the term of the Development Agreement. During the ten months ended October 31, 2021, the Company paid an aggregate of $78,260 of accrued royalty fee. During the nine months ended July 31, 2022, the Company paid an aggregate of $49,139 of accrued royalty fee. During the nine months ended July 31, 2022, the Development Agreement was amended by both parties whereby the minimal royalty payment of $109,210 was extended through December 31, 2021 and the increased GMR of $218,380 would begin January 1, 2022 and the $436,770 GMR January 1, 2023. During the nine months ended July 31, 2022, the Company recorded $86,442 of royalty expense related to the GMR. As of July 31, 2022, an aggregate total of $109,199 of accrued royalty feewas reflected, with $61,794 included in accounts payable and $44,405 included in accrued expense and other liabilities in the accompanying unaudited consolidated balance sheets. As of July 31, 2022 and October 31, 2021, a total of $109,199 and $71,896 of accrued royalty fee, respectively, was reflected under accrued expense and other liabilities in the accompanying unaudited consolidated balance sheets. Hungry Fan Brand, LLC On February 18, 2021, the Company and Hungry Fan Brand, LLC (“Hungry Fan”) (collectively as “Parties”) entered into a Joint Product Development and Distribution Agreement (the “Development Agreement”), effective the same date. The Development Agreement shall remain in effect for twelve months from the effective. Pursuant to the Development Agreement, the Parties shall jointly contribute and be responsible for the development of the Hungry Fan Meals, under the terms and conditions of the Development Agreement. For the use of Hungry Fan Meals and all associated intellectual property for the benefit of the Hungry Fan Meals, the Company shall pay to Hungry Fan the following: (i) 10% of all Net Revenue generated from the sale of the Hungry Fan Meals (the “Hungry Fan Royalty”). For the purpose of this agreement “Net Revenue” shall be defined as gross sales generated on Hungry Fan Meals less discounts and returns. The Hungry Fan Royalty generated during each calendar month in which an agreement is in effect shall be due and payable by the 10 th th In addition, subject to the terms and conditions of this Development Agreement, the Company shall pay to Hungry Fan a guaranteed minimum compensation of $24,000 over twelve months (the “GMC”), to be paid in installments of $2,000 per month, by the 10 th Red Velvet XOXO, LLC On March 19, 2021, the Company and Red Velvet XOXO LLC, a New York corporation (“Red Velvet”) (collectively as “Parties”) entered into a Joint Product Development and Distribution Agreement (the “Development Agreement”), effective the same date. The Development Agreement shall remain in effect for twelve months from the effective date unless sooner terminated as defined in the Development Agreement, or unless extended by mutual agreement of the Parties. Pursuant to the Development Agreement, the Parties shall collaboratively develop a brand of desserts, marketed and sold exclusively utilizing Red Velvet’s recipes (the “Red Velvet Desserts”) under the Home Bistro label, under the terms and conditions of the Development Agreement. For the use of Red Velvet Desserts and all associated intellectual property for the benefit of the Red Velvet Desserts, Bistro shall pay to Red Velvet the following: (i) 10% of all Net Revenue generated from the sale of the Red Velvet Desserts (the “Velvet Desserts Royalty”). For the purpose of this agreement “Net Revenue” shall be defined as gross sales generated on Red Velvet Desserts less discounts and returns. The Velvet Desserts Royalty generated during each calendar month in which an agreement is in effect shall be due and payable by the 10th business day of the following month in which the Velvet Desserts Royalty was earned and; (ii) 10% of all Net Revenue generated from the sale of Home Bistro and Prime Chop brand orders in which a Red Velvet Desserts dedicated code was used at the time of purchase (“Velvet Desserts Commission”). The Velvet Desserts Commission generated during each calendar month in which an agreement is in effect shall be due and payable by the 10th business day of the following month in which the Velvet Desserts Commission was earned. During the ten months ended October 31, 2021, Red Velvet earned $198 of royalty fees pursuant to terms of the Development Agreement. As of July 31, 2022 and October 31, 2021, $198 of accrued royalty fee was reflected under accrued expense and other liabilities in the accompanying consolidated balance sheets. Chef Roblé & Co. On April 13, 2021, the Company and Roblé Ali (“Roblé”), celebrity chef and reality TV personality “Chef Roblé & Co.” (collectively as “Parties”) entered into a Joint Product Development and Distribution Agreement (the “Development Agreement”), effective the same date. The Development Agreement shall remain in effect for two years from the effective date. Pursuant to the Development Agreement, the Parties shall jointly contribute and be responsible for the development of the Roblé Meals, under the terms and conditions of the Development Agreement. For the use of Roblé Meals and all associated intellectual property for the benefit of the Roblé Meals, the Company shall pay to Roblé the following: (i) 10% of all Net Revenue generated from the sale of the Roblé Meals (the “Roblé Royalty”). For the purpose of this agreement “Net Revenue” shall be defined as gross sales generated on Roblé Meals less discounts and returns. The Roblé Royalty generated during each calendar month in which an agreement is in effect shall be due and payable by the 10th business day of the following month in which the Roblé Royalty was earned and; (ii) 10% of all Net Revenue generated from the sale of Home Bistro and Prime Chop brand orders in which a Roblé dedicated code was used at the time of purchase (“Roblé Commission”). Upon execution of the Development Agreement, the Company shall provide Roblé with a dedicated code to publicly share for a mutually agreed upon percent off any purchase of Home Bistro and Prime Chop brand orders. The Company shall ensure that the code is valid and in effect for the entire term. The Roblé Commission generated during each calendar month in which an agreement is in effect shall be due and payable by the 10 th In addition, subject to the terms and conditions of this Development Agreement, the Company shall pay to Roblé a guaranteed minimum compensation of $36,000 for twelve months (the “GMC”) as follows: (i) $9,000 upon the Company’s receipt and approval of all recipes submitted by Roblé; (ii) $9,000 upon the commencement of selling of the Roblé Meals (“Selling Date”); (iii) $3,000 per month for a period of six months, commencing the month immediately following the Selling Date. The total aggregate compensation paid to Roblé shall be reduced by the GMC. During the transitional period ending October 31, 2021, the first condition has been satisfied by both parties and the Company paid $9,000 the GMC. As of July 31, 2022 and October 31, 2021, there were no accrued GMC as the Selling Date has not yet occurred. Claudia Cocina LLC On June 22, 2021, the Company and Claudia Cocina LLC (f/s/o Claudia Sandoval), a California limited liability company (“Claudia Cocina”) (collectively as “Parties”) entered into a Joint Product Development and Distribution Agreement (the “Development Agreement”). Pursuant to the Development Agreement, the Parties shall collaboratively develop a brand of meals, marketed and sold utilizing the Property (“CS Meals”) jointly with the Home Bistro label, under the terms and conditions of the Development Agreement. The Development Agreement is effective upon signature and shall remain in effect from the first date on which the CS Meals are commercially launched (the “Launch Date”) until the last day of the month that is one year from the Launch Date (the “Initial Term”). The Parties shall have the right to renew the Development Agreement for an additional one-year term (“Renewal Term”) (the Initial Term and the Renewal Term, individually and together, (the “Term”) upon mutual written consent, which consent must be provided no later than sixty days prior to the end of the current Term. The Renewal Term shall be on the same terms and conditions as provided herein for the Initial Term, except that the Guaranteed Minimum Sales and the Guaranteed Minimum Royalties (“GMR”) payable during the Renewal Term shall be mutually agreed to between the Parties. The Company issued 150,000 shares of common stock with grant date fair value of $150,000 based on the market price of common stock on grant date, that was deemed to be fully earned, non-assessable and irrevocable upon the execution of the Development Agreement and subject to a Lock-Up Leak-Out Agreement. The Company recorded the $150,000 as deferred compensation in the accompanying consolidated balance sheet to be amortized over the term of the Development Agreement. During the nine months ended July 31, 2022, the Company expensed $121,875 of the deferred compensation as product development expense in the accompanying unaudited consolidated statement of operations. As of July 31, 2022 and October 31, 2021, there were $0 and $121,875 of deferred compensation, respectively, related to this Development Agreement. Claudia Cocina shall receive 10% royalties on all Net Revenues (“Royalty”) generated from the sale of: (i) CS Meals; and (ii) Home Bistro and Prime Chop brand orders in which a CS dedicated code was used at the time of purchase, in accordance with the Royalty Schedule set forth in the Development Agreement. For the purpose of this Development Agreement “Net Revenue” shall be defined as gross sales of products less actual returns and refunds, which returns and refunds shall not exceed eight percent (8%) of such gross sales. In addition, the GMR for the Term shall be at least $36,000 per year in the aggregate, payable monthly at the rate of $3,000 per month or 10% of gross sales, whichever is higher for the month. The Company agrees that Royalty payments may only be credited to the year to which such payments apply (i.e., Royalty payments paid to Claudia Cocina during the first twelve months of the Agreement can only offset the GMR of the first twelve months, and not the subsequent 12-month period GMR). Payments made during any year during the Term, which are in excess of the GMR payments for the applicable year may not be credited towards another year. All GMR payments hereunder are non-refundable and are due upon the first CS Meals being launched which occurred in November 2021. During the nine months ended July 31, 2022, the Company recorded $21,000 of royalty expense related to the GMR. As July 31, 2022 and October 31, 2021, there were no accrued royalty fee. Chef Richard Blais On July 22, 2021 (“Effective Date”), the Company and Trail Blais, LLC (f/s/o Chef Richard Blais), celebrity chef and reality TV personality (“Chef Richard Blais”) (collectively as “Parties”), entered into a Joint Product Development and Distribution Agreement (the “Development Agreement”). Pursuant to the Development Agreement, the Parties shall collaboratively develop a brand of meals, marketed and sold utilizing the Property (“Blais Meals”) jointly with the Home Bistro label, under the terms and conditions of the Development Agreement. The Development Agreement shall remain in effect from the Effective Date until the last day of the month that is one-year from the Effective Date (“Term”), ending no later than July 30, 2022. The first twelve-month anniversary of the Development Agreement shall be deemed “Year One For the use of Chef Richard Blais and all associated intellectual property for the benefit of the Blais Meals, the Company shall pay to Blais the following: (i) 10% of all net revenue generated from the sale of Blais Meals (the “Blais Royalty”). For the purpose of this agreement “Net Revenue” shall be defined as gross sales generated on Blais Meals less discounts and returns. The Blais Royalty generated during each calendar month in which an agreement is in effect shall be due and payable by the 10 th th Perfect Athlete LLC On September 15, 2021 (“Effective Date”), the Company and Perfecting Athletes, LLC (“PA” or “Perfecting Athletes”) (collectively as “Parties”), entered into a Joint Product Development and Distribution Agreement (the “Development Agreement”). Pursuant to the Development Agreement, the Parties shall collaboratively develop a brand of meals, marketed and sold utilizing the Property (“PA Meals”) jointly with the Home Bistro label, under the terms and conditions of the Development Agreement. The Development Agreement shall remain in effect from the Effective Date until the last day of the month that is two-years from the Effective Date (“Term”). The first twelve-month anniversary of the Development Agreement shall be deemed “ Year One For the use of Perfecting Athletes and all associated intellectual property for the benefit of the PA Meals, the Company shall pay to Perfecting Athletes the following: (i) 10% of all net revenue generated from the sale of PA Meals (the “PA Royalty”). For the purpose of this agreement “Net Revenue” shall be defined as gross sales generated on PA Meals less discounts and returns. The PA Royalty generated during each calendar month in which an agreement is in effect shall be due and payable by the 10 th th Spicy Mango Foodies LLC On January 19, 2022 (“Effective Date”), the Company and Spicy Mango Foodies LLC (f/s/o Chef Priyanka Naik (“CPN”)) (collectively as “Parties”), entered into a Joint Product Development and Distribution Agreement (the “Development Agreement”). Pursuant to the Development Agreement, the Parties shall collaboratively develop a brand of meals, marketed and sold utilizing the Property (“CPN Meals”) jointly with the Home Bistro label, under the terms and conditions of the Development Agreement. The Development Agreement shall remain in effect from the Effective Date until the last day of the month that is two-year from the Effective Date (“Term”). The first twelve-month anniversary of the Development Agreement shall be deemed “Year One”. The Company shall only distribute the CPN Meals within the Term and any Renewal Term (defined below), as mutually agreed. The Company agrees that following the Term, the Company shall use best efforts to cease the distribution of all CPN Meals. The Parties shall have the right to renew the Development Agreement for an additional one-year term (“Renewal Term”) upon mutual written consent. The Company issued 100,000 shares of common stock with grant date fair value of $100,000 based on the market price of common stock on grant date, that was deemed to be fully earned, non-assessable and irrevocable upon the execution of the Development Agreement. The Company shall record it as deferred compensation to be amortized over the Term of the Development Agreement. The Company recorded the $100,000 as deferred compensation in the accompanying unaudited consolidated balance sheet and is being amortized over the two-year term of the Development Agreement. During the nine months ended July 31, 2022, the Company expensed $27,083 of the deferred compensation as product development expense in the accompanying unaudited consolidated statement of operations. As of July 31, 2022, there was $72,917 of deferred compensation related to this Development Agreement. For the use of Spicy Mango Foodies, LLC (“SMF”) and all associated intellectual property for the benefit of the CPN Meals, the Company shall pay to SMF the following: (i) 10% of all Net Revenue generated from the sale of CPN Meals (“SMF Royalty”). For the purpose of this agreement “Net Revenue” shall be defined as gross sales generated on CPN Meals less discounts and returns. The SMF Royalty generated during each calendar month in which an agreement is in effect shall be due and payable by the 10 th th Mini Melanie, LLC On February 22, 2022 (“Effective Date”), the Company and Mini Melanie, LLC (f/s/o Chef Melanie Moss (“MM”)) (collectively as “Parties”), entered into a Joint Product Development and Distribution Agreement (“Development Agreement”). Pursuant to the Development Agreement, the Parties shall collaboratively develop a brand of desserts (“Moss Deserts”) jointly with the Home Bistro label, under the terms and conditions of the Development Agreement. The Development Agreement shall remain in effect from the Effective Date until the last day of the month that is one-year from the Effective Date. For the use of MM and all associated intellectual property for the benefit of the Moss Deserts, the Company shall pay to MM 5% of all Net Revenue generated from the sale of Moss Deserts (“MM Royalty”). For the purpose of this agreement “Net Revenue” shall be defined as gross sales generated on Moss Deserts less discounts and returns. The MM Royalty generated during each calendar month in which an agreement is in effect shall be due and payable by the 10 th Consulting Agreements On April 1, 2021, the Company and Redstone Communications, LLC (“Redstone”) (collectively as “Parties”) entered into an agreement to provide strategic consulting services (“Agreement”). The Agreement shall remain in effect for twelve months from the effective date of April 1, 2021 until March 31, 2022. Pursuant to the Agreement, Redstone shall be paid, in cash, a monthly fee of $10,000 over the twelve months service period and received 2,000,000 shares of common stock with grant date fair value of $1,800,000 as compensation, which was recorded as deferred compensation in the accompanying consolidated balance sheet and amortized over the twelve months service period. In 2021, the Company amortized $1,050,000 of the deferred compensation. During the nine months ended July 31, 2022, the Company amortized $750,000 of the deferred compensation and was recorded as professional and consulting expense in the accompanying unaudited consolidated statement of operations. As of July 31, 2022 and October 31, 2021, the deferred compensation related to this Agreement was $0 and $750,000, respectively. On September 10, 2021, the Company and Bench International, LLC (“Bench International”) (collectively as “Parties”) entered into an agreement to marketing consulting services (“Agreement”). The Agreement shall remain in effect for twelve months from the effective date of September 10, 2021. Pursuant to the Agreement, Bench International shall be paid, in cash, and aggregate amount of $350,000 to be paid in seven monthly instalments of $50,000 beginning September 2021 until March 2022. In 2021, the Company paid an aggregate amount of $100,000. During the nine months ended July 31, 2022, the Company paid an aggregate amount of $205,000. During the nine months ended July 31, 2022, the Company recognized $246,667 of expense related to this Agreement and recorded as selling and marketing expenses in the accompanying unaudited consolidated statement of operations. As of July 31, 2022 and October 31, 2021, the prepaid expense related to this Agreement were $0 and $41,667, respectively. On October 1, 2021, the Company and a consultant (collectively as “Parties”) entered into a consulting agreement which shall remain in effect until April 1, 2022, unless sooner terminated as provided in the agreement, or unless extended by agreement of the Parties. Pursuant to the agreement, the Company issued warrants to purchase 500,000 of common stock (“Warrant”) with a grant date fair value of $678,253 for services rendered and was recorded as professional and consulting expenses in the accompanying consolidated statement of operations in 2021. The Warrant vested upon issuance, has an exercise price of $0.001 and expiration date of October 1, 2026. In addition, the consultant shall receive $3,000 per month, payable in cash on the first of each month commencing on the effective date. Consulting Agreement – Related Party On October 1, 2021, the Company and Michael Novielli through Dutchess Capital Partners, LLC (“Dutchess Capital”) (collectively as “Parties”) entered into a consulting agreement which shall remain in effect until April 1, 2022 unless sooner terminated as provided in the agreement, or unless extended by agreement of the Parties. Michael Novielli currently serves as a member of the Board of Directors and is considered a related party. Pursuant to the agreement, Dutchess Capital received warrants to purchase 1,000,000 of common stock (“Warrant”) with a grant date fair value of $1,356,507, for services rendered and was recorded as professional and consulting expenses – related party in the accompanying consolidated statement of operations. The Warrant vested upon issuance, had exercise price of $0.001 and expiration date of October 1, 2026. In addition, Dutchess Capital shall receive $10,000 per month, payable in cash on the first of each month commencing on the effective date. For the three and nine months ended July 31, 2022, professional and consulting expense – related party amounts to $30,000 and $90,000, respectively. Lock-Up and Leak Out Agreements In 2021 and during the nine months ended July 31, 2022, the Company and various stockholders (collectively as “Parties”) entered into a Lock-Up and Leak Out Agreement (“Lock-Up Agreements”). Pursuant to the Lock-Up Agreements, stockholders, including the stockholders’ affiliated entities, agreed that for the period beginning on the respective effective dates of their Lock-Up Agreements and ending in the period between October 2021 to June 2023 (the “Lock-Up Period”), the stockholders will not offer, sell, contract to sell, pledge, give, donate, transfer or otherwise dispose of, directly or indirectly, any shares of Company’s common stock or securities convertible into or exercisable for common stock or securities or rights convertible into or exchangeable or exercisable for any common stock, whether owned by the stockholders as the date hereof or acquired subsequent to the date hereof (collectively, the “Lock-Up Shares”), enter into a transaction which would have the same effect, or enter into any swap, hedge or other arrangement that transfers, in whole or in part, any of the economic or voting consequences of ownership of such securities, whether any such aforementioned transaction is to be settled by delivery of the Lock-Up Shares or such other securities, in cash or otherwise, or publicly disclose the intention to make any such offer, sale, pledge or disposition, or to enter into any such transaction, swap, hedge or other arrangement. During the ten-months ended October 31, 2021, as consideration for the stockholders’ execution of the Lock-Up Agreements, the Company issued an aggregate of 112,500 shares of common stock with grant date fair value of $152,626 which was recorded as deferred compensation and amortized over the Lock-Up Period. During the nine months ended July 31, 2022, as consideration for the stockholders’ execution of the Lock-Up Agreements, the Company issued an aggregate of 516,748 shares of common stock with grant date fair value of $554,273 which was recorded as deferred compensation and amortized over the Lock-Up Period (see Note 11). During the nine months ended July 31, 2022, the Company amortized $670,212 of the deferred compensation (see Note 11) and was recorded as professional and consulting expense in the accompanying unaudited consolidated statement of operations. As of July 31, 2022 and October 31, 2021, the deferred compensation related to this Agreement were $0 and $115,938, respectively. License Agreement On June 24, 2021, the Company entered into a licensing agreement (“License Agreement”) with Ayesha Curry (see Note 4). The License Agreement has a term of three years and renewable under the terms and conditions specified in the License Agreement. Pursuant to the License Agreement the Company shall pay Ayesha Curry a 10% royalty fee of the ne

Subsequent Events

Subsequent Events	9 Months Ended
Subsequent Events	Jul. 31, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 13 – SUBSEQUENT EVENTS

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	9 Months Ended
Accounting Policies, by Policy (Policies)	Jul. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission (“SEC”) for interim financial information, which present the unaudited consolidated financial statements of the Company and its active wholly owned subsidiaries, Home Bistro Holdings, Inc. and Model Meals LLC (acquired on July 6, 2021) for the period ending July 31, 2022. All intercompany transactions and balances have been eliminated. It is management’s opinion that all material adjustments (consisting of normal recurring adjustments) have been made, which are necessary for a fair financial statement presentation. The results for the interim period are not necessarily indicative of the results to be expected for the fiscal year ending October 31, 2022. Certain information and disclosures normally included in the notes to the annual consolidated financial statements have been condensed or omitted from these interim consolidated financial statements. Accordingly, these interim consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Transition Report, due to our change in fiscal year end, on Form 10-KT filed with the SEC on January 31, 2022.
Going Concern	Going Concern The consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying unaudited consolidated financial statements, for the nine months ended July 31, 2022, the Company had a net loss and cash used in operations of $8,237,494 and $3,343,172, respectively. On July 31, 2022, the Company had an accumulated deficit, stockholders’ equity, and working capital deficit of $(29,951,604), $1,383,704 and $(2,936,693), respectively. These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the issuance date of this report. The Company’s primary source of operating funds has primarily from the sale of common stock and the issuance of convertible debt notes. The Company has experienced net losses from operations since inception but expects these conditions to improve in the near term and beyond as it develops its business model. Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash flow positive or raise additional debt and/or equity capital. Management believes that the Company’s capital resources are not currently adequate to continue operating and maintaining its business strategy for a period of twelve months from the issuance date of this report. If the Company is unable to raise additional capital or secure additional lending in the near future, management expects that the Company will need to curtail or cease operations. These consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates as of July 31, 2022 and October 31, 2021 include the assumptions used in the redemption recognition method for unredeemed gift cards, useful life of property and equipment and intangible assets, valuation of right-of-use (“ROU”) assets and lease liabilities, estimates of current and deferred income taxes and deferred tax valuation allowances, fair value of assets acquired and liabilities assumed in a business combination, and the fair value of non-cash equity transactions and derivative liabilities.
Cash	Cash For purposes of the statements of cash flows, the Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and money market accounts to be cash equivalents. On July 31, 2022 and October 31, 2021, the Company did not have any cash equivalents. The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits. As of July 31, 2022 and October 31, 2021, the bank balance was in excess of FDIC insured levels by approximately $0 and $2,025,000, respectively. The Company has not experienced any losses in such accounts through July 31, 2022.
Fair Value of Financial Instruments and Fair Value Measurements	Fair Value of Financial Instruments and Fair Value Measurements FASB ASC 820 - Fair Value Measurements and Disclosures, defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. FASB ASC 820 requires disclosures about the fair value of all financial instruments, whether or not recognized, for financial statement purposes. Disclosures about the fair value of financial instruments are based on pertinent information available to the Company on July 31, 2022. Accordingly, the estimates presented in these financial statements are not necessarily indicative of the amounts that could be realized on disposition of the financial instruments. FASB ASC 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The three levels of the fair value hierarchy are as follows: Level 1—Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date. Level 2—Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data. Level 3—Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information. The carrying amounts reported in the consolidated balance sheets for cash, due from and to related parties, prepaid expenses, accounts payable and accrued liabilities approximate their fair market value based on the short-term maturity of these instruments. Assets or liabilities measured at fair value on a recurring basis include embedded conversion options in convertible debt (see Note 4) and were as follows on July 31, 2022 and October 31, 2021: July 31, 2022 October 31, 2021 Description Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Derivative liabilities $ — $ — $ 153,206 $ — $ — $ 86,884 A roll forward of the level 3 valuation financial instruments is as follows: Nine Months Ended (Unaudited) Balance on October 31, 2021 $ 86,884 Increase in derivative liabilities included in debt discount 122,177 Change in fair value of derivative liabilities (55,855 ) Balance on July 31, 2022 $ 153,206 ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding equity instruments.
Derivative Liabilities	Derivative Liabilities The Company has certain financial instruments that are embedded derivatives associated with capital raises. The Company evaluates all its financial instruments to determine if those contracts or any potential embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 815-10 – Derivative and Hedging – Contract in Entity’s Own Equity
Goodwill and Indefinite Lived Intangible Assets	Goodwill and Indefinite Lived Intangible Assets Goodwill represents the excess of purchase prices over the fair value of nets assets acquired, is carried at cost. Goodwill is not amortized; rather, it is subject to a periodic assessment for impairment by applying a fair value-based test. Goodwill is evaluated for impairment on an annual basis at a level of reporting referred to as the reporting unit, and more frequently if adverse events or changes in circumstances indicate that the asset may be impaired. Goodwill and indefinite lived intangible assets are tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not (that is, a likelihood of more than 50%) that the fair value of the reporting unit is less than its carrying amount. The qualitative assessment considers macroeconomic conditions, industry and market considerations, cost factors and overall company financial performance. If the reporting unit does not pass the qualitative assessment, the carrying amount of the reporting unit, including goodwill, is compared to its fair value. When the carrying amount of the reporting unit exceeds its fair value, a goodwill impairment loss is recognized up to a maximum amount of the recorded goodwill related to the reporting unit. Goodwill impairment losses are not reversed. There was no impairment loss of goodwill or indefinite lived intangible assets for the nine months ended July 31, 2022.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets In accordance with ASC Topic 360, the Company reviews long-lived assets including intangible assets with finite life, for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value.
Inventory	Inventory Inventory consists of non-perishable food items distributed by the Company and are stated at the lower of cost and net realizable value utilizing the first-in first-out (FIFO) method. A reserve is established when management determines that certain inventories may not be saleable. If inventory costs exceed expected net realizable value due to obsolescence or quantities in excess of expected demand, the Company will record reserves for the difference between the cost and the net realizable value. These reserves are based on estimates and included in cost of sales. As of July 31, 2022 and October 31, 2021, the inventory balances were insignificant and the Company determined that there was no allowance needed.
Revenue Recognition	Revenue Recognition The Company’s revenues consist of high quality, direct-to-consumer, ready-made meals that can be ordered by customers through www.homebistro.com, www.modelmeals.com and restaurant quality meats and seafood through its Colorado Prime Brand. Revenues from the Company’s ready-made meals are recognized when the product is delivered to the customer and title has transferred. It is at this point in time that the Company’s performance obligations have been completed. Product sales are recorded net of any discounts or allowances and include shipping charges. Customers can purchase gift cards via phone or online through the Company’s e-commerce website. Gift card purchases are initially recorded as unredeemed gift card liabilities and are recognized as product sales upon redemption. Historically, the majority of gift cards are redeemed within two to three years of issuance. The Company does not charge administrative fees on unused gift cards, and its gift cards do not have an expiration date. Based on historical redemption patterns, a portion of issued gift cards are not expected to be redeemed (breakage). The Company uses the redemption recognition method for recognizing breakage related to unredeemed gift cards for which it has sufficient historical redemption information. Under the redemption recognition method, breakage revenue is recorded in proportion to, and over the time period gift cards are actually redeemed. The estimated breakage rate is based on historical issuance and redemption patterns and is re-assessed by the Company on a regular basis. At least three years of historical data, which is updated annually, is used to estimate redemption patterns. Model meals, the Company’s wholly-owned subsidiary, does not have sufficient historical redemption information to recognize breakage. Therefore, all issued gift cards are recorded as a liability upon issuance and revenue when used.
Cost of Sales	Cost of Sales The Company’s policy is to recognize product related cost of sales in conjunction with revenue recognition, when the product costs are incurred which is upon delivery of product. Cost of sales includes the food and processing costs directly attributable to fulfillment and the delivery of the product to customers including both inbound and outbound shipping costs. In addition, the royalty fee related to the Joint Product Development and Distribution Agreement (see Note 11) was also included in cost of sales. Shipping and handling costs incurred for product shipped to customers are included in cost of sales and amounted to $411,380 and $152,070 for the nine months ended July 31, 2022 and 2021, respectively. Shipping and handling costs charged to customers are included in product sales.
Stock-Based Compensation	Stock-Based Compensation Stock-based compensation is accounted for based on the requirements of ASC 718 – “Compensation–Stock Compensation”, which requires recognition in the financial statements of the cost of employee, non-employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award.
Advertising Costs	Advertising Costs The Company participates in various advertising programs. All costs related to advertising of the Company’s products are expensed in the period incurred. Advertising costs charged to operations were $940,580 and $307,980 for the nine months ended July 31, 2022 and 2021, respectively, which are presented on the accompanying unaudited consolidated statements of operations as selling and marketing expenses.
Income Taxes	Income Taxes The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date. The Company follows the accounting guidance for uncertainty in income taxes using the provisions of ASC 740. Using that guidance, tax positions initially need to be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. For the nine months ended July 31, 2022, the Company had no uncertain tax positions that qualify for either recognition or disclosure in the financial statements.
Leases	Leases The Company accounts for its leases using the method prescribed by ASC 842 – Lease Accounting Operating and financing lease ROU assets represents the right to use the leased asset for the lease term. Operating and financing lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the adoption date in determining the present value of future payments. Lease expense for minimum lease payments is amortized on a straight-line basis over the lease term and is included in general and administrative expenses in the consolidated statements of operations.
Basic and Diluted Loss Per Share	Basic and Diluted Loss Per Share Pursuant to ASC 260-10-45, basic loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the periods presented. Diluted loss per share is computed by dividing net loss by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during the period. Potentially dilutive common shares consist of common stock issuable for stock options and stock warrants (using the treasury stock method), convertible notes and common stock issuable. These common stock equivalents may be dilutive in the future. The potentially dilutive common stock equivalents as of July 31, 2022 and 2021 were excluded from the dilutive loss per share calculation as they would be antidilutive due to the net loss and included the following: July 31, 2022 2021 Common Stock Equivalents: Stock Warrants 17,750,156 12,071,461 Convertible Notes 7,821,102 1,512,844 Total 25,571,258 13,584,305
Concentration Risk	Concentration Risk The Company purchased approximately 100% of its food products from one vendor during the nine months ended July 31, 2021. The Company is not obligated to purchase from these vendors and, if necessary, there are other vendors from which the Company can purchase food products. As of July 31, 2021, the Company had no accounts payable balance to this vendor. During the nine months ended July 31, 2022, the Company had two kitchen facilities located at Pembroke Pines, FL 33009 and Santa Ana, CA. The Company started producing and packaging its food products at these locations in addition to purchasing food products from other vendors which mitigated this concentration risk.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2020, the FASB issued ASU 2020-06— Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and edging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”) Debt with Conversion and Other Options 1. Add a disclosure objective 2. Add information about events or conditions that occur during the reporting period that cause conversion contingencies to be met or conversion terms to be significantly changed 3. Add information on which party controls the conversion rights 4. Align disclosure requirements for contingently convertible instruments with disclosure requirements for other convertible instruments 5. Require that existing fair value disclosures in Topic 825, Financial Instruments, be provided at the individual convertible instrument level rather than in the aggregate. Additionally, for convertible debt instruments with substantial premiums accounted for as paid-in capital, amendments in ASU 2020-06 added disclosures about (1) the fair value amount and the level of fair value hierarchy of the entire instrument for public business entities and (2) the premium amount recorded as paid-in capital. The amendments in ASU 2020-06 are effective for public business entities, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Entities should adopt the guidance as of the beginning of its annual fiscal year and are allowed to adopt the guidance through either a modified retrospective method of transition or a fully retrospective method of transition. In applying the modified retrospective method, entities should apply the guidance to transactions outstanding as of the beginning of the fiscal year in which the amendments are adopted. Transactions that were settled (or expired) during prior reporting periods are unaffected. The cumulative effect of the change should be recognized as an adjustment to the opening balance of retained earnings at the date of adoption. If an entity elects the fully retrospective method of transition, the cumulative effect of the change should be recognized as an adjustment to the opening balance of retained earnings in the first comparative period presented. The Company early adopted ASU 2020-06 effective November 1, 2021 and did not have a significant impact on its consolidated financial statements. In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40). The new ASU addresses issuer’s accounting for certain modifications or exchanges of freestanding equity-classified written call options. This amendment is effective for all entities, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted. The Company does not believe the adoption of this ASU will have a significant impact on its consolidated financial statements. Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on its consolidated financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	9 Months Ended
Summary of Significant Accounting Policies (Tables)	Jul. 31, 2022
Schedule of a roll forward of the level 3 valuation financial instruments Abstract
Schedule of assets or liabilities measured at fair value	July 31, 2022 October 31, 2021 Description Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Derivative liabilities $ — $ — $ 153,206 $ — $ — $ 86,884
Schedule of a roll forward of the level 3 valuation financial instruments	Nine Months Ended (Unaudited) Balance on October 31, 2021 $ 86,884 Increase in derivative liabilities included in debt discount 122,177 Change in fair value of derivative liabilities (55,855 ) Balance on July 31, 2022 $ 153,206
Schedule of computation of diluted shares outstanding and all dilutive securities	July 31, 2022 2021 Common Stock Equivalents: Stock Warrants 17,750,156 12,071,461 Convertible Notes 7,821,102 1,512,844 Total 25,571,258 13,584,305

Acquisition of a Subsidiary (Ta

Acquisition of a Subsidiary (Tables)	9 Months Ended
Acquisition of a Subsidiary (Tables)	Jul. 31, 2022
Acquisition of a Subsidiary (Tables) [Line Items]
Schedule of fair value the assets acquired and liabilities assumed at the date of the acquisition	Total Assets acquired: Current assets $ 97,140 Computer software 66,198 Customer relationships 43,000 Trademark 505,000 Goodwill 1,809,357 Total assets acquired at fair value 2,520,695 Less: total liabilities assumed (432,302 ) Net asset acquired $ 2,088,393 Purchase consideration paid: Fair value of common shares issued $ 2,028,393 Cash consideration 60,000 Total purchase consideration paid $ 2,088,393
Schedule of consolidated results of operations	Nine Months Ended July 31, (Unaudited) Net Revenues $ 2,485,615 Net Loss $ (2,539,633 ) Net Loss per Share $ (0.12 )

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
Goodwill and Intangible Assets (Tables)	Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of goodwill	Estimated July 31, October 31, (Unaudited) Goodwill Indefinite $ 1,809,357 $ 1,809,357 Less: impairment — — Goodwill, net $ 1,809,357 $ 1,809,357
Schedule of intangible assets	Estimated July 31, October 31, (Unaudited) Computer software 3.5 years $ 66,198 $ 66,198 Customer relationships 7 years 43,000 43,000 Trademark Indefinite 505,000 505,000 License agreement 3 years 2,620,000 2,620,000 Total 3,234,198 3,234,198 Less: accumulated amortization (683,719 ) (8,837 ) Intangible assets, net $ 2,550,479 $ 3,225,361 Intangible assets with a finite life, net $ 2,045,479 $ 2,720,361
Schedule of amortization of intangible assets	Year ending October 31: Amount 2022 $ 224,962 2023 899,845 2024 898,147 2025 6,143 2026 6,143 2027 6,143 2028 4,096 Total $ 2,045,479

Convertible Notes (Tables)

Convertible Notes (Tables)	9 Months Ended
Convertible Notes (Tables)	Jul. 31, 2022
Schedule of Convertible Notes [Abstract]
Schedule of convertible notes	July 31, October 31, (Unaudited) Principal amount $ 992,302 $ 1,028,179 Add: put premium on stock-settled debt 83,058 - Less: debt discount (361,444 ) (477,541 ) Convertible notes payable, net $ 713,916 $ 550,638 Principal amount – related party $ — $ 63,069 Less: debt discount – related party — (32,897 ) Convertible note payable - related party, net $ — $ 30,172 Total convertible notes payable, net $ 713,916 $ 580,810
Schedule of fair value of the derivative liabilities	July 31, Dividend rate — % Term (in years) 0.09 to 0.50 Volatility 55% to 90 % Risk—free interest rate 0.04 to 2.90 % Default probability 10.0% to 12.5 % Probability of uplist offering 50 %

Notes Payable (Tables)

Notes Payable (Tables)	9 Months Ended
Notes Payable (Tables)	Jul. 31, 2022
Debt Disclosure [Abstract]
Schedule of note payable	July 31, October 31, (Unaudited) Principal amount $ 306,900 $ 306,900 Less: current portion (17,198 ) (15,361 ) Notes payable – long-term portion $ 289,702 $ 291,539
Schedule of minimum principal payments under notes payable	Year ended October 31, 2022 (remaining) $ 15,620 Year ended October 31, 2023 6,369 Year ended October 31, 2024 6,608 Year ended October 31, 2025 6,859 Thereafter 271,444 Total principal payments $ 306,900

Unredeemed Gift Cards (Tables)

Unredeemed Gift Cards (Tables)	9 Months Ended
Unredeemed Gift Cards (Tables)	Jul. 31, 2022
Unredeemed Gift Card Disclosure Abstract
Schedule of unredeemed gift cards activities	July 31, October 31, (Unaudited) Beginning balance $ 164,912 $ 48,311 Acquired gift card liability (see Note 3) — 87,260 Sale of gift cards 121,603 186,749 Promotional and other gift cards issued 84,250 — Revenue from breakage (22,810 ) (60,515 ) Gift card redemptions (113,323 ) (96,893 ) Ending balance $ 234,632 $ 164,912

Lease Liabilities (Tables)

Lease Liabilities (Tables)	9 Months Ended
Lease Liabilities (Tables)	Jul. 31, 2022
Lease Liabilities [Abstract]
Schedule of operating lease right-of-use assets	July 31, October 31, (Unaudited) Operating ROU assets $ 336,614 $ 336,614 Less accumulated reductions (153,736 ) (68,105 ) Balance of Operating ROU assets, net $ 182,878 $ 268,509
Schedule of operating lease liabilities	July 31, 2022 October 31, (Unaudited) Operating lease liabilities $ 339,532 $ 339,532 Reduction of operating lease liabilities (151,738 ) (71,178 ) Total 187,794 268,354 Less: short term portion (86,699 ) (101,431 ) Long term portion $ 101,095 $ 166,923
Schedule of future minimum operating lease payments	Year Amount Ending October 31, 2022 (remaining) $ 25,394 Ending October 31, 2023 102,846 Ending October 31, 2024 79,991 Total minimum non-cancellable operating lease payments 208,231 Less: discount to fair value (20,437 ) Total operating lease liabilities on July 31, 2022 $ 187,794
Schedule of financing right-of-use	July 31, 2022 October 31, (Unaudited) Financing ROU assets $ 200,509 $ 200,509 Less accumulated depreciation (69,621 ) (19,494 ) Balance of financing ROU assets, net $ 130,888 $ 181,015
Schedule of financing lease liability	July 31, October 31, (Unaudited) Financing lease payables for equipment $ 200,509 $ 200,509 Reduction of financing lease liability (59,648 ) (13,650 ) Total 140,861 186,859 Less: short term portion (66,926 ) (62,210 ) Long term portion $ 73,935 $ 124,649
Schedule of future minimum lease payments under the financing lease agreement	Year Amount Year ending October 31, 2022 (remaining) $ 19,500 Year ending October 31, 2023 78,000 Year ending October 31, 2024 58,500 Total minimum non-cancellable financing lease payments 156,000 Less: discount to fair value (15,139 ) Total financing lease liabilities on July 31, 2022 $ 140,861

Stockholders_ Equity (Deficit)

Stockholders’ Equity (Deficit) (Tables)	9 Months Ended
Stockholders’ Equity (Deficit) (Tables)	Jul. 31, 2022
Stockholders’ Equity (Deficit) [Abstract]
Schedule of expected life of issued stock warrants	Dividend rate — Term (in years) 2.5 to 5 years Volatility 61% to 69% Risk-free interest rate 0.14% to 2.80%
Schedule of outstanding stock warrants	Number of Weighted Weighted Balance on October 31, 2021 15,745,066 $ 0.170 7.4 Warrants issued for services 100,000 1.500 4.1 Warrants issued pursuant to employment agreements 500,000 0.001 4.9 Warrants issued in connection with convertible debt 1,405,090 0.575 3.0 Warrants exercised (1,596,595 ) 1.350 Balance on July 31, 2022 16,153,561 $ 0.090 6.4 Stock warrants exercisable on July 31, 2022 16,153,561 $ 0.090 6.4

Organization and Nature of Op_2

Organization and Nature of Operations (Details)	Jul. 06, 2021 USD ($) shares
Accounting Policies [Abstract]
Aggregate shares (in Shares) \| shares	2,008,310
Fair value amount	$ 2,028,393
Paid cash amount	$ 60,000

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	9 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Oct. 31, 2021
Accounting Policies [Abstract]
Net loss	$ 8,237,494
Cash used in operations	3,343,172
Accumulated deficit	(29,951,604)
Stockholders' deficit	1,383,704
Working capital deficit	(2,936,693)
FDIC insured amount	$ 0		$ 2,025,000
Percentage of fair value	50%
Shipping and handling costs	$ 411,380	$ 152,070
Advertising costs	$ 940,580	$ 307,980
Food products purchased, percentage	100%

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of assets or liabilities measured at fair value - USD ($)	Jul. 31, 2022	Oct. 31, 2021
Level 1 [Member]
Summary of Significant Accounting Policies (Details) - Schedule of assets or liabilities measured at fair value [Line Items]
Derivative liabilities
Level 2 [Member]
Summary of Significant Accounting Policies (Details) - Schedule of assets or liabilities measured at fair value [Line Items]
Derivative liabilities
Level 3 [Member]
Summary of Significant Accounting Policies (Details) - Schedule of assets or liabilities measured at fair value [Line Items]
Derivative liabilities	$ 153,206	$ 86,884

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details) - Schedule of a roll forward of the level 3 valuation financial instruments	9 Months Ended
	Jul. 31, 2022 USD ($)
Schedule Of ARoll Forward Of The Level3 Valuation Financial Instruments Abstract
Balance at beginning	$ 86,884
Increase in derivative liabilities included in debt discount	122,177
Change in fair value of derivative liabilities	(55,855)
Balance at ending	$ 153,206

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details) - Schedule of computation of diluted shares outstanding and all dilutive securities - USD ($)	9 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Common Stock Equivalents:
Stock Warrants	$ 17,750,156	$ 12,071,461
Convertible Notes	7,821,102	1,512,844
Total	$ 25,571,258	$ 13,584,305

Acquisition of a Subsidiary (De

Acquisition of a Subsidiary (Details)	Jul. 06, 2021 USD ($) shares
Disclosure Text Block Supplement [Abstract]
After the exchange, description	As a result, Model Meals became a wholly owned subsidiary of the Company, and the members of Model Meals received an aggregate of 2,008,310 shares of common stock with grant date fair value of $ 2,028,393 (see Note 1) and were paid $60,000 in cash.
Aggregate shares (in Shares) \| shares	2,008,310
Fair value of common stock	$ 2,028,393
Cash	$ 60,000

Acquisition of a Subsidiary (_2

Acquisition of a Subsidiary (Details) - Schedule of fair value the assets acquired and liabilities assumed at the date of the acquisition	9 Months Ended
	Jul. 31, 2022 USD ($)
Assets acquired:
Current assets	$ 97,140
Computer software	66,198
Customer relationships	43,000
Trademark	505,000
Goodwill	1,809,357
Total assets acquired at fair value	2,520,695
Less: total liabilities assumed	(432,302)
Net asset acquired	2,088,393
Purchase consideration paid:
Fair value of common shares issued	2,028,393
Cash consideration	60,000
Total purchase consideration paid	$ 2,088,393

Acquisition of a Subsidiary (_3

Acquisition of a Subsidiary (Details) - Schedule of consolidated results of operations	9 Months Ended
	Jul. 31, 2022 USD ($) $ / shares
Schedule Of Consolidated Results Of Operations Abstract
Net Revenues	$ 2,485,615
Net Loss	$ (2,539,633)
Net Loss per Share (in Dollars per share) \| $ / shares	$ (0.12)

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Details) - USD ($)		3 Months Ended	9 Months Ended
Goodwill and Intangible Assets (Details) - USD ($)	Jul. 06, 2021	Jul. 31, 2022	Jul. 31, 2022	Jul. 31, 2021	Jun. 24, 2021
Goodwill and Intangible Assets (Details) [Line Items]
Net Assets	$ 279,036
Consideration	2,088,393
Net assets acquired	$ 1,809,357
Aggregate of shares of common stock (in Shares)		2,266,667	2,266,667		2,266,667
Aggregate fair value		$ 2,969,334	$ 2,969,334		$ 2,969,334
Shares of common stock (in Shares)		2,000,000	2,000,000
Fair value			$ 2,620,000
Amortization expense related to the intangible assets		$ 224,961	674,882
Common Stock [Member]
Goodwill and Intangible Assets (Details) [Line Items]
Net assets acquired			$ 2,620,000
Celebrity Chef [Member]
Goodwill and Intangible Assets (Details) [Line Items]
Shares of common stock (in Shares)		2,000,000	2,000,000

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Details) - Schedule of goodwill - USD ($)		9 Months Ended
	Oct. 31, 2021	Jul. 31, 2022
Schedule Of Goodwill Abstract
Estimated Life		Indefinite
Goodwill	$ 1,809,357	$ 1,809,357
Less: impairment
Goodwill, net	$ 1,809,357	$ 1,809,357

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets (Details) - Schedule of intangible assets - USD ($)	9 Months Ended
	Jul. 31, 2022	Oct. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Total	$ 3,234,198	$ 3,234,198
Less: Accumulated amortization	(683,719)	(8,837)
Intangible assets, net	2,550,479	3,225,361
Intangible assets with a finite life, net	$ 2,045,479	2,720,361
Computer Software [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Life	3.5 years
Total	$ 66,198	66,198
Customer relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Life	7 years
Total	$ 43,000	43,000
Trademark [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Life	Indefinite
Total	$ 505,000	505,000
License agreement [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Life	3 years
Total	$ 2,620,000	$ 2,620,000

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets (Details) - Schedule of amortization of intangible assets	Oct. 31, 2022 USD ($)
Schedule Of Amortization Of Intangible Assets Abstract
2022	$ 224,962
2023	899,845
2024	898,147
2025	6,143
2026	6,143
2027	6,143
2028	4,096
Total	$ 2,045,479

Convertible Notes (Details)

Convertible Notes (Details) - USD ($)								1 Months Ended											6 Months Ended	9 Months Ended
Convertible Notes (Details) - USD ($)	Sep. 30, 2021	Sep. 08, 2021	Sep. 01, 2021	May 28, 2021	Apr. 07, 2021	Mar. 30, 2021	Mar. 22, 2021	Jul. 31, 2022	Jul. 19, 2022	May 31, 2022	May 24, 2022	May 18, 2022	Oct. 31, 2021	May 31, 2021	May 17, 2021	Apr. 30, 2021	Mar. 31, 2021	Jan. 27, 2021	Apr. 30, 2022	Jul. 31, 2022	Jul. 31, 2021	Jan. 31, 2021
Convertible Notes (Details) [Line Items]
Received net proceeds																	$ 150,000
Net of OID																	$ 15,000
Commitment fee shares (in Shares)																	75,000
Warrants to purchase shares of common stock (in Shares)																	75,000
Cash payments, description								The July 2022 Note accrues interest at an annual interest rate of 8%, has a default interest rate of 22%, and matures on January 19, 2024 (the “Maturity Date”). The Investor may convert the July 2022 Note into shares of the Company’s common stock 180 days after the Issue Date until the later of (i) the Maturity Date and (ii) the date the Company pays any amounts owed in connection with an event of default. The per share conversion price into which the July 2022 Note is convertible into shares of common stock (the “Conversion Price”) is 65% multiplied by the average of the lowest two closing bid prices for the common stock during the ten trading days ending on the last trading day prior to the conversion date.The Company has the right to prepay the outstanding principal amount of the Note, plus any accrued interest on the outstanding principal (including any default interest) at a rate of (x) 120% during the period ending 120 days after the Issue Date and (y) 125% during the period between 121 days and 180 days after the Issue Date. The Company does not have a prepayment right following the expiration of the 180-day period. Upon the occurrence and during the continuation of any event of default under the Note, the Note becomes immediately due and payable and the Company is obligated to pay the Investor in full satisfaction of its obligations thereunder an amount equal to the greater of (i) the principal amount then outstanding plus accrued interest (including any default interest) through the date of full repayment multiplied by 150% and (ii)(a) the highest number of shares of Common Stock issuable upon conversion of the default sum at the Conversion Price, multiplied by (b) the highest closing price for the Common Stock during the period beginning on the date of first occurrence of the event of default and ending one day prior to the mandatory prepayment date.									The 75,000 shares of common stock and 75,000 warrant issued were valued at $36,499 and $12,352, respectively, using the relative fair value method and the Commitment Share True-up had a fixed monetary value of $34,500, all recorded as a debt discount to be amortized over the twelve-month term of the note. The March 2021 Note V mature on March 1, 2022 and a one-time interest charge of 10% was applied on the issue date and will be payable on the maturity date. Upon an event of default, the outstanding balance will immediately and automatically increase to 140% of the outstanding balance under the March 2021 Note V immediately prior to the occurrence of the Event of Default and becomes immediately due and payable. The Company shall make nine monthly cash payments (“Amortization Payments”), in the amount of $20,167 due on the first day of each month, beginning July 1, 2021. The investor may only convert the March 2021 Note V at any time or times on or after the occurrence of an Event of Default. The March 2021 Note V was convertible at the rate equal to 105% of the lowest trading price occurring during the twenty-five consecutive trading days immediately preceding the applicable conversion date (“Conversion Price”).
Debt discount								$ 361,444					$ 510,438							$ 361,444
Exercise price (in Dollars per share)										$ 0.575
Ownership limitation, percentage												4.99%
Principal amount																	$ 165,000
Ownership limitation percentage														4.99%
Interest expense																				83,058
Outstanding balance																				237,308
Principal value								154,250												154,250
Premium value																				83,058
Aggregate fixed monetary value													209,688							0
Conversion option										$ 122,177
Change in fair value of derivative liability																				55,855
Amortization of debt issuance costs and discounts																				388,145	$ 817,922
Securities Purchase Agreement Four [Member]
Convertible Notes (Details) [Line Items]
Ownership limitation, percentage																						4.99%
March 2021 Note I [Member]
Convertible Notes (Details) [Line Items]
Ownership limitation, percentage																	4.99%
March 2021 Warrant III [Member]
Convertible Notes (Details) [Line Items]
Ownership limitation, percentage																	4.99%
March 2021 Note V [Member]
Convertible Notes (Details) [Line Items]
Ownership limitation, percentage																	4.99%
September 2021 Note I [Member]
Convertible Notes (Details) [Line Items]
Ownership limitation, percentage	4.99%
May 2021 Note I [Member]
Convertible Notes (Details) [Line Items]
Principal payments													41,159
Accrued interest													5,842
May 2021 Note II [Member]
Convertible Notes (Details) [Line Items]
Aggregate principal amount								236,781												236,781
Cash payments, description				On May 28, 2021, the Company closed a Securities Purchase Agreement (the “May 2021 SPA II”) with an investor for the sale of the Company’s convertible note. Pursuant to the May 2021 SPA II, the Company (i) issued a convertible note with principal amount of $285,000 (the “May 2021 Note II”) with the Company receiving $250,000 in net proceeds, net of $28,500 of OID and $6,500 of legal fees; (ii) issued 150,000 shares of common stock (the “Commitment Shares”) as commitment fee and; (iii) issued warrant to purchase up to 150,000 shares of common stock (the “May 2021 Warrant II”, and together with the May 2021 SPA II and the May 2021 Note II, the “May 2021Agreements II”). The 150,000 shares of common stock and 150,000 warrant issued were valued at $69,583 and $30,326, respectively, using the relative fair value method, all recorded as a debt discount to be amortized over the twelve-month term of the note. The May 2021 Note II matured on May 26, 2022 and a one-time interest charge of 10% was applied on the issue date and will be payable on the maturity date. Upon an event of default, the outstanding balance will immediately and automatically increase to 140% of the outstanding balance under the May 2021 Note II immediately prior to the occurrence of the event of default and becomes immediately due and payable. The Company made nine monthly cash payments (“Amortization Payments”), in the amount of $31,350 due on the first day of each month, beginning August 26, 2021.
Exercise price (in Dollars per share)														$ 2.5
Accrued interest													236,781							14,019
Ownership limitation percentage														4.99%
Debt conversion, description				The May 2021 Note II is convertible at a conversion price of $0.70 (“Conversion Price”).
Securities Purchase Agreement Four [Member]
Convertible Notes (Details) [Line Items]
Aggregate principal amount																		$ 330,000
Received net proceeds																		300,000
Net of OID																		$ 33,000
Commitment fee shares (in Shares)																		150,000
Warrants to purchase shares of common stock (in Shares)																		150,000
Shares of common stock (in Shares)																		150,000
Warrants issued (in Shares)																		150,000
Shares of common stock value																		$ 85,981
Fair value of warrants																		31,821
Commitment fair value																		$ 93,750
Maturity date																		February 1, 2022
Interest rate per annum																		8%
Increase interest rate																		140%
Warrants to purchase shares of common stock (in Shares)																						150,000
Debt discount																						$ 31,821
Exercise price (in Dollars per share)																						$ 2.5
Securities Purchase Agreement Three [Member]
Convertible Notes (Details) [Line Items]
Cash payments, description																		The investor may only convert the January 2021 Note II at any time or times on or after the occurrence of an Event of Default. The January 2021 Note II was convertible at the rate equal to 105% of the lowest trading price occurring during the twenty-five consecutive trading days immediately preceding the applicable conversion date (“Conversion Price”). The January 2021 Agreements II contain other provisions, covenants, and restrictions common with this type of debt transaction. The January 2021 SPA II also provides the investor with certain “piggyback” registration rights, permitting them to request that the Company include the issued shares for sale in certain registration statements filed by the Company under the Securities Act of 1934, as amended. During the transitional period ending October 31, 2021, the Company paid $213,570 of principal and $24,030 of accrued interest. During the nine months ended July 31, 2022, the Company paid the remaining $116,430 of principal and $2,370 of accrued interest. As of July 31, 2022, and October 31, 2021, the January 2021 Note II had outstanding principal and accrued interest of $0 and $116,430, respectively.
March 2021 Note I [Member]
Convertible Notes (Details) [Line Items]
Aggregate principal amount							$ 55,000	0												0
Received net proceeds							50,000						31,533
Net of OID							$ 5,000
Commitment fee shares (in Shares)							25,000
Cash payments, description							The 25,000 shares of common stock and 25,000 warrant issued were valued at $6,949 and $1,346, respectively, using the relative fair value method and the Commitment Share True-up had a fixed monetary value of $5,133, all recorded as a debt discount to be amortized over the twelve-month term of the note. The March 2021 Note I matured on March 1, 2022 and a one-time interest charge of 10% was applied on the issue date and will be payable on the maturity date. Upon an event of default, the outstanding balance was immediately and automatically increase to 140% of the outstanding balance under the March 2021 Note I immediately prior to the occurrence of the Event of Default and becomes immediately due and payable. The Company made nine monthly cash payments (“Amortization Payments”), in the amount of $6,455 due on the first day of each month, beginning July 1, 2021. The investor may only convert the March 2021 Note I at any time or times on or after the occurrence of an Event of Default. The March 2021 Note I was convertible at the rate equal to 105% of the lowest trading price occurring during the twenty-five consecutive trading days immediately preceding the applicable conversion date (“Conversion Price”). The March 2021 Agreements I contain other provisions, covenants, and restrictions common with this type of debt transaction. The March 2021 SPA I also provides the investor with certain “piggyback” registration rights, permitting them to request that the Company include the issued shares for sale in certain registration statements filed by the Company under the Securities Act of 1934, as amended. During the transitional period ending October 31, 2021, the Company paid $23,467 of the principal and $2,353 of accrued interest.
Warrants to purchase shares of common stock (in Shares)							25,000										25,000
Debt discount								$ 31,533									$ 1,346			$ 31,533
Exercise price (in Dollars per share)								$ 742									$ 2.5			$ 742
March 2021 Note III – Related Party [Member]
Convertible Notes (Details) [Line Items]
Aggregate principal amount						$ 110,000
Received net proceeds						100,000
Net of OID						$ 10,000
Commitment fee shares (in Shares)						50,000
Warrants to purchase shares of common stock (in Shares)						50,000
Cash payments, description						The 50,000 shares of common stock and 50,000 warrant issued were valued at $23,718 and $7,924, respectively, using the relative fair value method and the Commitment Share True-up had a fixed monetary value of $22,250, all recorded as a debt discount to be amortized over the twelve-month term of the note. The March 2021 Note III matured on March 30, 2022 and a one-time interest charge of 10% was applied on the issue date and will be payable on the maturity date. Upon an event of default, the outstanding balance will immediately and automatically increase to 140% of the outstanding balance under the March 2021 Note III immediately prior to the occurrence of the Event of Default and becomes immediately due and payable. The Company made nine monthly cash payments (“Amortization Payments”), in the amount of $12,911 due on the first day of each month, beginning July 1, 2021. The investor may only convert the March 2021 Note III at any time or times on or after the occurrence of an Event of Default. The March 2021 Note III was convertible at the rate equal to 105% of the lowest trading price occurring during the twenty-five consecutive trading days immediately preceding the applicable conversion date (“Conversion Price”).
March 2021 Note III [Member]
Convertible Notes (Details) [Line Items]
Principal payments													46,931						$ 63,069
Accrued interest													4,714						1,487
Outstanding principal													63,069						$ 0
March 2021 Warrant III [Member]
Convertible Notes (Details) [Line Items]
Warrants to purchase shares of common stock (in Shares)																	50,000
Debt discount																	$ 7,924
Exercise price (in Dollars per share)																	$ 2.5
March 2021 Note V [Member]
Convertible Notes (Details) [Line Items]
Warrants to purchase shares of common stock (in Shares)																	75,000
Debt discount																	$ 12,352
Exercise price (in Dollars per share)																	$ 2.5
Principal payments													68,191							$ 96,809
Accrued interest													12,477							4,025
Outstanding principal								$ 0					96,809							0
April Financing [Member]
Convertible Notes (Details) [Line Items]
Aggregate principal amount					$ 165,000
Received net proceeds					146,500
Net of OID					$ 15,000
Commitment fee shares (in Shares)					75,000
Warrants to purchase shares of common stock (in Shares)					75,000
Fair value of warrants																$ 9,669
Cash payments, description					75,000 shares of common stock and 75,000 warrant issued were valued at $31,913 and $9,669, respectively, using the relative fair value method and the Commitment Share True-up had a fixed monetary value of $27,375, recorded as a debt discount to be amortized over the twelve-month term of the note. The April 2021 Note I matured on March 30, 2022 and a one-time interest charge of 8% was applied on the issue date and will be payable on the maturity date. Upon an event of default, the outstanding balance will immediately and automatically increase to 140% of the outstanding balance under the April 2021 Note immediately prior to the occurrence of the Event of Default and becomes immediately due and payable. The Company made nine monthly cash payments (“Amortization Payments”), in the amount of $19,800 due on the first day of each month, beginning July 1, 2021. The investor may only convert the April 2021 Note at any time or times on or after the occurrence of an Event of Default. The April 2021 Note is convertible at the rate equal to 105% of the lowest trading price occurring during the twenty-five consecutive trading days immediately preceding the applicable conversion date (“Conversion Price”). The April 2021 Agreements contain other provisions, covenants, and restrictions common with this type of debt transaction. The April 2021 SPA also provides the investor with certain “piggyback” registration rights, permitting them to request that the Company include the issued shares for sale in certain registration statements filed by the Company under the Securities Act of 1934, as amended. During the transitional period ending October 31, 2021, the Company paid $69,316 of principal and $9,884 of accrued interest. During the nine months ended July 31, 2022, the Company paid the remaining $95,684 of principal and $3,316 of accrued interest. As of July 31, 2022 and October 31, 2021, the April 2021 Note had outstanding principal of $0 and $95,684, respectively.
Warrants to purchase shares of common stock (in Shares)																75,000
Exercise price (in Dollars per share)																$ 2.5
Legal fees					$ 3,500
Ownership limitation percentage																4.99%
Securities Purchase Agreement Ten [Member]
Convertible Notes (Details) [Line Items]
Aggregate principal amount															$ 132,000
Received net proceeds															111,700
Net of OID															$ 12,000
Commitment fee shares (in Shares)															165,000
Shares of common stock (in Shares)															60,000
Cash payments, description															The 60,000 shares of common stock and 60,000 warrant issued were valued at $26,824 and $9,767, respectively, using the relative fair value method and the Commitment Share True-up had a fixed monetary value of $26,700, recorded as a debt discount to be amortized over the twelve-month term of the note. The May 2021 Note I matured on May 10, 2022 and a one-time interest charge of 10% was applied on the issue date and will be payable on the maturity date; in an event of default, the interest rate shall increase to 16% per annum. Upon an event of default, the outstanding balance will immediately and automatically increase to 140% of the outstanding balance under the May 2021 Note I immediately prior to the occurrence of the event of default and becomes immediately due and payable. The Company made nine monthly cash payments (“Amortization Payments”), in the amount of $15,667 due on the first day of each month, beginning August 9, 2021. The investor may only convert the May 2021 Note I at any time or times on or after the occurrence of an event of default. The May 2021 Note I is convertible at the rate equal to 105% of the lowest trading price occurring during the twenty-five consecutive trading days immediately preceding the applicable conversion date (“Conversion Price”).
Warrants to purchase shares of common stock (in Shares)														60,000
Principal payments																				90,841
Accrued interest																				3,161
Outstanding principal								0					90,841							0
Legal fees															$ 8,300
Purchase shares of common stock (in Shares)															60,000
Securities Purchase Agreement Ten [Member] \| May 2021 Note II [Member]
Convertible Notes (Details) [Line Items]
Fair value of warrants														$ 30,326
Commitment fair value														$ 9,767
Warrants to purchase shares of common stock (in Shares)														150,000
Exercise price (in Dollars per share)														$ 1.5
Outstanding principal								0												0
May 2021 Note II [Member]
Convertible Notes (Details) [Line Items]
Principal payments													48,219
Accrued interest													14,481
September 2021 Note I [Member]
Convertible Notes (Details) [Line Items]
Aggregate principal amount			$ 110,000
Received net proceeds			100,000
Net of OID			$ 10,000
Commitment fee shares (in Shares)			50,000
Warrants to purchase shares of common stock (in Shares)			50,000
Cash payments, description			The 50,000 shares of common stock and 50,000 warrant issued were valued at $24,877 and $9,493, respectively, using the relative fair value method, recorded as a debt discount to be amortized over the nine-month term of the note. The September 2021 Note I matured on June 1, 2022 and a one-time OID charge of 10% was applied on the issue date and will be payable on the maturity date. Upon an event of default, the outstanding balance will immediately and automatically increase to 140% of the outstanding balance under the September 2021 Note I immediately prior to the occurrence of the event of default and becomes immediately due and payable. The Company made nine monthly cash payments (“Amortization Payments”), in the amount of $13,444 due on the first day of each month, beginning October 1, 2021. The investor may only convert the September 2021 Note I at any time or times on or after the occurrence of an event of default. The September 2021 Note I was convertible at the rate equal to 105% of the lowest trading price occurring during the twenty-five consecutive trading days immediately preceding the applicable conversion date (“Conversion Price”).
Warrants to purchase shares of common stock (in Shares)	50,000
Debt discount	$ 9,493
Exercise price (in Dollars per share)	$ 2.5
Accrued interest																				0
Outstanding principal													110,000
September 2021 Note I [Member]
Convertible Notes (Details) [Line Items]
Principal payments																				110,000
Accrued interest																				10,996
September 2021 Note II [Member]
Convertible Notes (Details) [Line Items]
Aggregate principal amount		$ 250,000
Received net proceeds		218,250
Net of OID		$ 25,000
Shares of common stock (in Shares)		114,000
Fair value of warrants	$ 21,004
Cash payments, description		The 114,000 shares of common stock and 114,000 warrant issued were valued at $59,468 and $21,004, respectively, using the relative fair value method, recorded as a debt discount to be amortized over the twelve-month term of the note. The September 2021 Note II matured on August 1, 2022 and 10% of OID was applied on the issue date and will be payable on the maturity date. Upon an event of default, the outstanding balance will immediately and automatically increase to 140% of the outstanding balance under the September 2021 Note II immediately prior to the occurrence of the event of default and becomes immediately due and payable. The Company shall make nine monthly cash payments (“Amortization Payments”), in the amount of $30,556 due on the first day of each month, beginning December 1, 2021. If the first day of any calendar month is not on a business day, then the Company shall make monthly payments on the next business day. The investor may only convert the September 2021 Note II at any time or times on or after the occurrence of an event of default. The September 2021 Note II is convertible at the rate equal to 105% of the lowest trading price occurring during the twenty-five consecutive trading days immediately preceding the applicable conversion date (“Conversion Price”).
Warrants to purchase shares of common stock (in Shares)	114,000
Exercise price (in Dollars per share)	$ 2.5
Principal payments																				219,875
Accrued interest																				24,573
Outstanding principal								30,125					$ 250,000							30,125
Legal fees		$ 6,750
Ownership limitation percentage	4.99%
Purchase shares of common stock (in Shares)		114,000
May 2022 Note I [Member]
Convertible Notes (Details) [Line Items]
Aggregate principal amount												$ 500,000
Received net proceeds												450,000
Net of OID												$ 40,000
Shares of common stock (in Shares)												769,231
Warrants issued (in Shares)												869,565
Shares of common stock value												$ 93,641
Fair value of warrants										$ 93,641
Cash payments, description												The May 2022 Note I bears an annual interest rate of 15% and matures on May 18, 2023. The May 2022 Note I is convertible at any time or times on or after the occurrence of an event of default, at a price equal to $0.39, provided, however, that if the Company consummates an Uplist Offering (as defined in this May 2022 Note I) within 180 calendar days after the issuance date, then the conversion price shall equal 75% of the Uplist Offering. If the date of a respective conversion under the May 2022 Note I, is prior to the date of the Uplist Offering, then the Conversion Price shall equal $0.39 per share. At any time prior to an event of default the Company shall have the option to pre-pay the outstanding principal at an amount equal to 115% of the outstanding balance plus accrued.
Warrants to purchase shares of common stock (in Shares)										869,565
Exercise price (in Dollars per share)										$ 0.575
Legal fees												$ 10,000
Ownership limitation percentage										4.99%
Exercise price percentage										120%
Principal amount outstanding								500,000												500,000
May 2022 Note II [Member]
Convertible Notes (Details) [Line Items]
Aggregate principal amount											$ 125,000
Received net proceeds											102,500
Net of OID											$ 12,500
Shares of common stock (in Shares)											217,391
Warrants issued (in Shares)											217,391
Shares of common stock value											$ 24,902
Fair value of warrants										$ 24,902
Cash payments, description											The May 2022 Warrant I issued to the investor, provides for the right to purchase up to 869,565 shares of common stock; (i) valued at $93,641 using the relative fair value method and recorded as a debt discount to be amortized over the twelve-month term of the May 2022 Note I; (ii) exercisable at $0.575, provided, however, upon the Uplist Offering, the exercise price shall equal 120% of the Uplist Offering; after180 calendar days from the issuance date the exercise price shall be $0.575; (iii) subject to adjustments and 4.99% ownership limitation and; (iv) expires on the third-year anniversary from the date of issuance. If the Company at any time while the May 2022 Note I and May 2022 Warrant I are outstanding, sell or grant any option to purchase, sell, grant any right to re-price, or otherwise dispose of or issue any common stock or common stock equivalents (other than an exempt issuance as defined in the May 2022 Note I and May 2022 Warrant I), at a share price per less than the initial conversion and/or exercise price then the conversion and/or exercise price shall be reduced equal to such price and the number of common stock and/or warrant shares issuable thereunder shall be increased. The May 2022 Note I and May 2022 Warrant I also provide the investor with certain “piggyback” registration rights, permitting them to request that the Company include the shares issued upon conversion of the note or exercise of the warrant, respectively, for sale in certain registration statements filed by the Company under the Securities Act of 1933, as amended. As of July 31, 2022, the May 2022 Note I had outstanding principal of $500,000. May 2022 Note II On May 24, 2022, the Company entered into a Securities Purchase Agreement (“May 2022 SPA II”) with an investor for the sale of the Company’s convertible note. Pursuant to the May 2022 SPA II, the Company; (i) issued a convertible note with principal amount of $125,000 (“May 2022 Note II”) with the Company receiving $102,500 in net proceeds, net of $12,500 of OID and $10,000 of legal fees; (ii) issued warrants to purchase up to 217,391 shares of common stock (“May 2022 Warrant II”). The 217,391 warrants issued were valued at $24,902 using the relative fair value method, recorded as a debt discount to be amortized over the twelve-month term of the note. The May 2022 Note II bears an annual interest rate of 15% and matures on May 24, 2023. The May 2022 Note II is convertible at any time or times on or after the occurrence of an event of default, at a price equal to the lower of; (i) 75% of the closing price of the common stock on the date of the investment, and (ii) 90% of the lowest VWAP for the common stock during the five trading day period ending on the latest complete trading day prior to the conversion date however if the Company consummates an Uplist Offering (as defined in the May 2022 Note II) within the 180 calendar days after the issuance date, then the conversion price shall equal 75% of the offering price per share of common stock at which the Uplist Offering is made. Unless otherwise adjusted pursuant to the terms of the May 2022 Note II, if the date of a conversion under the May 2022 Note II is prior to the date of the Uplist Offering, then the conversion price shall equal $0.345 per share. At any time prior to an event of default the Company shall have the option to pre-pay the May 2022 Note II at an amount equal to 115% of the outstanding balance plus accrued and unpaid interest on the outstanding balance. Upon the occurrence and during the continuation of any event of default, the May 2022 Note II shall become immediately due and payable at an amount equal to 150% of the outstanding principal plus accrued and unpaid interest and any default interest, if any.
Warrants to purchase shares of common stock (in Shares)										217,391
Exercise price (in Dollars per share)										$ 0.575
Legal fees											$ 10,000
Ownership limitation percentage										4.99%
Exercise price percentage										120%
Principal amount outstanding								125,000												125,000
May 2022 Note II [Member] \| Warrant [Member]
Convertible Notes (Details) [Line Items]
Exercise price (in Dollars per share)										$ 0.575
May 2022 Note III [Member
Convertible Notes (Details) [Line Items]
Aggregate principal amount											182,927
Received net proceeds											150,000
Net of OID											$ 18,293
Shares of common stock (in Shares)											318,134
Warrants issued (in Shares)											318,134
Shares of common stock value											$ 36,442
Fair value of warrants										$ 36,442
Cash payments, description											The May 2022 Note III bears an annual interest rate of 15% and matures on May 24, 2023. The May 2022 Note III is convertible at any time or times on or after the occurrence of an event of default, at a price equal to the lower of; (i) 75% of the closing price of the common stock on the date of the investment, and (ii) 90% of the lowest VWAP for the common stock during the five trading day period ending on the latest complete trading day prior to the conversion date however if the Company consummates an Uplist Offering (as defined in the May 2022 Note III) within the 180 calendar days after the issuance date, then the conversion price shall equal 75% of the offering price per share of common stock at which the Uplist Offering is made. Unless otherwise adjusted pursuant to the terms of the May 2022 Note III, if the date of a conversion under the May 2022 Note III is prior to the date of the Uplist Offering, then the conversion price shall equal $0.345 per share. At any time prior to an event of default the Company shall have the option to pre-pay the May 2022 Note III at an amount equal to 115% of the outstanding balance plus accrued and unpaid interest on the outstanding balance. Upon the occurrence and during the continuation of any event of default, the May 2022 Note III shall become immediately due and payable at an amount equal to 150% of the outstanding principal plus accrued and unpaid interest and any default interest, if any. Upon an event of default, at the option of the investor the conversion price shall equal 90% of the lowest VWAP for the common stock during the five-trading day period prior to the conversion date.
Warrants to purchase shares of common stock (in Shares)										318,134
Exercise price (in Dollars per share)										$ 0.575
Legal fees											$ 14,634
Ownership limitation percentage										4.99%
Exercise price percentage										120%
Principal amount outstanding								$ 182,927												$ 182,927
May 2022 Note III [Member \| Warrant [Member]
Convertible Notes (Details) [Line Items]
Exercise price (in Dollars per share)										$ 0.575
July 2022 Note [Member]
Convertible Notes (Details) [Line Items]
Aggregate principal amount									$ 154,250
Received net proceeds									138,000
Legal fees									$ 16,250
Securities Purchase Agreement Two [Member]
Convertible Notes (Details) [Line Items]
Cash payments, description																				The March Financings, April 2021 Financing and May 2021 Note I (collectively as “Notes”), as discussed above, included a Commitment Share True-Up provision whereby if during the period beginning on the six-month anniversary of the date of the closing date and ending on the later of (i) the maturity date, or (ii) the date on which the Notes, is fully satisfied and cancelled (the “True-Up Period”), the then lowest traded price of the Company’s common stock (“Common Stock”) for any Trading Day within the True-Up Period (“Subsequent Share Price”), as reported on the Company’s principal market, is less than the closing price of the Company’s common stock on the closing date of each Note, then the Company shall, within three (3) trading days of holder’s provision of written notice in (“True-Up Notice”), issue and deliver to the holder an additional number of duly and validly issued, fully paid and non-assessable shares of Common Stock equal to (X) the quotient of the Commitment Value (as defined below) divided by the Subsequent Share Price, multiplied by 1.5, less (Y) the Commitment Shares. The “Commitment Value” shall mean the product of the Commitment Shares multiplied by the closing price of the Company’s common stock on the Closing Date of each Note. Any additional shares of Common Stock issuable as defined in the Notes (“True-up Shares”), if required to be issued shall be issued provided however, that in no event shall the holder be entitled to receive shares of common stock in excess of the amount that would result in beneficial ownership by the holder and its affiliates of 4.99% of the outstanding shares of Common Stock at that time. For purposes of the provision to the immediately preceding sentence, beneficial ownership shall be determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Regulations 13D-G thereunder. The Company shall at all times reserve shares of its Common Stock for Holder in an amount equal to 300% multiplied by (X) the quotient of the Commitment Value divided by the lowest traded price of the Common Stock during the five Trading Days immediately preceding the respective date of calculation, multiplied by 1.5, less (Y) the Original Shares. At the inception of the respective Notes, the value of the true-up shares is based on a fixed monetary amount known at inception to be settled with a variable number of shares if triggered which reflects stock settled debt. During the nine months ended July 31, 2022, the Company fully repaid all Notes that included the Commitment Share True-Up Provision resulting in the reduction in the accrued True-up Shares of $209,688 which was netted with the interest expense in the accompanying unaudited consolidated statement of operations.

Convertible Notes (Details) - S

Convertible Notes (Details) - Schedule of convertible notes - USD ($)	Jul. 31, 2022	Oct. 31, 2021
Schedule Of Convertible Notes Abstract
Principal amount	$ 992,302	$ 1,028,179
Add: put premium on stock-settled debt	83,058
Less: debt discount	(361,444)	(477,541)
Convertible notes payable, net	713,916	550,638
Principal amount – related party		63,069
Less: debt discount – related party		(32,897)
Convertible note payable - related party, net		30,172
Total convertible notes payable, net	$ 713,916	$ 580,810

Convertible Notes (Details) -_2

Convertible Notes (Details) - Schedule of fair value of the derivative liabilities	9 Months Ended
	Jul. 31, 2022
Convertible Notes (Details) - Schedule of fair value of the derivative liabilities [Line Items]
Dividend rate
Probability of uplist offering	50%
Minimum [Member]
Convertible Notes (Details) - Schedule of fair value of the derivative liabilities [Line Items]
Term (in years)	2 years 6 months
Risk—free interest rate	0.14%
Maximum [Member]
Convertible Notes (Details) - Schedule of fair value of the derivative liabilities [Line Items]
Term (in years)	5 years
Risk—free interest rate	2.80%
Convertible Debt [Member]
Convertible Notes (Details) - Schedule of fair value of the derivative liabilities [Line Items]
Dividend rate
Convertible Debt [Member] \| Minimum [Member]
Convertible Notes (Details) - Schedule of fair value of the derivative liabilities [Line Items]
Term (in years)	1 month 2 days
Volatility	55%
Risk—free interest rate	0.04%
Default probability	10%
Convertible Debt [Member] \| Maximum [Member]
Convertible Notes (Details) - Schedule of fair value of the derivative liabilities [Line Items]
Term (in years)	6 months
Volatility	90%
Risk—free interest rate	2.90%
Default probability	12.50%

Notes Payable (Details)

Notes Payable (Details) - USD ($)		1 Months Ended	9 Months Ended	12 Months Ended
Notes Payable (Details) - USD ($)	Nov. 12, 2020	May 20, 2020	Jul. 31, 2022	Oct. 31, 2021	Jun. 17, 2020
SBA Loan Agreement [Member]
Notes Payable (Details) [Line Items]
Bears interest rate					3.75%
Accrued interest			$ 11,927	$ 7,721
Company received in advanced					$ 150,000
Instalment payments					$ 731
Outstanding principal balance			150,000	150,000
SBA Loan Agreement [Member] \| Economic Injury Disaster Loan [Member]
Notes Payable (Details) [Line Items]
Working capital		$ 149,900
Net of processing fee		$ 100
Bears interest rate		3.75%
Installment payments amount		$731
Outstanding principal balance amount			149,900	149,900
Accrued interest			12,360	8,152
November Note Payable [Member]
Notes Payable (Details) [Line Items]
Bears interest rate	5%
Accrued interest			600	338
Outstanding principal balance			$ 7,000	$ 7,000
Proceeds received from issuance of note	$ 7,000
Maturity date	Nov. 12, 2021

Notes Payable (Details) - Sched

Notes Payable (Details) - Schedule of notes payable - USD ($)	Jul. 31, 2022	Oct. 31, 2021
Schedule Of Notes Payable Abstract
Principal amount	$ 306,900	$ 306,900
Less: current portion	(17,198)	(15,361)
Notes payable – long-term portion	$ 289,702	$ 291,539

Notes Payable (Details) - Sch_2

Notes Payable (Details) - Schedule of minimum principal payments under notes payable	Jul. 31, 2022 USD ($)
Schedule Of Minimum Principal Payments Under Notes Payable Abstract
Year ended October 31, 2022 (remaining)	$ 15,620
Year ended October 31, 2023	6,369
Year ended October 31, 2024	6,608
Year ended October 31, 2025	6,859
Thereafter	271,444
Total principal payments	$ 306,900

Advance Payable (Details)

Advance Payable (Details) - USD ($)			1 Months Ended		9 Months Ended
Advance Payable (Details) - USD ($)	Apr. 06, 2022	Apr. 05, 2022	Apr. 16, 2022	Aug. 31, 2021	Jul. 31, 2022	Oct. 31, 2021	Jul. 09, 2021
Advance Payable (Details) [Line Items]
Outstanding balance					$ 67,945
Outstanding balance advance					135,017
July Advance Agreement [Member]
Advance Payable (Details) [Line Items]
Principal amount							$ 95,000
Repayment of notes payable							$ 107,350
Remitting percentage							17%
Outstanding balance paid						$ 27,055
August Advance Agreement [Member]
Advance Payable (Details) [Line Items]
Outstanding balance					34,000
Principal amount received				$ 34,000
Advance repaid				$ 38,420
Total customer payments percentage				17%
PayPal Advance Agreement I [Member]
Advance Payable (Details) [Line Items]
Principal amount received		$ 25,000
Advance repaid		$ 27,502
Total customer payments percentage		30%
Debt discount		$ 2,502
Outstanding balance					15,822
Outstanding balance advance					11,680
April Advance Agreement I [Member]
Advance Payable (Details) [Line Items]
Outstanding balance					25,990
Principal amount received	$ 23,000
Advance repaid	$ 25,990
Total customer payments percentage	17%
Debt discount	$ 2,990
April Advance Agreement II [Member]
Advance Payable (Details) [Line Items]
Principal amount received	120,000
Advance repaid	$ 135,600
Total customer payments percentage	17%
Debt discount	$ 15,600
April Advance Agreement III [Member]
Advance Payable (Details) [Line Items]
Principal amount received	42,000		$ 110,000
Advance repaid	$ 47,460		$ 124,300
Total customer payments percentage	30%		17%
Debt discount	$ 5,460		$ 14,300
Advance Agreement II and III [Member]
Advance Payable (Details) [Line Items]
Outstanding balance advance					48,043
April Advance Agreement IV [Member]
Advance Payable (Details) [Line Items]
Outstanding balance advance					96,867
Paid amount					$ 27,433

Unredeemed Gift Cards (Details)

Unredeemed Gift Cards (Details) - Schedule of unredeemed gift cards activities - USD ($)	9 Months Ended	12 Months Ended
	Jul. 31, 2022	Oct. 31, 2021
Schedule Of Unredeemed Gift Cards Activities Abstract
Beginning balance	$ 164,912	$ 48,311
Acquired gift card liability (see Note 3)		87,260
Sale of gift cards	121,603	186,749
Promotional and other gift cards issued	84,250
Revenue from breakage	(22,810)	(60,515)
Gift card redemptions	(113,323)	(96,893)
Ending balance	$ 234,632	$ 164,912

Lease Liabilities (Details)

Lease Liabilities (Details) - USD ($)					3 Months Ended	9 Months Ended
Lease Liabilities (Details) - USD ($)	Nov. 11, 2021	Jul. 13, 2021	Jul. 06, 2021	Jun. 01, 2021	Jul. 31, 2022	Jul. 31, 2022	Oct. 31, 2021
Lease Liabilities [Abstract]
Operating right-of-use asset			$ 76,136		$ 182,878	$ 182,878	$ 268,509
Operating right-of-use liability			79,054
Rent expense			$ 14,140			$ 182,043
Lease agreement, description	On November 11, 2021, the Company renewed its lease agreement (“Renewed Lease Agreement”) for their California kitchen facility, effective on January 1, 2022. The Renewed Lease Agreement provides for (i) a term of six months from the effective date which terminated on June 30, 2022; (ii) a monthly base rent of $9,960 and; (iii) a monthly storage fee of $2,340. The Renewed Lease Agreement can be terminated with two months’ notice. The Company has elected not to recognize right-of-use (“ROU”) assets and lease liabilities for short-term leases that have a term of 12 months or less (see Note 2).			On June 1, 2021, the Company entered into a lease agreement, effective July 13, 2021, for its facility in Pembroke Pine, Florida. The lease is for a period of 36 months commencing in July 2021 and expiring in July 2024. Pursuant to the lease agreement, the Company shall pay a monthly base rent of; (i) $8,062 in the first year; (ii) $8,465 in the second year and; (iii) $8,888 in the third year.
Operating lease liabilities discount rate					10%	10%
Financing agreement, description		On July 13, 2021, the Company entered into a financing agreement with a lessor for the purchase of equipment. Pursuant to the financing agreement, the Company shall make a monthly payment of $6,500 for a period of 36 months commencing in August 2021 through August 2024. The monthly payment shall consist of $6,000 cash and $500 in gift card allowance, reflected in the accompanying unaudited consolidated balance sheet under accrued expense and other liabilities. At the effective date of the financing agreement, the Company recorded a financing lease payable of $200,509.
Financing lease liability discount rate					10%	10%
Depreciation expense					$ 16,709	$ 50,127

Lease Liabilities (Details) - S

Lease Liabilities (Details) - Schedule of operating lease right-of-use assets - Operating Lease Liabilities [Member] - USD ($)	Jul. 31, 2022	Oct. 31, 2021
Lease Liabilities (Details) - Schedule of operating lease right-of-use assets [Line Items]
Operating ROU assets	$ 336,614	$ 336,614
Less accumulated reductions	(153,736)	(68,105)
Balance of Operating ROU assets, net	$ 182,878	$ 268,509

Lease Liabilities (Details) -_2

Lease Liabilities (Details) - Schedule of operating lease liabilities - Operating Lease Liabilities [Member] - USD ($)	Jul. 31, 2022	Oct. 31, 2021
Lease Liabilities (Details) - Schedule of operating lease liabilities [Line Items]
Operating lease liabilities	$ 339,532	$ 339,532
Reduction of operating lease liabilities	(151,738)	(71,178)
Total	187,794	268,354
Less: short term portion	(86,699)	(101,431)
Long term portion	$ 101,095	$ 166,923

Lease Liabilities (Details) -_3

Lease Liabilities (Details) - Schedule of future minimum operating lease payments - Operating Lease Liabilities [Member]	Jul. 31, 2022 USD ($)
Lease Liabilities (Details) - Schedule of future minimum operating lease payments [Line Items]
Ending October 31, 2022 (remaining)	$ 25,394
Ending October 31, 2023	102,846
Ending October 31, 2024	79,991
Total minimum non-cancellable operating lease payments	208,231
Less: discount to fair value	(20,437)
Total operating lease liabilities on July 31, 2022	$ 187,794

Lease Liabilities (Details) -_4

Lease Liabilities (Details) - Schedule of financing right-of-use - Financing Lease Liability [Member] - USD ($)	Jul. 31, 2022	Oct. 31, 2021
Lease Liabilities (Details) - Schedule of financing right-of-use [Line Items]
Financing ROU assets	$ 200,509	$ 200,509
Less accumulated depreciation	(69,621)	(19,494)
Balance of financing ROU assets, net	$ 130,888	$ 181,015

Lease Liabilities (Details) -_5

Lease Liabilities (Details) - Schedule of financing lease liability - USD ($)	Jul. 31, 2022	Oct. 31, 2021
Schedule Of Financing Lease Liability Abstract
Financing lease payables for equipment	$ 200,509	$ 200,509
Reduction of financing lease liability	(59,648)	(13,650)
Total	140,861	186,859
Less: short term portion	(66,926)	(62,210)
Long term portion	$ 73,935	$ 124,649

Lease Liabilities (Details) -_6

Lease Liabilities (Details) - Schedule of future minimum lease payments under the financing lease agreement	Jul. 31, 2022 USD ($)
Schedule Of Future Minimum Lease Payments Under The Financing Lease Agreement Abstract
Year ending October 31, 2022 (remaining)	$ 19,500
Year ending October 31, 2023	78,000
Year ending October 31, 2024	58,500
Total minimum non-cancellable financing lease payments	156,000
Less: discount to fair value	(15,139)
Total financing lease liabilities on July 31, 2022	$ 140,861

Related Party Balances and Tr_2

Related Party Balances and Transactions (Details) - USD ($)	9 Months Ended
Related Party Balances and Transactions (Details) - USD ($)	Jul. 31, 2022	Jul. 31, 2021
Related Party Transactions [Abstract]
Related party transaction, rate	50%
Shipping charges	10%
Related party costs	$ 288,731	$ 121,008

Stockholders_ Equity (Deficit_2

Stockholders’ Equity (Deficit) (Details) - USD ($)								1 Months Ended													3 Months Ended			6 Months Ended	9 Months Ended
Stockholders’ Equity (Deficit) (Details) - USD ($)	May 02, 2022	Nov. 08, 2021	Jul. 06, 2021	Apr. 07, 2021	Apr. 01, 2021	Feb. 02, 2021	Jan. 12, 2021	Jun. 30, 2022	May 24, 2022	May 18, 2022	Mar. 25, 2022	May 28, 2021	May 17, 2021	Apr. 29, 2021	Mar. 31, 2021	Mar. 30, 2021	Mar. 29, 2021	Mar. 25, 2021	Mar. 22, 2021	Dec. 31, 2020	Jan. 31, 2022	Jul. 31, 2021	Jan. 31, 2021	Apr. 30, 2022	Jul. 31, 2022	Sep. 30, 2021	Jul. 31, 2021	Oct. 31, 2021	Feb. 03, 2021
Stockholders’ Equity (Deficit) (Details) [Line Items]
Preferred stock, shares authorized (in Shares)																									20,000,000			20,000,000
Preferred stock, par value (in Dollars per share)																									$ 0.001			$ 0.001
Common stock, shares authorized (in Shares)																									1,000,000,000			1,000,000,000
Common stock, par value (in Dollars per share)																									$ 0.001			$ 0.001
Aggregate shares (in Shares)																								516,748
Grant date fair value		$ 726,000
Per share market price (in Dollars per share)		$ 1.21																							$ 1.01
Shares of common stock (in Shares)																									60,000
Professional and consulting fee																									$ 60,600
Fair value				$ 30,694								$ 67,645	$ 26,824		$ 36,499	$ 11,845	$ 24,504		$ 6,949					$ 554,273					$ 85,981
Issued share (in Shares)				75,000								150,000	60,000		75,000	25,000	50,000		25,000										150,000
Granted shares (in Shares)																									45,989
Grant date fair value per share (in Dollars per share)																									$ 0.65
Interest expense																									$ 83,058
Average price per share (in Dollars per share)																								$ 1.07
Maturity date											Mar. 25, 2027
Convertible notes payable descriptions									●On May 24, 2022, the Company issued a warrant to purchase up to 217,391 shares of common stock to a non-affiliate investor as additional commitment fee pursuant to a convertible (see Note 5). The warrant; (i) was valued at $24,902 using the relative fair value method and recorded as a debt discount to be amortized over the life of the note; (ii) has an exercise price of $0.575; (iii) subject to the adjustments and 4.99%, ownership limitation and; (iv) expires on the third-year anniversary from the date of issuance.
Debt discount									$ 36,442	$ 93,641						$ 3,957	$ 7,924								$ 426,495		$ 817,922
Exercise price (in Dollars per share)									$ 0.575	$ 0.575						$ 2.5	$ 2.5
Ownership limitation percentage										4.99%
Warrant purchase shares (in Shares)									318,134	869,565						25,000	50,000
Exercisable stock warrants (in Dollars per share)																									$ 0.22
Intrinsic value																									$ 2,876,945
Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Preferred stock, shares authorized (in Shares)																									20,000,000
Preferred stock, par value (in Dollars per share)																									$ 0.001
Common Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Aggregate shares (in Shares)		600,000			2,000,000																	1,206,605			1,932,204
Aggregate net cash proceeds																						$ 866,770			$ 1,368,492
Aggregate grant date fair value					$ 1,800,000
Aggregate of common stock price,per share (in Dollars per share)					$ 0.9
Deferred compensation																									726,000
Fair value																$ 23,718
Issued share (in Shares)																50,000
Deferred Compensation, Share-Based Payments [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Deferred compensation																									750,000
Deferred compensation																						$ 600,000					$ 600,000
Common Stock Issued for Services and Prepaid Services [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Grant date fair value																									$ 60,600
Stock Warrants [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Expected life of stock warrant																									2 years
Convertible Notes Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Debt discount																			$ 1,346
Warrant purchase shares (in Shares)																			25,000
Convertible Notes Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Grant date fair value																									$ 29,879
Interest expense																									29,879
Purchase shares (in Shares)						150,000
Convertible notes payable descriptions							●On January 12, 2021, the Company issued a warrant to purchase up to 55,000 shares of common stock to a non-affiliate investor as an additional commitment fee pursuant to a note amendment. The warrant; (i) was valued at $6,173 using the relative fair value method and recorded as a debt discount to be amortized over the life of the note; (ii) has an exercise price of $2.50; (iii) subject to the adjustments and 4.99%, ownership limitation and; (iv) expires on the fifth-year anniversary from the date of issuance.
Debt discount				$ 9,592		$ 31,821						$ 30,328	$ 9,767		$ 12,352
Exercise price (in Dollars per share)				$ 2.5		$ 2.5						$ 1.5	$ 2.5		$ 2.5				$ 2.5
Warrant purchase shares (in Shares)				75,000								150,000	60,000		75,000			78,250
Commitment Fee with Convertible Notes Payables [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Ownership limitation percentage				4.99%		4.99%			4.99%			4.99%	4.99%		4.99%	4.99%	4.99%	4.99%	4.99%
Commitment Fee with Convertible Notes Payables [Member] \| Common Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Ownership limitation percentage																	4.99%
Product Development Agreements [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Grant date fair value																					$ 100,000
Granted shares (in Shares)																					100,000
Amortized period																					2 years
Deferred compensation as product development expense																									370,677
Deferred compensation																									237,603
Consulting Agreement [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Deferred compensation																									0			$ 750,000
Lock-Up & Leak Out Agreements [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Deferred compensation																									$ 670,212
Deferred compensation																												$ 115,939
Grant date fair value	$ 27,500
Granted shares (in Shares)	25,000
Grant date fair value per share (in Dollars per share)	$ 1.1
Professional fees	$ 27,500
Stock-Based Compensation [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Aggregate shares (in Shares)											250,000
Grant date fair value											$ 374,560			$ 24,750
Granted shares (in Shares)														25,000
Grant date fair value per share (in Dollars per share)														$ 0.99
Issued price (in Dollars per share)											$ 0.001
Market price per share (in Dollars per share)											$ 1.5
Acquisition of Subsidiary [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Grant date fair value			$ 2,028,393
Granted shares (in Shares)			2,008,310
Membership agreement percentage			100%
Warrant Exchange Agreements [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Aggregate shares (in Shares)	3,048,917
Grant date fair value								$ 195,490
Granted shares (in Shares)								674,100
Grant date fair value per share (in Dollars per share)								$ 0.29
warrant shares (in Shares)	922,495							674,100
Exercise price (in Dollars per share)	$ 0.75																									$ 2.5
Deemed dividend	$ 2,578,446
Fair value	$ 2,578,446
Temporary Equity, Par or Stated Value Per Share (in Dollars per share)	$ 0.51
Agreement stock issued (in Shares)								674,100
Settlement expense								$ 195,490
Settlement Agreements [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Settlement agreements description								On June 30, 2022, pursuant to a stock repurchase and settlement agreement and a lock-up and settlement agreement, the Company issued an aggregate of 585,000 shares of its common stock with grant date fair value of 169,650, or $0.29 per share, based on the market price of common stock on grant date, for the stockholders’ execution of a Lock-Up & Leak Out Agreement. In connection with these agreements, the Company recorded settlement expense of $185,344. In connection with the stock repurchase and settlement agreement the Company agreed to repurchase 166,667 shares of its common stock from an investor for $150,000. In connection with this agreement the Company recorded a common stock repurchase obligation of $150,000 and reduced additional paid-in capital by $150,000. In July 2022, the Company paid $50,000 towards this common stock repurchase agreement. On July 31, 2022, the common stock repurchase obligation related to this agreement amounted to $100,000.
Professional Services [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Maturity date																					May 18, 2025		Dec. 08, 2025
Purchase shares (in Shares)																					100,000		10,640
Warrants exercise price (in Dollars per share)																					$ 1.5		$ 1.27
Aggregate grant date fair value (in Shares)																					36,777		11,471
Convertible Notes Payable [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Aggregate shares (in Shares)																				119,535
Fair value							$ 17,296													$ 38,264
Issued share (in Shares)							29,385
Debt discount																	$ 8,350	$ 4,744
Exercise price (in Dollars per share)																	$ 2.5	$ 2.5
Warrant purchase shares (in Shares)																	50,000

Stockholders_ Equity (Deficit_3

Stockholders’ Equity (Deficit) (Details) - Schedule of expected life of issued stock warrants	9 Months Ended
	Jul. 31, 2022
Stockholders’ Equity (Deficit) (Details) - Schedule of expected life of issued stock warrants [Line Items]
Dividend rate
Minimum [Member]
Stockholders’ Equity (Deficit) (Details) - Schedule of expected life of issued stock warrants [Line Items]
Term (in years)	2 years 6 months
Volatility	61%
Risk-free interest rate	0.14%
Maximum [Member]
Stockholders’ Equity (Deficit) (Details) - Schedule of expected life of issued stock warrants [Line Items]
Term (in years)	5 years
Volatility	69%
Risk-free interest rate	2.80%

Stockholders_ Equity (Deficit_4

Stockholders’ Equity (Deficit) (Details) - Schedule of outstanding stock warrants	9 Months Ended
	Jul. 31, 2022 $ / shares shares
Schedule Of Outstanding Stock Warrants Abstract
Number of Stock Warrants, Beginning Balance \| shares	15,745,066
Weighted Average Exercise Price, Beginning Balance \| $ / shares	$ 0.17
Weighted Average Remaining Contractual Life (Years), Beginning Balance	7 years 4 months 24 days
Number of Stock Warrants Warrants issued for services \| shares	100,000
Weighted Average Exercise Price Warrants issued for services \| $ / shares	$ 1.5
Weighted Average Remaining Contractual Life (Years) Warrants issued for services	4 years 1 month 6 days
Number of Stock Warrants Issued pursuant to employment agreements \| shares	500,000
Weighted Average Exercise Price Issued pursuant to employment agreements \| $ / shares	$ 0.001
Weighted Average Remaining Contractual Life (Years) Issued pursuant to employment agreements	4 years 10 months 24 days
Number of Stock Warrants, Warrants issued in connection with convertible debt \| shares	1,405,090
Weighted Average Exercise Price, Warrants issued in connection with convertible debt \| $ / shares	$ 0.575
Weighted Average Remaining Contractual Life (Years), Warrants issued in connection with convertible debt	3 years
Number of Stock Warrants, Warrants exercised \| shares	(1,596,595)
Weighted Average Exercise Price, Warrants exercised \| $ / shares	$ 1.35
Number of Stock Warrants, Ending Balance \| shares	16,153,561
Weighted Average Exercise Price, Ending Balance \| $ / shares	$ 0.09
Weighted Average Remaining Contractual Life (Years), Ending Balance	6 years 4 months 24 days
Number of Stock Warrants, Stock warrants exercisable \| shares	16,153,561
Weighted Average Exercise Price, Stock warrants exercisable \| $ / shares	$ 0.09
Weighted Average Remaining Contractual Life (Years), Stock warrants exercisable	6 years 4 months 24 days

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)

1 Months Ended

3 Months Ended

9 Months Ended

10 Months Ended

Jan. 01, 2023

Jan. 02, 2022

Oct. 02, 2021

Sep. 10, 2021

Jun. 24, 2021

Apr. 01, 2021

Apr. 20, 2020

Jun. 30, 2022

Mar. 25, 2022

Jan. 19, 2022

Sep. 15, 2021

Jul. 22, 2021

Jun. 22, 2021

Sep. 22, 2020

Jul. 31, 2022

Oct. 31, 2021

May 28, 2021

May 17, 2021

Apr. 07, 2021

Mar. 31, 2021

Mar. 30, 2021

Mar. 29, 2021

Mar. 22, 2021

Feb. 03, 2021

Feb. 22, 2018

Commitments and Contingencies (Details) [Line Items]

Expires date

Mar. 27, 2027

Aggregate purchase price

$ 150,000

Repurchase amount

$ 150,000

Description of repurchase agreement

The Company shall pay to the Shareholder the Purchase Price in immediately available funds,
as follows: (1) $50,000 which was be paid upon the complete execution of this Stock Repurchase Agreement, and the related Settlement
Agreement and Release, and the Lock-up and Leak-out Agreement; (2) $50,000 to be paid 30 days after the complete execution of the Stock
Repurchase Agreement, the Settlement Agreement and Release, and the Lock-up and Leak-out Agreement; and (3) the final $50,000 to be paid
60 days after the complete execution of the Stock Repurchase Agreement, the Settlement Agreement and Release, and the Lock-up and Leak-out
Agreement.. As of July 31, 2022, the Company had $100,000 of common stock repurchase obligation outstanding.

Common stock repurchase

$ 100,000

Warrants issued (in Shares)

150,000

60,000

75,000

25,000

50,000

25,000

150,000

Royalty payment

86,442

Accrued royalty fee

6,000

Minimal royalty payment

109,210

GMR expense

$ 436,770

$ 218,380

Accrued royalty fee

$ 109,199

109,199

Accounts payable

61,794

Accrued expense and other liabilities

44,405

Total accrued royalty fee

109,199

$ 71,896

Minimum compensation

24,000

Paid installment

2,000

Accrued royalty fee

198

Professional and consulting expense

30,000

90,000

Royalty fee percentage

10%

Common Stock [Member]

Commitments and Contingencies (Details) [Line Items]

Warrants issued (in Shares)

50,000

1 Year [Member]

Commitments and Contingencies (Details) [Line Items]

Royalty payment

$ 109,210

2 Year [Member]

Commitments and Contingencies (Details) [Line Items]

Royalty payment

218,380

3 Year [Member]

Commitments and Contingencies (Details) [Line Items]

Royalty payment

$ 436,770

May Employment Agreement [Member]

Commitments and Contingencies (Details) [Line Items]

Annual salary

$ 120,000

Shares of common stock (in Shares)

250,000

Grand date fair value

$ 187,280

Exercisable per share (in Dollars per share)

$ 0.001

Financial term

2 years

Employment Agreement [Member]

Commitments and Contingencies (Details) [Line Items]

Annual salary

$ 120,000

Shares of common stock (in Shares)

2,000,000

Grand date fair value

$ 2,714,971

Exercisable per share (in Dollars per share)

$ 0.001

Expired term

Oct. 01, 2026

Lease Obligation Settlement [Member]

Commitments and Contingencies (Details) [Line Items]

Rental obligation

$ 109,235

Payment of obligation

$ 50,000

Remaining due lease obligation, amount

21,400

22,900

Put Option Agreement and Stock Repurchase Agreement [Member]

Commitments and Contingencies (Details) [Line Items]

Put option agreement, description

On
April 20, 2020, the Company and a stockholder entered into a Put Option Agreement (see Note 3), pursuant to which, among other things,
the Company agreed, at the election of the stockholder, to purchase certain shares of common stock from such stockholder no sooner than
two years from the date of the Put Option Agreement also referred to herein as Market Period. Pursuant to the Put Option Agreement, in
the event that the stockholder does not generate $1.3 million dollars also referred to herein as Total Investment in gross proceeds from
the sale of its shares of common stock by the second anniversary of the Put Option Agreement, then the stockholder has the right to cause
the Company to purchase shares held by the stockholder at a price equal to the difference between the Total Investment and the net proceeds
actually realized by the stockholder from shares of common stock sold during the Market Period and the number of shares of common stock
held by the stockholder on the date the put right is exercised. The put right expired fourteen (14) days from end of the Market Period.
In connection with the Put Option Agreement, the Company recorded an initial common stock repurchase obligation in the amount of $1.3
million, reflected in the accompanying consolidated balance sheets as common stock repurchase obligation, and reduction of additional
paid in capital upon entering the Put Option Agreement. The repurchase obligation is re-assessed by the Company each reporting period
and adjusted for the proceeds received by the stockholder from sale of common stock. During the ten months ended October 31, 2021, the
Company recorded a reduction of $681,725. During the nine months ended July 31, 2022, the Company recorded a reduction of $113,072. As
of July 31, 2022, the Company has recorded an aggregate reduction of $794,797 for net proceeds realized by the stockholder on sale of
Company common stock which was reclassified to additional paid in capital. As of July 31, 2022 and October 31, 2021, the Company had
$505,203 and $618,275 million of common stock repurchase obligation outstanding, respectively.

Corlich Enterprises, Inc [Member]

Commitments and Contingencies (Details) [Line Items]

Warrants issued (in Shares)

300,000

Accrued royalty fee

49,139

78,260

Hungry Fan Royalty [Member]

Commitments and Contingencies (Details) [Line Items]

Accrued royalty fee

$ 4,000

1,000

Net revenue percentage

10%

Paid installment

14,000

Hungry Fan Commission [Member]

Commitments and Contingencies (Details) [Line Items]

Net revenue percentage

10%

Velvet Desserts Royalty [Member]

Commitments and Contingencies (Details) [Line Items]

Net revenue percentage

10%

Velvet Desserts Commission [Member]

Commitments and Contingencies (Details) [Line Items]

Net revenue percentage

10%

Royalty fees

198

Accrued royalty fee

$ 198

Roblé Royalty [Member]

Commitments and Contingencies (Details) [Line Items]

Net revenue percentage

10%

Roblé Commission [Member]

Commitments and Contingencies (Details) [Line Items]

Net revenue percentage

10%

Chef Roblé & Co [Member]

Commitments and Contingencies (Details) [Line Items]

Revenue share agreement, description

In
addition, subject to the terms and conditions of this Development Agreement, the Company shall pay to Roblé a guaranteed minimum
compensation of $36,000 for twelve months (the “GMC”) as follows: (i) $9,000 upon the Company’s receipt and approval
of all recipes submitted by Roblé; (ii) $9,000 upon the commencement of selling of the Roblé Meals (“Selling Date”);
(iii) $3,000 per month for a period of six months, commencing the month immediately following the Selling Date. The total aggregate compensation
paid to Roblé shall be reduced by the GMC. During the transitional period ending October 31, 2021, the first condition has been
satisfied by both parties and the Company paid $9,000 the GMC. As of July 31, 2022 and October 31, 2021, there were no accrued GMC as
the Selling Date has not yet occurred.

Claudia Cocina LLC [Member]

Commitments and Contingencies (Details) [Line Items]

Minimum compensation

$ 121,875

Common stock share issued (in Shares)

150,000

Common share fair value

$ 150,000

Amortized deferred compensation

$ 0

121,875

Development Agreement, description

Cocina shall receive 10% royalties on all Net Revenues (“Royalty”) generated from the sale of: (i) CS Meals; and (ii) Home
Bistro and Prime Chop brand orders in which a CS dedicated code was used at the time of purchase, in accordance with the Royalty Schedule
set forth in the Development Agreement. For the purpose of this Development Agreement “Net Revenue” shall be defined as gross
sales of products less actual returns and refunds, which returns and refunds shall not exceed eight percent (8%) of such gross sales.
In addition, the GMR for the Term shall be at least $36,000 per year in the aggregate, payable monthly at the rate of $3,000 per month
or 10% of gross sales, whichever is higher for the month. The Company agrees that Royalty payments may only be credited to the year to
which such payments apply (i.e., Royalty payments paid to Claudia Cocina during the first twelve months of the Agreement can only offset
the GMR of the first twelve months, and not the subsequent 12-month period GMR). Payments made during any year during the Term, which
are in excess of the GMR payments for the applicable year may not be credited towards another year. All GMR payments hereunder are non-refundable
and are due upon the first CS Meals being launched which occurred in November 2021. During the nine months ended July 31, 2022, the Company
recorded $21,000 of royalty expense related to the GMR. As July 31, 2022 and October 31, 2021, there were no accrued royalty fee.

Chef Richard Blais [Member]

Commitments and Contingencies (Details) [Line Items]

Royalty payment

$ 56,250

Accrued royalty fee

1,815

Total accrued royalty fee

8,065

Common stock share issued (in Shares)

150,000

Amortized deferred compensation

$ 172,500

147,344

$ 147,344

Development Agreement, description

For
the use of Chef Richard Blais and all associated intellectual property for the benefit of the Blais Meals, the Company shall pay to Blais
the following: (i) 10% of all net revenue generated from the sale of Blais Meals (the “Blais Royalty”). For the purpose of
this agreement “Net Revenue” shall be defined as gross sales generated on Blais Meals less discounts and returns. The Blais
Royalty generated during each calendar month in which an agreement is in effect shall be due and payable by the 10th business
day of the following month in which the Blais Royalty was earned; (ii) 10% of all Net Revenue generated from the sale of Home Bistro
and Prime Chop brand orders in which a Blais Dedicated Code was used at the time of purchase (“Blais Commission”). The Blais
Commission generated during each calendar month in which an agreement is in effect shall be due and payable by the 10th business
day of the following month in which the Blais Commission was earned and; (iii) Guaranteed Minimum Royalty. Subject to the terms and conditions
of the Development Agreement, the Company shall pay to Chef Richard Blais a guaranteed minimum compensation of $75,000 for each twelve-month
period the Development Agreement is in effect (“GMC”) payable monthly at the rate of $6,250 per month, beginning on the earlier
of the launch of Blais Meals or ninety days after the execution of this Development Agreement.

Agreement term

1 year

Fair value of market price

$ 172,500

Deferred compensation

$ 0

147,344

Total GMR payable

51,815

Total payable

43,750

Perfect Athlete LLC [Member]

Commitments and Contingencies (Details) [Line Items]

Common stock share issued (in Shares)

150,000

Amortized deferred compensation

$ 255,000

$ 74,375

74,375

Agreement term

1 year

Fair value of market price

$ 255,000

Deferred compensation

$ 164,687

$ 239,063

Perfect Athlete LLC [Member] | PA Royalty [Member]

Commitments and Contingencies (Details) [Line Items]

Net revenue percentage

10%

Perfect Athlete LLC [Member] | PA Commission [Member]

Commitments and Contingencies (Details) [Line Items]

Net revenue percentage

10%

Spicy Mango Foodies LLC [Member]

Commitments and Contingencies (Details) [Line Items]

Common stock share issued (in Shares)

100,000

Amortized deferred compensation

$ 100,000

Fair value of market price

$ 100,000

Spicy Mango Foodies LLC [Member] | Minimum [Member]

Commitments and Contingencies (Details) [Line Items]

Deferred compensation

$ 27,083

Spicy Mango Foodies LLC [Member] | Maximum [Member]

Commitments and Contingencies (Details) [Line Items]

Deferred compensation

$ 72,917

Spicy Mango Foodies LLC [Member] | SMF Royalty [Member]

Commitments and Contingencies (Details) [Line Items]

Net revenue percentage

10%

Spicy Mango Foodies LLC [Member] | SMF Commission [Member]

Commitments and Contingencies (Details) [Line Items]

Net revenue percentage

10%

Consulting Agreements [Member]

Commitments and Contingencies (Details) [Line Items]

Development Agreement, description

On
October 1, 2021, the Company and a consultant (collectively as “Parties”) entered into a consulting agreement which shall
remain in effect until April 1, 2022, unless sooner terminated as provided in the agreement, or unless extended by agreement of the Parties.
Pursuant to the agreement, the Company issued warrants to purchase 500,000 of common stock (“Warrant”) with a grant date
fair value of $678,253 for services rendered and was recorded as professional and consulting expenses in the accompanying consolidated
statement of operations in 2021. The Warrant vested upon issuance, has an exercise price of $0.001 and expiration date of October 1,
2026. In addition, the consultant shall receive $3,000 per month, payable in cash on the first of each month commencing on the effective
date.

On
September 10, 2021, the Company and Bench International, LLC (“Bench International”) (collectively as “Parties”)
entered into an agreement to marketing consulting services (“Agreement”). The Agreement shall remain in effect for twelve
months from the effective date of September 10, 2021. Pursuant to the Agreement, Bench International shall be paid, in cash, and aggregate
amount of $350,000 to be paid in seven monthly instalments of $50,000 beginning September 2021 until March 2022. In 2021, the Company
paid an aggregate amount of $100,000. During the nine months ended July 31, 2022, the Company paid an aggregate amount of $205,000. During
the nine months ended July 31, 2022, the Company recognized $246,667 of expense related to this Agreement and recorded as selling and
marketing expenses in the accompanying unaudited consolidated statement of operations. As of July 31, 2022 and October 31, 2021, the
prepaid expense related to this Agreement were $0 and $41,667, respectively.

On
April 1, 2021, the Company and Redstone Communications, LLC (“Redstone”) (collectively as “Parties”) entered
into an agreement to provide strategic consulting services (“Agreement”). The Agreement shall remain in effect for twelve
months from the effective date of April 1, 2021 until March 31, 2022. Pursuant to the Agreement, Redstone shall be paid, in cash, a monthly
fee of $10,000 over the twelve months service period and received 2,000,000 shares of common stock with grant date fair value of $1,800,000
as compensation, which was recorded as deferred compensation in the accompanying consolidated balance sheet and amortized over the twelve
months service period. In 2021, the Company amortized $1,050,000 of the deferred compensation. During the nine months ended July 31,
2022, the Company amortized $750,000 of the deferred compensation and was recorded as professional and consulting expense in the accompanying
unaudited consolidated statement of operations. As of July 31, 2022 and October 31, 2021, the deferred compensation related to this Agreement
was $0 and $750,000, respectively.

Capital Partners LLC [Member]

Commitments and Contingencies (Details) [Line Items]

Development Agreement, description

the Company and Michael Novielli through Dutchess Capital Partners, LLC (“Dutchess Capital”) (collectively
as “Parties”) entered into a consulting agreement which shall remain in effect until April 1, 2022 unless sooner terminated
as provided in the agreement, or unless extended by agreement of the Parties. Michael Novielli currently serves as a member of the Board
of Directors and is considered a related party. Pursuant to the agreement, Dutchess Capital received warrants to purchase 1,000,000 of
common stock (“Warrant”) with a grant date fair value of $1,356,507, for services rendered and was recorded as professional
and consulting expenses – related party in the accompanying consolidated statement of operations. The Warrant vested upon issuance,
had exercise price of $0.001 and expiration date of October 1, 2026. In addition, Dutchess Capital shall receive $10,000 per month, payable
in cash on the first of each month commencing on the effective date.

Lock-Up and Leak Out Agreements [Member]

Commitments and Contingencies (Details) [Line Items]

Common stock share issued (in Shares)

112,500

Amortized deferred compensation

$ 670,212

Fair value of market price

$ 152,626

Deferred compensation

$ 0

$ 115,938

Lock-Up and Leak Out Agreements [Member] | Common Stock [Member]

Commitments and Contingencies (Details) [Line Items]

Common stock share issued (in Shares)

516,748

Fair value of market price

$ 554,273